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ABSTRACT
Towards completely automated glycan synthesis
Matteo Panza
Doctor of Philosophy, University of Missouri – St. Louis
Prof. Alexei V. Demchenko, Advisor
Carbohydrates are ubiquitous both in nature as biologically active compounds and
in medicine as pharmaceuticals. Although there has been continued interest in the synthesis
of carbohydrates, chemical methods require specialized knowledge and hence remain
cumbersome. The need for development of rapid, efficient and operationally simple
procedures has come to the fore. This dissertation focuses on the development of a fully
automated platform that will enable both experts and non-specialists to perform the
synthesis of glycans. Existing automated methods for the synthesis of oligosaccharides are
highly sophisticated, operationally complex, and require significant user know-how. By
contrast, high performance liquid chromatography (HPLC) equipment-based automation
introduced by our lab represents a highly accessible method of synthesis. This approach
offers operational simplicity by delivering all reagents using standard liquid handling
components and convenient real-time reaction monitoring of every step using detectors and
standard computer software and interface. Many operations still require the operator
intervention, and the entire technology remains semi-manual.
Building upon promising preliminary results, this dissertation aimed to generate a
universal platform for the fully automated synthesis of glycans. To achieve the complete
automation of the solid phase synthesis that has the potential to revolutionize glycan
synthesis, this dissertation focuses on the following aspects: 1) the development of new
concepts for chemical glycosylation applicable to stereoselective formation of challenging
1,2-cis glycosidic bonds; 2) implementation of autosamplers and switch valves as new
components to achieve operator-less automation; and 3) the development of new
chemically stable resins for solid phase synthesis. With these key developments, we have
acquired a reliable and simple platform for fully-automated oligosaccharide synthesis. The
proof of concept was assessed by the synthesis of a number of target glycans. Synthesis of
ii

carbohydrates and other classes of biomolecules using this user-friendly and fullyautomated platform will accelerate discovery in many scientific disciplines, most
prominently chemistry, automation, and therapeutic-agents development.
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CHAPTER 1

Automated chemical oligosaccharide
synthesis: a novel approach to
traditional challenges

Panza, M.; Pistorio, S. G.; Stine, K. J., Demchenko, A. V., Automated chemical
oligosaccharide synthesis: a novel approach to traditional challenges. Chem. Rev., 2018,
118, 8105-8150
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1.1. Introduction: carbohydrates, oligosaccharides, biological roles and medical
implications
Carbohydrates, the “essential molecules of life,”1 play key roles in various
biological processes. Carbohydrates are involved from the very beginning of life:
fertilization occurs through carbohydrate-protein interaction.2 Carbohydrates
contribute to human health by facilitating joint lubrication, cell growth, and the
inflammatory and immune responses.3 The exponential increase in interest in
sugars and the notable growth of all areas of glycosciences also reveals the
involvement of carbohydrates in processes detrimental for human health. Viral
infections, bacterial- and parasite-related diseases, metastasis, and rejection of
transplanted tissues are only a few of these processes that can be mentioned.4 The
pathogenesis of diabetes, septicemia, cancer, pneumonia, malaria, AIDS, and
hepatitis are all carbohydrate-mediated processes. Understanding the roles of
carbohydrates in these processes has stimulated many biomedical discoveries
involving

glycosciences.5-7

Investigation

of

carbohydrate

composition,8

conformation,9 interaction with other molecules and with themselves 10,11 are some
other areas of inquiry in the field. Isolation of carbohydrates from natural sources
represents a viable approach to providing samples for the biological testing of
these molecules. However, it is chemical synthesis that allows access to both
natural carbohydrates and their mimetics, which are often of interest due to their
therapeutic4,12 or diagnostic13-15 potential. Challenges related to the synthesis and
purification of carbohydrates and the lack of universal methods applicable to all
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systems is the key bottleneck of glycosciences. As a result, examples of large-scale
development of carbohydrate-based pharmaceuticals including heparin and its
analogs,16,17

antibiotics,18,19

glycoconjugate-based

vaccines,20-24

and

other

applications6,7,25 are still rare.
Oligosaccharide sequences are found in numerous natural compounds and
constitute the core of many therapeutics. The presence of glycans in glycoproteins,
glycolipids, glycosaminoglycans and in other conjugates presents a treasure of
potential information on cellular differentiation and condition. Over half of all
proteins in the human body are N- or O-glycosylated3 and cell surfaces present a
rich multitude of glycolipids and glycosaminoglycans, in addition to the presence
of a variety of free oligosaccharides.26 Glycans carrying information of biological
significance are found in every body fluid, on cell surfaces, and within cells.
Glycan biomarker discovery is accelerating aided by advances in
separation,

mass

spectrometric

analysis,27-29

and

in

glycan-lectin

array

technologies.30 Efforts to map the entire glycome of a cell have recently been
reported.31 Glycans have been identified as markers for many different forms of
cancer including breast, colon, lung, etc.32-34 Increases or decreases in the levels of
certain glycans and changes in branching patterns can indicate the presence and
progression of disease.35 For example, one study showed that prostate cancer can
be distinguished from benign prostatic hypertrophy via distinction of a specific
glycoform by lectin binding.36 In cerebrospinal fluid, the presence of a unique Nlinked glycan on transferrin has been used to distinguish Alzheimer’s disease from

Matteo Panza | UMSL 2019 | Page 4

a condition arising from abnormal metabolism.37 Profiling of N-glycans on IgG
has been found useful for following the metabolic disorder of galactosaemia. 38
Many families of glycoconjugates represent important therapeutic targets.
High mannose, hybrid, and complex N-glycan families (Figure 1.1A) that are
involved in many fundamental processes,39-41 as well as in mediation of the
pathogenesis of cancers,42 AIDS,43 Alzheimer’s disease,37 etc.38 have stimulated
many synthetic developments.41,44-51 Another representative example is the
globoside family of glycosphingolipids (Figure 1.1B, Neu –N-acetylneuraminic
acid, Fuc - fucose) whose members present a broad range of significant biological
roles as glycan biomarkers. For example, Gb3 is overexpressed in colorectal
adenoma cells,52 in Burkitt’s lymphoma cells,53 and in breast and ovarian cancer.54
Gb3 is found on the glycolipid that accumulates in the lysosomes of individuals
suffering from Fabry disease.55 Iso-Gb3 is found on natural killer T cells.56 Gb4
has been found to be enhanced and attached to longer fatty acid chains in vascular
endothelial cells undergoing an inflammatory response. 57 Stage-specific embryonic
antigens SSEA-3 and SSEA-4 are glycosphingolipids found on the surface of
human embryonic stem cells but not on differentiated cells. 58 SSEA-4 was found
expressed in a variant of non-small cell lung cancer cells,59 and on embryonal
carcinoma cells in the ovaries.60 Globo-H is a target antigen for the development of
vaccines against prostate and breast cancer,61 for which clinical trials are
underway. Globo-H and SSEA-3 have been found expressed on breast cancer stem
cells.62 Many synthetic developments have been applied to the synthesis of
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globosides, and Globo-H in particular.63-68 More examples of the value of glycans
and glycoconjugates as biomarkers are steadily emerging.

Figure 1.1. Representative structures of common linear and branched
oligosaccharide motifs
Oligosaccharides or glycans can be obtained by isolation from natural
sources or prepared enzymatically and/or chemically. All three major approaches
are viable, but none yet can significantly outperform the others. This chapter is
dedicated to chemical synthesis, which, in spite of recent progress, remains
challenging. As a result, synthesis of even moderately complex glycans and their
conjugates still require significant resources. This limits accessibility of these
essential targets to only a small circle of glycoscientists and inhibits their industrial
production and application. Recent development of dependable techniques for
oligosaccharide synthesis using traditional manual synthesis are introduced in
Section 1.2 of this chapter. An overview of very attractive and potentially
transformative automated technologies that are expected to facilitate access to
oligosaccharides is presented in Section 1.3.
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A majority of complex sugars are oligomers in which monomeric units
(monosaccharides) are connected via glycosidic bonds. The latter are obtained by
glycosylation, a reaction discussed in section 1.2.1. Certain mechanistic
conventions discussed in section 1.2.1. have been established and many factors
that affect the outcome of glycosylations discussed in sections 1.2.1. are known.
Nevertheless, chemical glycosylation remains challenging. Oligosaccharide
synthesis brings about further challenges. Both traditional and expeditious
strategies are known. Various one-pot strategies that offer a streamlined access to
oligosaccharides have been developed. Supported and tagged synthesis has also been
investigated. In particular, solid-phase synthesis, widely used in the preparation of
oligopeptides and oligonucleotides, has also been applied to the preparation of
oligosaccharides. This approach can streamline synthesis by eliminating the need
to purify reaction intermediates and by simplifying the removal of excess reagents.
Similar advantages are seen in the tagged synthesis wherein soluble polymer
supports, ionic liquids and fluorous-based protecting groups have successfully
been used to expedite oligosaccharide assembly.
Dedicated attempts to automate oligosaccharide synthesis resulted in the
development of a number of platforms and technologies for their automated
chemical synthesis. These developments are reviewed in section 3. Early attempts
by Takahashi and Wong to develop the automated chemical syntheses in solution
set the benchmark in the fiel. Those early attempts have also shown difficulties
associated with the automation. To expedite polymer supported oligosaccharide
synthesis, Seeberger introduced an automated approach. The automation was
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initially based on a modified peptide synthesize. In 2012, Seeberger et al. reported
the “first fully automated solid-phase oligosaccharide synthesizer”. Around the
same time Pohl, Demchenko-Stine, and Nokami have developed alternative
automation platforms discussed in sections 1.3.3, 1.3.5, and 1.3.6. Operation of all
automated synthesizers is controlled by a computer. The greatest advantage of
employing the computer interface along with liquid handling hardware and
software is to allow recording successful automated sequences that can be then
repeated over and over with an expected high degree of reproducibility.

1.2.

Traditional manual synthesis of oligosaccharides
Glycosidic linkages are obtained by glycosylation, a reaction of the

nucleophilic displacement of an anomeric leaving group (LG) on the glycosyl
donor by a hydroxyl group of the glycosyl acceptor.69 The remaining functional
groups of both reaction counterparts (hydroxyl groups, amines, and carboxylic acid
groups) are masked with respective temporary protective groups. A detailed
mechanism of chemical glycosylation is unknown, but certain aspects, factors, and
pathways have been established.70-93 With a notable progress in the field of
chemical glycosylation,83,86-88,94 this reaction remains challenging. Beyond that,
traditional stepwise oligosaccharide synthesis requires careful strategic planning to
achieve

protecting

and/or

leaving

group

introduction/removal

between

glycosylation steps. In addition, purification and reagent separation become
difficult with large oligosaccharide sequences. Many selective, chemoselective,
and regioselective strategies have been developed to streamline oligosaccharide

Matteo Panza | UMSL 2019 | Page 8

synthesis by reducing the number of additional steps.95 Other advanced techniques,
such

as

solid-phase

synthesis,96,97

have

been

developed

to

streamline

oligosaccharide synthesis. These approaches reduce the need to purify reaction
intermediates and simplify the excess reagents removal.

1.2.1. Chemical glycosylation
The glycosylation reaction is the central reaction in glycochemistry.
(Scheme 1.1) The glycosylation involves a promoter or activator-assisted reaction
between a glycosyl donor and glycosyl acceptor. Along with the formation of a
glycosidic bond, a new chirality center is produced. Therefore, particular care
should be taken of stereocontrol. Discussed below are basic principles of chemical
glycosylation and factors that have an effect on the reaction outcome. In addition
to the glycosylation reaction, there are many competing processes that may
simultaneously occur. Side reactions that often complicate stereocontrol of
glycosylation and may have a profound effect on yields include, but are not limited
to, migration, elimination, cyclization substitution, and redox reactions.69,98

Reaction mechanism
The promoter-assisted departure of the leaving group leads to the formation
of a glycosyl cation that is stabilized via an oxacarbenium ion intermediate
(Scheme 1.1). The acceptor attack on the flattened oxacarbenium intermediate can
take place either from the top or the bottom face of the sugar ring. As a result,
uncontrolled glycosylations may lead to the formation of mixtures of 1,2-trans and
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1,2-cis glycosides. Typical glycosylation conditions favor a unimolecular SN1
mechanism, or may proceed at the SN1-SN2 interface,99 and the reaction involves
four major steps.100
Step 1. Formation of the activated donor as a result of the interaction of the
LG and the promoter (Scheme 1.1 A-B). This step can be either reversible or
irreversible depending on the type of the leaving group used and the method of
activation.93 There are a few reports indicating that the glycosyl acceptor attack
may be directed to the activated donor.101-106 This SN2-like displacement pathway
is desirable because it would allow for the stereospecific inversion of the
stereochemistry at the anomeric carbon. Step 2. Dissociation of the LG, a typically
irreversible expulsion of the activated leaving group (LGA), is the ratedetermining step (RDS). It leads to the formation of a glycosyl carbocation and/or
its stabilized resonance form, an oxacarbenium ion. The latter is often responsible
for scrambling the stereoselectivity of the reaction. Other intermediates, the
existence of which is often ignored, or whose impact on the reaction is
underestimated, may also form at this stage with or without counteranion B. Step
3. As a consequence of the sp2-hybridization of the anomeric (C-1) carbon and the
existence of the oxacarbenium ion in a flattened half-chair conformation the
subsequent attack of the glycosyl acceptor is possible from both the bottom face of
the ring (pathway a) and the top face (pathway b). As a result, “uncontrolled”
glycosylation often leads to the formation of a mixture of products. Step 4. Upon
the proton transfer the formation of the glycosidic bond becomes irreversible (the
termination step).80
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Scheme 1.1. General outline of the chemical glycosylation reaction
The earliest reactions performed by Michael,107 Fischer,108 and Koenigs/Knorr109
at the turn of the 20th century showcased the complexity of the glycosylation reaction. At
that stage, glycosylations of sugar acceptors were quite inefficient and even the synthesis
of disaccharides represented a challenge. The first attempts to solve this problem gave
rise to the development of new activators.110-112 The early attempts to improve the
glycosylation reaction have also revealed the necessity to find a delicate balance between
the reactivity and stereoselectivity.113,114
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Building blocks: glycosyl donors and acceptors
One of the main directions has been the investigation of leaving groups beyond
the original halides, hemiacetals, and peracetates introduced by Helferich in 1933.115
Thus, in the 1970s - early 1980s a few new classes of glycosyl donors were
developed.116,117 This first wave introduced thioglycosides,118-121 1,2-orthoesters,122,123 Oimidates,124,125 thioimidates,126-128 and glycosyl fluorides129 as alternative leaving groups.
Many glycosyl donors introduced during that period have become common even to this
day. The next wave of new methods arrived in the late 1980’s. Among the new leaving
groups introduced were glycosyl esters/carbonates,130-132 thiocyanates,133 diazirines,134
xanthates,135

glycals,136,137

phosphites,138,139

sulfoxides,140

sulfones,141

selenium

glycosides,142 alkenyl glycosides,143-145 and heteroaryl glycosides.146 These developments
were followed by a variety of more recent methodologies and improvements. These
include glycosyl iodides,147 phosphates,148 Te-glycosides,149 sulfonylcarbamates,150
disulfides,151 2-(hydroxycarbonyl)benzyl glycosides,152 novel thio-153,154 and Oimidates155,156 as well as alkynyl-based leaving groups.157-166 In addition, a variety of very
recent methodologies167-169 have brought the use of classic glycosyl donors, such as
glycals,170,171 hemiacetals,105,172,173 or halides174,175 to an entirely different level of
flexibility and versatility.
Beyond studying the anomeric leaving group, protecting group effects have been
investigated. Seminal work of Lemieux70 and Fletcher,176,177 has led to appreciation that
the reactivity of glycosyl halides and the stereoselectivity of glycosylation is directly
correlated to the nature of the protecting groups, especially at the neighboring C-2
position. The participation of the neighboring 2-O-acyl substituent typically leads
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to the formation of 1,2-trans linkages.73,178 In this case, the oxacarbenium ion can
be further stabilized via an acyloxonium (dioxalenium) intermediate. Since the
bottom face of the sugar ring in the acyloxonium intermediate is blocked, the
glycosyl acceptor will approach from the top face (Figure 1.2A). Following this
method, a 1,2-trans linkage is typically produced with high stereoselectivity,
however, sometimes 1,2-orthoesters or 1,2-cis-linked glycosides are formed.
Demchenko and co-workers introduced glycosyl donors equipped with a 2-Opicolinyl ether participating group that provides entire 1,2-trans stereoselectivity in
glycosylations (Figure 1.2B).179,180 Mlynarski and co-workers investigated orthonitrobenzyl (NBn) as a participating group.181 Liu and co-workers investigated
another alkyl participating group, o-cyanobenzyl (CBn) at the C-2 position of a
glycosyl donor.104 An interesting feature of this glycosylation method is that a
single glycosyl donor can yield either α- or β-linked products depending on the
nature of the glycosyl acceptor.

Figure 1.2. Directing neighboring participating groups at C-2
The presence of a non-participating group at C-2 such as benzyl is typically
necessary for the synthesis of 1,2-cis glycosides. However, the non-participating
substituent alone cannot provide stereocontrol, which makes the synthesis of 1,2-
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cis glycosides much more challenging. Although the anomeric effect favours the
formation of the α-product,182 the stereoselectivity of uncontrolled glycosylations
can be low. In these cases, other factors for controlling stereoselectivity such as
structural features of the reactants and reaction conditions become increasingly
important. For example, Boons et al introduced chiral auxiliaries capable of
producing trans-decalin-like intermediates depicted in Figure 2C.183-187 This
opposite face of the ring type of participation helps to obtain 1,2-cis linked
glycosides with very high stereoselectivity.188 Turnbull and co-workers designed a
similar concept showing that an oxathiane donor is also capable of highly αselective glycosylations.189,190 Fairbanks showed the versatility of 2-(thiophen-2yl)methyl derivatives for stereoselective 1,2-cis glycosylation.191
The effects of remote substituents, particularly those capable of steric
hindrance, powerful electron-withdrawal, or long-range participation, have been
known for some time.192-196 Observed for a variety of sugar series including Dgalacto,197,198 L-fuco,199,200 L-rhamno,201 D-manno,202 and D-gluco203 the remote
effects can be weaker than those by the C-2 substituent. More recent studies, by
Kim et al,204 Nifantiev et al,205 Crich et al,206,207 Hung et al,208 and others209,210
showed how important the remote effects can be. A somewhat unexpected effect
was noted for remote picolinyl ethers (Pic) and picoloyl esters (Pico). While 2picolinyl participates at the anomeric center via the six-membered ring
intermediate (see Figure 1.2B)180 the action of the remote groups is different. It has
been demonstrated that the nitrogen atom of the remote picolinyl/picoloyl groups
is able to form a hydrogen bonding with the hydroxyl group of the glycosyl
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acceptor. This leads to high syn-selectivity with respect to the picolinyl/picoloyl
substituent.211 This reaction named H-bond-mediated aglycone delivery or HAD
gave high α-gluco212 and β-manno213 selectivity even at room temperature. As an
extension to this study, the synthesis of β-mannan213 and α-glucans214 has been
reported. Mong and co-workers applied 6-O-picoloyl-2-deoxy glycosyl donors to
stereoselective synthesis of β-glycosides.215 Very recently, De Meo216 and Tsai217
investigated the effect of picoloyl substituents on sialylations. Yang et al employed
a similar 2-quinolinecarbonyl group to stereoselective synthesis of β-D- and β-Larabinofuranosides.218
Torsional effects induced by the cyclic protecting groups may also affect
both the reactivity of glycosyl donors and/or the stereoselectivity of glycosylations.
The work by Crich et al. on the synthesis of β-mannosides76,87,219-221 is the best
known example of the deactivating (and stereodirecting) effect of the 4,6-Obenzylidene substituent. Benzylidene effect is due torsional strain222 that restricts
the conformational flexibility of the pyranose ring and also enhanced electronwithdrawal.223 A variety of other cyclic groups have been investigated. In
particular, studies of 2-amino glycosyl donor protected with 2,3-transoxazolidinone by Kerns et al,224-227 Oscarson et al,228 Ye et al,229-232 and Ito et
al,233,234 yielded useful techniques for the synthesis 1,2-cis glycosides and glycosyl
donors with switchable selectivity. Crich et al. demonstrated the utility of the 2,3O-carbonate

protection

for

α-selective

for

mannosylation

and

rhamnosylation,206,235 as well as β-glucosylation.236 The effect of 3,4-O-carbonate
protection is weaker and it shows a slight bias toward β-selectivity.237 The 4,5-
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O,N-oxazolidinone protection of sialyl donors often provides high yields and αstereoselectivities in sialylations and helps to suppress competing elimination.238240

The effect of the glycosyl acceptor on the stereoselectivity of glycosylation
has also been investigated. The mechanistic outline of the glycosylation reaction
(vide supra) implies that the RDS is unimolecular and should not be affected by
the nature of the glycosyl acceptor (Scheme 1.1). However, the donor-acceptor
mismatch concept of Paulsen241 and Fraser-Reid/Lopez242-246 as well as the double
stereo-differentiation phenomenon247 present a strong counterargument. In fact,
different selectivities are often obtained for different glycosyl acceptors. Typically, the
alcohol reactivity is inversely correlated with the stereoselectivity whereas the most
reactive hydroxyls give the lowest α/β-ratios. For instance, glycosylation of axial 4-OH
of galactose often gives excellent 1,2-cis stereoselectivity. Occasionally, primary
hydroxyl groups can lead to higher selectivity than their secondary counterparts,
particularly for reactions partially proceeding via the bimolecular mechanism. Toshima et
al introduced a new technique that is based on the chiral recognition of aglycones.248

Reaction conditions
Several other factors including temperature, solvent, amount and type of
promoter used can influence the outcome of chemical glycosylation by affecting its
stereoselectivity and yield. Kinetically controlled reactions at low temperatures
favor the formation of β-linked products,249,250 although opposite results have also
been obtained.251,252 The solvent effect on the stereoselectivity of glycosylation
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reactions has been widely studied.256,258-263 In general, polar reaction solvents
increase the rate of the β-glycoside formation via charge separation between O-5
and β-O-1. If the synthesis of α-glycosides is desired, CH2Cl2, ClCH2CH2Cl or
toluene would be suitable candidates as the reaction solvents. However, there are
more powerful forces than simple solvation. Thus, ethereal solvents are beneficial
for α-selective glycosylation because diethyl ether,253 tetrahydrofuran,253 and
dioxane254 have a tendency to form the equatorial O-linked intermediate.
Conversely, nitrile solvents help the formation of β-glycosides because there
reactions were thought to proceed via the axial glycosyl nitrilium cation
intermediate.195,255 More recently, the Mong group suggested that in addition to the
anomeric effect the formation of 1,2-cis nitrilium species is further reinforced by
the participation of the oxygen atom at C-2.256 This would results in the formation
of the glycosyl oxazolinium intermediate that is leading to the β-product as a result
of the top-face nucleophilic attack. 255,257-262
Many decades ago, glycosylations of unreactive acceptors were very
inefficient.109,110 Initial attempts to improve the glycosylation reaction by
Zemplen111 and Helferich112 have also showed that faster reactions may result in
lower stereoselectivity.113,114 Some reactive glycosyl donors can be activated under
Lewis acid catalysis. The best-known examples of these leaving groups include
trichloroacetimidoyl (TCAI),263,264 N-phenyl trifluoroacetimidoyl (PTFAI),265 and
phosphites/phosphates.266 The use of transition metal catalysts based on
palladium267,268 and nickel270,271 developed by Nguyen et al for TCAI donors offers
new opportunities for stereocontrol.167 Many other current methodologies for
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glycosylation, such as glycosylation with S-aryl/alkyl thioglycosides, use
stoichiometric promoters. Bi(V)269,270 and Au(III)191 catalyzed activations of
thioglycosides represent other new promising directions in glycosylation
chemistry.169,269 Recently there has been an explosion in the study of goldcatalyzed activation of alkynes to exploit the low oxophilic character of gold and
the excellent functional group compatibilities these catalysts exhibit. 159,162,271-274
Another emerging approach is the use of (thio)ureas as organocatalysts for
glycosylations with glycosyl chlorides.170,174,175,275,276 The underpinning idea for
developing alternative methodologies for the promotion of glycosyl chlorides is to
avoid the heavy metal catalyst utilized in traditional Koenigs-Knorr reactions.109,110
Ye and co-workers developed a catalytic system that makes advantage of the
hydrogen-bond donor ability of urea.174 These activation conditions allowed for
smooth glycosidation of per-benzylated galactosyl, mannosyl and rhamnosyl
chlorides. The glycosides were achieved in high yields and excellent αstereoselectivities, but these reactions required the use of benzene as a solvent,
high temperature, and long reaction times. For example, as depicted in Scheme
1.2A, activation of donor 1.1 with the urea-derived catalyst 1.3 for the reaction
with glycosyl acceptor 1.2 in the presence of K2CO3 afforded disaccharide 1.4 in
excellent stereoselectivity and yield. A phosphine additive, TTMPP, was found
advantageous in achieving good selectivity with glucosyl donors.
Very recently, Jacobsen and co-workers studied a series of chiral thiourea
catalysts for the activation of glycosyl chlorides.175 In contrast to the previous
example, the reaction affords disaccharides with high β-stereoselectivity, even in
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the absence of the neighboring participating group. The direct access to the
formation of β-mannosides is another advantageous application of this reaction.
For example, as depicted in Scheme 1.2B, activation of donor 1.5 with the chiral
thiourea-derived catalyst 1.7 for reaction with glycosyl acceptor 1.6 in the presence
of isobutylene oxide (IBO) afforded disaccharide 1.8 in high β-stereoselectivity
and yield. IBO is used as an electrophilic trap to scavenge HCl produced in these
reactions. The reaction mechanism has been studied and some features, such as
stereospecific inversion, in combination with the independence from the
stereochemical relationship between electrophile and nucleophile suggest the S N2like nature of the displacement.
In addition, over the recent years there has been a noticeable shift in focus
of the mechanistic glycosylation chemistry field towards studying stereoelectronics
and

conformation

of

the

starting

intermediates.74,75,77,79,80,82,84,91,100,172,223,277-290

material
While

and

the

key

reaction

stereoelectronic

and

conformational effects on reactivity have been studied extensively, the impact of
these effects on stereoselectivity remains elusive. Although some model studies
helped to establish general trends,75,82,277-280,290,291 practical application of the
conformational factors to stereocontrol of glycosylation is still limited. Reagent- or
additive-controlled

glycosylations

and

reactions

with

reagent-dependent

switchable selectivity are becoming active areas of research. 105,292-299
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Scheme 1.2. Examples of urea and thiourea-based organocatalytic reactions
Special cases and indirect methods
While some sugar series follow general trends, there are classes of
compounds and linkages that require special methods. These special cases of
glycosylation

include

the

following

major

classes

of

compounds.

2-

Deoxysugars,300,301 that are discussed in a separate review in this special issue. 302
2-Amino-2-deoxy sugars,303 require additional steps and a careful selection of
suitable protecting groups at C-2, most commonly 2,2,2-trichloroethoxycarbonyl
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(Troc) or phthaloyl (Phth) for the synthesis of 1,2-trans and azide for the synthesis
of 1,2-cis linked glycosides. The difficulty of the direct β-mannosylation304 was
addressed by developing a variety of indirect approaches such as C-2 oxidationreduction, C-2 inversion, anomeric alkylation, and intramolecular aglycone
delivery (vide infra).305,306 Crich and co-workers discovered that 4,6-Obenzylidene protected donors provide excellent β-manno stereoselectivity.76,87,219221

The HAD method developed by Demchenko provides nearly complete β-

selectivity in mannosylation at room temperature.213 Other useful approaches to the
synthesis of β-mannosides include Kim’s o-carboxybenzyl leaving group
approach152 and van der Marel’s C-5 carboxylate approach.307-310
An area of intramolecular glycosylation has also been developed to enhance
the production of difficult glycosidic linkages. A better stereocontrol is achieved
by tethering the reaction counterparts and restricting the glycosyl acceptor
attack.311-318 The best known example, intramolecular aglycone delivery (IAD),
was introduced by Barresi and Hindsgaul.319 Over the years, IAD has evolved into
a powerful means to perform glycosylations of complex targets with high
efficiency and yields.320-323 The major improvement of this approach has emerged
with the implementation of a 2-napthylmethyl group (Nap) as a tether group.323 A
representative example is depicted in Scheme 1.3. The treatment of a mixture of donor
1.9 and acceptor 1.10 with 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) produces a
mixed acetal that can be directly glycosidated in the presence of MeOTf and 2,6-di-tertbutyl-4-methylpyridine (DTBMP) followed by acetylation to give disaccharide 1.11 in an
excellent yield of 90% and complete β-selectivity.323 Initially investigated for the

Matteo Panza | UMSL 2019 | Page 21

synthesis of β-mannosides, α-glucosides, and β-arabinofuranosides,323 this
approach was extended to the synthesis of β-rhamnosides324 and other challenging
targets.315,325-331
The synthesis of 1,2-trans furanosides can be achieved with 2-O-acylated
glycosyl donors.332,333 The synthesis of 1,2-cis furanosides is more difficult due to
high conformational flexibility of the five-membered ring and lack of the anomeric
effect. Recent advancements make use of glycosyl donors with the furanose ring
locked into a single conformation This was achieved with 2,3-anhydro,334,335 3,5O-(di-tert-butylsilylene),336,337

or

3,5-O-tetraisopropyldisiloxanylidene338

protection. Young and co-workers successfully applied the HAD approach to 1,2cis glycofuranosylation.218
In spite of extensive efforts and notable progress, the chemical synthesis of
α-sialosides also remains challenging.339-344 Destabilizing electron-withdrawing
carboxylate and the lack of a substituent at C-3 often drive sialylation reactions
toward competitive elimination. This side-reaction leads to the formation of a 2,3dehydro derivative. In addition, the lack of a participating group means that
stereoselectivity of sialylations can be low. To overcome these problems, a variety
of leaving groups, participating auxiliaries, and activation conditions for
sialylations have been developed. In recent years, it became evident that the
remote N-substituent at C-5 may have a strong effect both on stereoselectivity of
sialylations and the reactivity of sialyl donors. 342 A particular advance has been
made with 4,5-O,N-oxazolidinone derivatives,238-240 and more recently with 5isothiocyanate,345 that provide high yields and stereoselectivities in sialylations and
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help to suppress the competing elimination. An investigation of the effect of remote
picoloyl groups at C-4 in the presence of excess of triflic acid offered new mechanistic
insights into the sialic acid chemistry.216 This methodology has been extended in to the
synthesis of 7,8-di-picoloylated donors bearing benzoyl protection at the other
positions.217

Scheme 1.3. Synthesis of β-mannosides via intramolecular aglycone delivery
A number of methods that do not include a formal glycosylation step have
been developed.346,347 Since these indirect procedures include multistep syntheses
practical application of these techniques is envisaged for the synthesis of
glycosidic linkages that cannot be easily accessed by conventional technologies.
O’Doherty

developed

a

well-rounded

methodology

for

Pd(0)-catalyzed

glycosylations, wherein carbohydrate chirality centers are installed postglycosylationally.

The

de

novo

asymmetric

synthesis

methodology

was
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instrumental for obtaining many mono-, di-, and oligosaccharide derivatives by
means of palladium-catalyzed reactions.348-351

1.2.2. Oligosaccharide synthesis
Glycosylation is only part of the challenge synthetic chemists confront during the
synthesis of oligomeric sequences. A traditional stepwise approach requires additional
manipulations after each glycosylation step. This multi-step reaction cycle is then
repeated again until oligosaccharide of the desired chain length is obtained. This becomes
increasingly inefficient at the advanced stages of the assembly,95,352 often leads to a
dramatic drop in yield, and as a consequence, lesser availability of glycans. Many
advanced strategies that streamline oligosaccharide assembly by minimizing or even
eliminating leaving or protecting group manipulations between coupling steps are based
either on chemoselective or on selective activation of leaving groups.95 One-pot strategies
help to expedite the oligosaccharide synthesis further. The one-pot sequences typically
consist of the glycosylation steps only, but a minimal number of deprotection steps may
also be included. Since all the sequential reactions are performed in a single flask (pot),
the purification is only performed at the stage of the final product and purification of the
intermediates is not required.

Conventional linear and convergent block synthesis
A traditional stepwise approach requires additional synthetic steps for the
conversion of the disaccharide intermediate into the second-generation glycosyl donor or
acceptor. Modified disaccharides are then coupled with a glycosyl donor (or acceptor) to
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obtain a trisaccharide. This reaction sequence is then repeated again until oligosaccharide
of the desired chain length is obtained. Despite the need for additional protecting group
manipulations between the glycosylation steps the linear approach is still in common use
and a relevant example, the synthesis of the blood-group determinant H-type II
pentasaccharide 1.23 is depicted in Scheme 1.4.353

Scheme 1.4. Conventional linear oligosaccharide synthesis with alternating
glycosylation and deprotection steps
Galactosyl phosphate 1.12 is glycosylated with acceptor 1.13 in the presence of
trimethylsilyl trifluoromethanesulfonate (TMSOTf), followed by removal of the
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temporary levulinoyl (Lev) protecting group. The sequence is repeated with TCAI and
phosphate donors, as well as Lev and 2-azidomethylbenzoyl (AMB) removable
protecting groups, to afford the target pentasaccharide in 60% overall yield. Numerous
improvements of this basic concept include the use of solid-supported synthesis354 or
fluorous protecting groups355 that significantly facilitate separation of products from the
reactants (vide infra). The convergent building block approach is a faster way to obtain
larger oligosaccharides.356-358 According to this strategy, oligosaccharide fragments are
pre-synthesized and then converged by means of a glycosylation reaction.

Scheme 1.5. Convergent block synthesis of ganglioside GP3
Additional protection/deprotection steps may still be required but the over-all assembly is
faster due to the use of oligomeric building blocks. The block synthesis is particularly
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useful for the purpose of the introduction of a “difficult” linkage at an earlier stage of the
saccharide assembly.359 Convergent block synthesis also streamlines the formation of
oligosaccharide sequences containing two or more repeat units.
A relevant recent example, the synthesis of ganglioside GP3, developed by Kiso
and co-workers is illustrated in Scheme 1.5.360 The synthesis of this complex structure
was designed to avoid the introduction of “difficult” units including ceramide, α-galacto,
and unusual internal α-sialo linkages. Tetrasaccharides 1.24 and 1.25, both of which were
obtained using a convergent [2+2] glycosylation strategy, were coupled in the presence of
N-iodosuccinimide (NIS) and trifluoromethanesulfonic acid (TfOH) at 0 °C. As a result,
an octasaccharide was obtained in 91% yield. The latter was reprotected and converted
into TCAI donor 1.26 that was coupled with glycosyl ceramide acceptor 1.27 in the
presence of TMSOTf affording the target ganglioside 1.28 in 77% yield. The recent
synthetic effort in the area of convergent assembly field49,361-368 has culminated in the
synthesis of a large mycobacterial arabinogalactan oligosaccharide containing 92
monosaccharide residues (92-mer) by Ye and co-workers.369

Expeditious strategies for oligosaccharide synthesis
Expeditious strategies streamline oligosaccharide assembly by minimizing or
even completely eliminating manipulations between coupling steps.95 All of these
approaches can be classified into the following major categories. First, chemoselective
approaches wherein the reactivity of building blocks is modulated by the protecting
groups. Second, selective approaches that are based on selective activation of certain
leaving groups. Third, preactivation-based approaches that can be used with any

Matteo Panza | UMSL 2019 | Page 27

protecting and leaving groups. Fourth, regioselectivity-based approaches rely on the
differential reactivity of different acceptor groups.
Fraser-Reid’s seminal work on armed-disarmed approach showed that the
building block reactivity can be modulated through the choice of protecting groups.370,371
Thus, benzylated (electronically activated, armed) building blocks are significantly more
reactive than their acylated (Bz, disarmed) counterparts (Scheme 1.6A).

Usually,

protecting groups in both reaction components and careful selection of mild reaction
conditions have to be taken into consideration to allow direct chemoselective activation
of the armed glycosyl donor over the disarmed glycosyl acceptor. The convenience of
this approach is that the same leaving group can be used for all building blocks in the
sequence. However, “protecting groups do more than protect,”372 and this can affect the
stereochemical outcome and limit the scope of the method. For instance, the classical
armed-disarmed approach can only lead to the formation of cis-trans-patterned
oligosaccharide sequences.
In recent years, the scope of the original armed-disarmed concept has been
expanded373 and a number of efforts to quantify or even predict the reactivity of building
blocks have been reported by Fraser-Reid,222,374 Ley,375 Wong,376 and others.377 Wong’s
study also revealed a number of building blocks that extend beyond the traditional armeddisarmed boundary. Boons showed that 2,3-O-carbonate protected glycosyl donors are
less reactive than disarmed acylated derivatives.378 Subsequently, Demchenko reported
that 2-Bn-3,4,6-tri-Bz protected donors are even less reactive than their disarmed per-Bz
counterparts (superdisarmed). This unexpected protecting group effect was explained by
the existence of the O2/O5 cooperative effect that takes into consideration the
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stabilization of reaction intermediates, rather than only the electronics of the starting
material.379 In this case, the destabilization of the glycosyl cation is due to the electron
poor environment of O-5 and the lack of anchimeric assistance.
Two concepts for superarming glycosyl donors have also emerged, further
expanding the original scope of the armed-disarmed approach. First, Bols showed that
superarming can be achieved by changing the equatorial-rich 4C1 conformation to an
axial-rich skew-boat conformation by creating steric congestion with TBDMS protecting
groups at the C-2, 3 and 4 positions.84,285-288 These donors showed a hefty 20-fold
increase in reactivity over the armed per-benzylated counterparts because the
conformational change simplifies transition of the starting material into the oxacarbenium
ion that is most stable in the all-axial half-chair arrangement.75,277,278,280,291 Second,
Demchenko reported building blocks wherein the superarming was achieved via the
O2/O5 cooperative effect. Glycosyl donors equipped with the superarming 2-Bz-3,4,6-triBn pattern were 10-fold more reactive than their armed counterparts.380-382 In this case,
the stabilization of the glycosyl cation is possible both from the electron rich O-5 and
from 2-Bz via the anchimeric assistance. With the two different approaches to superarm
glycosyl donors, conformational and anchimeric, Bols and Demchenko jointly developed
2-Bz-3,4-di-TBS protected glycosyl donor. Glycosylations with the hybrid donors were
swift, high yielding and β-selective.383,384
This study showed that the conformational arming is a powerful tool to increase
the reactivity and to achieve excellent yields. The anchimeric arming effects are weaker,
but the participation ensures complete 1,2-trans selectivity.
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Scheme 1.6. Chemoselective (A) and selective (B) activation approaches to
expeditious oligosaccharide synthesis
Another general concept to expedite oligosaccharide synthesis is to achieve
selective activation of different leaving groups, and it is practically independent of the
nature of the protecting groups (Scheme 1.6B). One example presented below has a
unique alignment of six different leaving groups, which were selectively activated
affording hexasaccharide 1.39 in only five steps (Scheme 1.7).385 First, thiocyanate
glycoside donor 1.29 was activated with Cu(OTf)2 over S-thiazolinyl (STaz) acceptor
1.30 in 89% yield. Subsequently, disaccharide 1.31 was coupled with S-benzoxazolyl
(SBox) glycosyl donor 1.32 in the presence of benzyl bromide to achieve the
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trisaccharide 1.33 in 67% yield. The latter was coupled with fluoride acceptor 1.34 in the
presence of MeOTf to produce tetrasaccharide 1.35 in 87% yield. Tetrasaccharide 1.35
was then reacted with SEt acceptor 1.36 in the presence of AgClO4/Cp2ZrCl2 to afford
the pentasaccharide 1.37 in 84% yield. Lastly, the coupling of O-pentenyl acceptor 1.38
with the pentasaccharide 1.37 using MeOTf as an activator produced hexasaccharide 1.39
in 72% yield.

Scheme 1.7. Hexasaccharide synthesis in five selective activation steps
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Among all known selective activation strategies,95 Ogawa’s orthogonal concept is
arguably the most advantageous.386,387 This technique used two chemically distinct
glycosylation reactions and the selective activation of two orthogonal leaving groups is
then reiterated (Scheme 1.6B).
The classic variation of the orthogonal activation involves building blocks bearing
S-phenyl and fluoro leaving groups.388 As shown in Scheme 1.8, phenyl thioglycoside
1.40 is selectively activated over fluoride acceptor 1.41 in the presence of NIS/AgOTf.
The fluoro leaving group of disaccharide 1.42 is then activated over thioglycoside
acceptor 1.43 in the presence of Cp2Hf2Cl2/AgOTf. This selective activation sequence is
then reiterated to provide tetrasaccharide 1.44. Ideally, the orthogonal approach allows
for an unlimited number of reiterations of the two orthogonal leaving groups, which is
conceptually very attractive.

Scheme 1.8. Orthogonal activation of phenylthio glycosides and fluorides
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In practice, however, the yields, which are typically inversely correlated to the
size of the glycosyl donor involved, decreased dramatically at the later stage of the
assembly. A number of complementary combinations of orthogonal leaving groups and
conceptual modifications have been implemented.385,387,389-399
A number of concepts for selective activation have been introduced.145,398,400 For
example, in the two-step activation approach both glycosyl donor and glycosyl acceptor
initially bear the same type of a leaving group. In order to couple these two reactants, a
different leaving group is introduced into the glycosyl donor. Upon the selective
activation of the donor, this two-step activation sequence can be reiterated. Discovered
for thioglycoside conversion into bromides356 this approach was extended to other
systems.371,401-403 For example, Danishefsky’s reiterative assembly approach involving
glycal precursors that are converted into 1,2-anhydrosugars with dimethyldioxirane
(DMDO)404 clearly illustrated the versatility of this strategy.137,405-407 Thus, 1,2anhydrosugar 1.47 generated from glycal 1.46 could be activated over glycal acceptor
1.48 in the presence of ZnCl2 to afford 1,2-trans-linked disaccharide 1.49 in 81%
(Scheme 1.9). The epoxidation-glycosylation sequence can be then reiterated to yield
larger oligosaccharides.
More recently, the versatility of the two-step activation was demonstrated by a
one-pot pre-activation procedure,408-410 according to which S-tolyl glycosides are
converted in situ into a reactive intermediate. These pre-activation types of couplings
cannot be formally classified as oligosaccharide synthesis via selective activations and it
occupies its own niche.66,229,230,232,237,260,411-416 This strategy is particularly advantageous
in conjunction with the one-pot oligosaccharide synthesis that will be discussed below.
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Scheme 1.9. Glycal-epoxide method for iterative oligosaccharide synthesis
A number of useful expeditious approaches are based on regioselectivity of
different acceptor groups. Thus, a two-directional strategy for glycan synthesis makes use
of a building block capable of reacting first as a glycosyl donor and then as an acceptor.
For example, building block 1.50 is first glycosidated with the reactive glycosyl acceptor
1.51 and then glycosylated directly at the deactivated position (synthesis of 1.54, Scheme
1.10).417 Hydroxyl deactivation can be achieved by introducing electron-withdrawing
groups at surrounding positions. The use of temporary masking moieties (trityl, silyl) that
can act as protecting groups in the first step and then be removed directly during
glycosylation, has become a logical extension of this technique.418,419 The use of the
glycosyl donor/acceptor unit on the solid support is another efficient way to “deactivate”
the hydroxyl moiety in comparison to the solution-based acceptor (vide infra).420

Oligosaccharide synthesis in one pot
One-pot strategies allow to streamline glycan synthesis because all glycosylations
are performed in a single flask (pot) and do not require purification of intermediates.421423

All one-pot strategies are based on the following five major concepts. The first

approach discovered by Kahne and co-workers,424 remains the only pure one-pot concept
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because the synthesis is performed with all reaction components present in the reaction
flask from the beginning. In all other approaches, the reactants are added sequentially,
typically upon the consumption of the first batch of compounds.

Scheme 1.10. Two-directional approach for the synthesis of pentasaccharide 1.54
The fact that all reactants are present from the beginning implies that fine-tuning
of all reaction components is required. According to this concept, the most reactive
leaving group reacts with the most reactive hydroxyl first. Subsequent reaction between
the second-ranked reactive leaving group and second-ranked hydroxyl takes place after
the first step has been completed, etc. The concept of the conformational superarming
developed by Bols et al.287,288 was also applied to a one-pot synthesis with all three
reaction components present from the beginning.287,384
The second approach is based on chemoselective activation wherein the reactivity
of the glycosyl donor and acceptor is differentiated by varying the electronic properties of
protecting groups.375-377 A relevant example is shown in Scheme 1.11 (synthesis of 1.59)
wherein the sequential activation of 1.55, 1.56, and 1.57 was based on their relative
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reactivity, which was found to be 17000/162.8/13.1, respectively.376 In contrast to the
first concept, building block 1.57 is added only after the reaction between 1.55 and 1.56
is completed, etc.

Scheme 1.11. One-pot synthesis of tetrasaccharide 1.59 via chemoselective
activation
The third approach is based on selective activation of one leaving group over
another. Since the number of leaving groups that can be aligned for multi-step sequential
activation is still limited only few examples are known. Highlighted herein is the
synthesis of a linear tetrasaccharide derivative 1.62 that was accomplished in 73% yield
over three sequential glycosylation steps.425 This was achieved by the stepwise activation
of SBox donor 1.60 over S-ethyl glycoside 1.61. The S-ethyl moiety of the disaccharide
intermediate was then activated over STaz acceptor 1.30. Finally, the STaz leaving group
of the trisaccharide intermediate was activated for the reaction with glycosyl acceptor 1.2
(Scheme 1.12).
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Scheme 1.12. One-pot synthesis of tetrasaccharide 1.62 via sequential selective
activation of building blocks equipped with different leaving groups
The fourth approach is based on pre-activation and hence it is practically
independent of the building block reactivity. A representative example illustrated in
Scheme 1.13 deals with a straightforward synthesis of the tumor associated carbohydrate
antigen Globo-H hexasaccharide.66 Thus, preactivation of fucosyl donor 1.63 at -78 oC
with p-TolSCl and AgOTf was followed by the addition of acceptor 1.64 along with a
hindered base 2,4,6-tri-(t-butyl)-pyrimidine (TTBP). The temperature was then increased
to -20 oC and the trisaccharide intermediate was formed. The reaction mixture was cooled
again to -78 oC followed by the addition of AgOTf and p-TolSCl. After that, galactose
acceptor 1.65 and TTBP were added and the reaction mixture was warmed to -20 oC.
When acceptor 1.65 has disappeared, the temperature was lowered to -78 oC and the
sequence was reiterated for glycosylation of lactose acceptor 1.66. The resulting Globo H
hexasaccharide -1.67 was formed in 47% yield based on the four-component reaction
that required only 7 h to complete the assembly.
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Scheme 1.13. Preactivation-based one-pot synthesis of Globo-H hexasaccharide 1.67
The fifth concept for one-pot oligosaccharide synthesis relies on the
differentiation between various hydroxyl groups, such as primary vs. secondary or
equatorial vs. axial, have been explored.426

1.2.3. Supported and tagged oligosaccharide synthesis
Further breakthroughs in the area of synthetic chemistry came with the
development of supported or tagged organic synthesis techniques. As a consequence, the
last two decades have also witnessed dramatic improvements in the area of supported
oligosaccharide synthesis. Supported synthesis is very attractive as it allows for the rapid
synthesis of oligosaccharide sequences without the necessity of purifying (and
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characterizing)

the

intermediates.

Another

important

advantage

of

supported

oligosaccharide synthesis is that it simplifies reagent excess removal. It can be achieved
either by filtration if insoluble polymer or other solid phase supports are used or,
alternatively, by fractionation, extraction or precipitation if soluble polymer supports or
other supports/tags are employed.

Synthesis on solid phases
Solid-phase synthesis using insoluble polymer supports (beads)96,97 has been
widely used in the preparation of many classes of molecules of interest. 96,97,427,428
Preparations of oligopeptides429 and oligonucleotides430 have been reported using
insoluble supports. Merrifield431 was the first to report the synthesis of peptide chains
using polystyrene beads. The introduction of solid phases into the carbohydrate synthesis
is credited to Fréchet and Schuerch who reported the first oligosaccharide synthesis on
solid support.432 Since those pioneering studies, the solid-phase synthesis has been widely
utilized in a routine preparation of oligosaccharides and glycopeptides, and it is attracting
renewed attention in connection with combinatorial chemistry433 and automation.354,434
The two main strategies used for solid-phase synthesis of oligosaccharide are
called donor-bound and acceptor-bound. In the first approach depicted in Scheme 1.14A,
the acceptor is bound to the resin either through the anomeric position or one of positions
away from the anomeric center. This approach has an important conceptual advantage by
using highly reactive solution-based monosaccharide donor. As a result, the yields remain
high, even at the advanced stages of the assembly. With the increasing size of the
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oligosaccharide, the solid phase bound reaction sites extend further into solution phase,
which also contributes to high yields that are achieved by means of this strategy.

Scheme 1.14. Glycosylation on polymer support
The second concept, the donor-based approach depicted in Scheme 1.14B, relies
on the donor bound to the polymer support. After the glycosylation has occurred, the
temporary protecting group on the acceptor is turned into a suitable leaving group and the
chain elongation steps can be reiterated. In principle, the chain elongation can be
continued directly, if a suitable set of orthogonal leaving groups is chosen. However, the
main disadvantage of the donor-bound approach relates to the origins of the glycosylation
mechanism. Glycosyl donors are much more prone to side reactions than are glycosyl
acceptors. Donor that underwent a side reaction, or simply was hydrolyzed, cannot
conduct further chain elongation and this will ultimately terminate the oligosaccharide
sequencing.
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Figure 1.3. Solid supports for oligosaccharide synthesis: Merrifield’s resin (A),
Tentagel (B) and JandaJel (C)
Also, the templated approach outlined in Scheme 1.13C, wherein both
components are connected to the same polymer support has been investigated. Twodirectional techniques, combining conventions of approaches A and B are also
known.63,420
Polymer beads or resins are the most commonly used supports for solid-phase
synthesis. Polystyrene beads crosslinked with 1% divinylbenzene found broad acceptance
in all fields since their introduction by Merrifield (Figure 1.3A).431 Initially invented for
peptide synthesis applications, the resin was successfully introduced into the solid phase
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synthesis of oligosaccharides.432 The high loading capacity and the compatibility with
many reaction conditions have been crucial for the popularity of polystyrene-based
resins. Since then, different solid supports with different swelling characteristics have
been explored: polystyrene grafted with different lengths of polyethylene glycol (PEG)
groups led to the development of Tentagel (Figure 1.3B), Hypogel and Argogel.
These resins are able to swell efficiently in both polar and non-polar solvents and
are capable of higher loading capacity. Another approach made use of modifying the
cross-linker by employing a tetrahydrofuran-derived bridge (Figure 1.3C).435 This resin
has been commercialized with the tradename of JandaJel. Although polystyrene resins are
fairly inert, it is noteworthy that some of these resins tend to partially decompose in the
presence of large amounts of TMSOTf.435 To address possible instability of polymeric
resins, non-swelling porous materials have been also been evaluated for solid-supported
oligosaccharide synthesis, and controlled-pore glass436 and nanoporous gold437,438 are two
of such materials to mention (vide infra).
The linker plays a central role in the synthesis of oligosaccharides using solidphases. Due to its labile nature, the linker itself has to be taken into account for
orthogonality in respect to all protecting (or leaving) groups that will be manipulated
during the various steps. For the same reason, various linkers stable under many different
conditions have been developed for carbohydrate synthesis.354,439 In addition to known
and widely used protecting group-derived linkers, such as succinoyl, alkoxybenzyl, and
silyl-based linkers, a new wave of photoreactive, metathesis or hydrogenation-removable
linkers had emerged.44,440-455 In the subsequent effort to develop new linkers with a
versatile installation and/or removal profile, recent developments included Reichardt’s
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spacer/linker,452 as well as Seeberger’s “Lenz linker,”456 safety catch linker,457 and
photocleavable linker.458 Some examples of recently developed linkers are summarized in
Figure 1.4.

Figure 1.4. Recently introduced linkers for polymer-supported oligosaccharide
synthesis
More recently, Seeberger at al. developed a traceless photocleavable linker that is
capable of producing oligosaccharides with the free reducing end.459 The linker offered
stability and yields comparable to the parent structure, making it a suitable choice for
future applications. The cleavage is achieved using a flow photoreactor, shown to be far
more efficient than the classical batch reactors.460
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Scheme 1.15. Acceptor-bound approach to the synthesis of oligosaccharide 1.73
As mentioned, most of the solid-phase syntheses involve glycosyl acceptor-bound
approach. One of the classical examples of this approach involves Schmidt’s synthesis of
a branched saccharide 1.73 depicted in Scheme 1.15.461 Lactose derivative 1.68 was
attached glycosidically to the carboxypolystyrene resin support in the presence of
TMSOTf. The chain was then extended by sequential removal of the orthogonal
protecting groups fluorenylmethoxycarbonyl (Fmoc) with triethyl amine Et3N and Lev
with hydrazine acetate. Upon cleavage from the resin, achieved by the treatment with
NaOMe/MeOH, and subsequent global acetylation with Ac2O/pyridine hexasaccharide
1.73 was obtained in 43% overall yield.
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Scheme 1.16. Chiral auxiliary-assisted synthesis of 1,2-cis-linked oligosaccharide
1.79

More recently, Boons et al. reported the synthesis of all-α-linked oligosaccharide
1.79 using chiral auxiliary mediated 1,2-cis glycosides on polymer support.186 As
depicted in Scheme 1.16, glucosyl donor 1.74 was attached glycosidically to the
hydroxypolystyrene resin support in the presence of TMSOTf. The chain was then
extended by sequential removal of the orthogonal protecting groups Fmoc (with
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piperidine) and allyloxycarbonyl (Alloc) with Pd(PPh3)4. Upon cleavage from the resin
and subsequent reprotection pentasaccharide 1.79 was obtained in 25% overall yield.

Scheme 1.17. Donor-bound synthesis of pentasaccharide 1.82
Most of the known syntheses involve a glycosyl acceptor-bound approach, but
examples involving glycosyl donor bound have also emerged. As reported by
Danishefsky et al,462 glycal 1.80 was attached to a Merrifield resin via a silyl linkage in
the presence of diisopropylethylamine (DIPEA, Scheme 1.17). The polymer-bound glycal
was then epoxidized with DMDO and the resulting 1,2-anhydro sugar was glycosidated
with acceptor 1.80 in the presence of ZnCl2 to provide the immobilized disaccharide.
This synthesis was reiterated until the desired oligosaccharide was obtained. The latter
was then cleaved off by the treatment with Bu4NF/AcOH to afford pentasaccharide 1.82
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in 58% yield.

Another similar examples of the donor-bound approach include the

synthesis of the Leb blood group antigen354,463 and selective activation of the SBox donor
over solution phase thioglycoside acceptor.464

Scheme 1.18. Orthogonal synthesis of a combinatorial library on solid phase
The application of orthogonal strategy, which is another example of a donorbound approach in polymer supported synthesis, was introduced by Ogawa.465 A more
recent example of this approach is illustrated in Scheme 1.18. As reported Kanie et
al.,391,392 polymer-bound donor 1.83 was activated selectively over fluoride acceptor 1.84
in the presence of dimethyl(methylthio)sulfonium trifluoromethanesulfonate (DMTST).
The immobilized glycosyl fluoride was then activated over S-phenyl acceptor 1.85 in the
presence of Cp2Hf(OTf)2. Finally, the immobilized S-phenyl trisaccharide was
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glycosidated with octanol in the presence of DMTST. The resulting oligosaccharide was
cleaved off and all eight diastereomers of 1.86 were separated by HPLC to provide a
useful combinatorial library.

Scheme 1.19. Peptide-templated oligosaccharide synthesis on polymer support
391

Short peptide chains immobilized on the solid support have been investigated

as templates for streamlining the oligosaccharide synthesis by Fairbanks et al.466-468 and
Warriner.469 As shown by Warriner, conjugate 1.87 containing the hydroxyproline-linked
glycosyl donor and acceptor pair with the glycine unit in between produced (1→4)-linked
disaccharide 1.89 in high yields (Scheme 1.19). A differential and highly substrate
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orientation-dependent stereoselectivity was observed by employing differently sequenced
templates, such as 1.88.

Scheme 1.20. STICS: Surface-Tethered Iterative Carbohydrate Synthesis
The application of emerging nanomaterials to organic synthesis has created the basis of
the STICS (surface-tethered iterative carbohydrate synthesis) technology is a
functionalized ‘stick’ made of chemically stable high surface area nanoporous gold that
allows performance of cost efficient and simple synthesis of oligosaccharide chains.438
Nanoporous gold can be prepared by dealloying Ag from Au-Ag alloy or from Au-Ag
alloy electrodeposited onto a gold surface in the presence of nitric acid.470-473 As depicted
in Scheme 1.20, a stack on NPG plates, carrying acceptor 1.91 anchored to the gold
surface with a thiolate linker, is assembled in a Teflon-shelved reactor. The
oligosaccharide assembly is accomplished by alternating the glycosylation, deprotection,
washing, and drying steps. Thus, 6-O-TBDPS protected S-benzoxazolyl (SBox) glycosyl
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donor 1.90 was coupled to the immobilized acceptor 1.91 in the presence of MeOTf.
Then, after a rinse, the tethered disaccharide intermediate was treated with Bu4NF to
remove the silyl group to afford the second generation glycosyl acceptor. After being
dried in vacuum, the latter was reacted with SBox donor 1.60. At the end of the synthesis,
the oligosaccharide can be cleaved off from the gold surface offering a useful potential
alternative both for directed and combinatorial synthesis.

Tagged synthesis (soluble polymer supports, ionic, fluorous)
Soluble polymer supports, many of which are based on a polyethyleneglycol
core, have also found their application in oligosaccharide synthesis. This method has
emerged to address problems of the resin-supported synthesis associated with slow
reactions and reactivity mismatch between unreactive solid-phase based and highly
reactive solution-based reactants.474,475 These supports, and everything attached to it,
are freely soluble in the reaction media, but could be precipitated by the addition of
diethyl ether or other suitable solvent and recovered by filtration. 476-478
Alternatively, nanofiltration or a size-exclusion separation offer other possible
alternatives for separation of polymer-bound molecules and the rest of the reaction
components.479 An elegant synthesis that combines advantages of the soluble polymersupported technology and convergent building block strategy was applied to the synthesis
of hexasaccharide 1.100 (Scheme 1.21).480 In this application, fluorenylmethoxycarbonyl
(Fmoc) and diethylisopropylsilyl (DEIPS) are used as temporary substituents that could
be removed with Et3N and TBAF, respectively, without affecting the linker. The
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polymer-bound intermediates obtained, such as 1.98, could be purified by recrystallization from absolute ethanol.

Scheme 1.21. Synthesis of dimeric Lex hexasaccharide using soluble polymer
support
Amongst other improvements of the supported oligosaccharide synthesis, fluorous
tags incorporating a long per-fluorinated alkyl chain allow the separation of all
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fluorinated from non-fluorinated species by partitioning between perfluorohexanes and
methanol (or toluene). For the synthesis of oligosaccharide 1.105 shown in Scheme
1.22.355

Scheme 1.22. A fluorous tag-assisted synthesis of pentasaccharide 1.10
Triol 1.101 was protected at the O-2, O-3, and O-4 positions with fluorous
protecting groups, using DCC/DMAP-mediated coupling with the fluorous acid 1.102.
The resulting “tagged” compound was detritylated with CSA (camphorsulfonic acid) and
LiCl to provide acceptor 1.104. The latter was glycosylated with glycosyl donor 1.103 in
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the presence of TMSOTf in EtOC4F9–diethyl ether to provide the respective tagged
disaccharide. Desilylation with HF in pyridine followed by glycosylation were reiterated
until the desired pentasaccharide 1.105 was obtained. More recently, less heavily
fluorinated tags and compounds have found a broad application in automated synthesis
(vide infra).
Another promising technique for tagged oligosaccharide synthesis that makes use
of an ionic-liquid support has recently emerged.481,482 Ionic liquid-supported assembly
also expedites oligosaccharide synthesis by eliminating the need for chromatographic
purification of the intermediates. After the desired reaction of the tagged compound has
been completed, the reaction mixture is concentrated. The excess of organic reagents is
removed by extraction with low polarity solvents in which the tagged compounds are
insoluble. Using the same principle, the inorganic reagents are eliminated with aqueous
washings to afford the pure target compound tagged with the ionic liquid. This approach
is illustrated by a synthesis that incorporates elements of an orthogonal strategy making
use of alternating activations of STol and F leaving groups and the convergent approach
depicted in Scheme 1.23.483,484 (1-Methylimdazoliumhexafluorophospho) acetyl ionic
liquid tag was introduced via the corresponding 6-chloroacetylated starting material by
reaction with N-methylimidazole and potassium hexafluorophosphate. The tagged
mannosyl fluoride donor 1.106 was glycosylated with thioglycoside acceptor 1.107 to
afford the IL-tagged disaccharide 1.110. Meanwhile, the analogous disaccharide 1.111
was produced using thioglycoside 1.108 as the donor and fluoride 1.109 as acceptor.
Each disaccharide was split into portions, and the tag was removed from one portion.
This gave a library of two disaccharide donors (1.110 and 1.111) and two disaccharide
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acceptors (1.112 and 1.113) that were converged to produce two tetrasaccharides. One of
the tetrasaccharides was untagged to produce glycosyl acceptor 1.114. Finally, the
synthesis is concluded with a [4+4] glycosylation between the tagged tetrasaccharide
fluoride donor and thioglycoside acceptor 1.114 to afford the final mannan
octasaccharide 1.115. Gouhier and co-workers485 reported efficient 1,2-cis glycosylations
using ionic liquid-supported thioglycoside in a two-directional419,420 manner.

Scheme 1.23. Convergent/orthogonal ionic liquid-tagged synthesis of mannans

1.3.

Automated synthesis of oligosaccharides
All traditional oligosaccharides contain multiple glycosidic linkages. This linkage

is obtained by a glycosylation reaction, which, in spite of significant progress overviewed
in Section 1.2.1 remains challenging due to the requirement to achieve stereocontrol and
suppress side reactions. Beyond that, as overviewed in Section 1.2.2, oligosaccharide
synthesis offers further challenges that may require further manipulations between each
glycosylation step. Due to significant advances, the chemical synthesis of many glycans
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can now be streamlined by using various methods and strategies in solution. Solid-phase
and tag-assisted syntheses, which were overviewed in Section 1.2.3, eliminate the need
for purifying intermediates and simplify the removal of excess reagents. Following
significant advancements in the preparation of peptides429,486 and oligonucleotides,430
since 1971 solid-phase synthesis has become a viable means for the preparation of
oligosaccharides.
However, there are significant differences between glycosylations in solution and
solid-phase synthesis that particularly affect glycosylation. Among a plethora of leaving
groups developed, a vast majority of glycosylations in solution make use of
thioglycosides487-490 and TCAI.125,263,264,491,492 Solid phase synthesis commonly demands
highly reactive TCAI, PTFAI265,493,494 or phosphates.148,495-499 A series of novel S- and Oimidates have been tested in reactions on solid phases, but their comparison with more
common donors showed no drastic difference.438,464,500-502 The use of thioglycosides as
donors in solid phase has also been reported (vide supra), but their relatively low
reactivity profile and the requirement for stoichiometric promoters limit their application.
Only recently, the use of thioglycosides in solid phases has been brought to practical
realization.503
The discoveries made over the course of traditional synthesis, wherein all
manipulations are performed manually have laid the basis for considering their
automation as an aid in synthesis manipulations. Automation introduces an idea of
operational simplicity, attractive for transferable methods and the development of
accessible methods for glycan production is essential for further innovations and practical
applications

in

all

areas

of glycosciences.

The development

of automated
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oligosaccharides

synthesizers

offers

a

potential

of

revolutionizing

the

way

oligosaccharides are produces. Hence, the development of a broadly useful technology
for scalable and transformative automation has emerged as a timely and significant area
of research.
Many automation platforms make use of a computer interface and liquid handling
equipment. This helps to minimize the human error factor and improve the
reproducibility of results and transferability to other platforms.504,505 The underpinning
idea of automation is that a successful automated sequence is recorded as a computer
program that can then be reproduced with a “press of a button”. In addition, many
automation platforms implement some tool for real-time reaction monitoring, which, in
turn, helps reduce the reaction time and the amount of reagents and solvents needed. This
section is dedicated to the overview of major research efforts dedicated to the refinement
and implementation of various automated platforms that have emerged in the past decade
following early efforts to automate solution-phase manual synthesis by Wong376,506,507
and Takahashi,508 and Seeberger’s peptide synthesizer-based platform for automated
synthesis on solid phase.509,510 Discussed below is the development of “the first fully
automated solid-phase oligosaccharide synthesizer” by Seeberger et al., initially in its
experimental form,456 that in 2014 was marketed as Glyconeer 2.1. Also discussed are
other automation efforts, primarily by Takahashi,511,512 Pohl,513 Demchenko/Stine,514 and
Nokami and co-workers515 that have been also emerging during about the same timeperiod.
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1.3.1. Early developments
As aforementioned, Wong et al. assigned relative reactivity values (RRVs) to a
wide library of building blocks that were then used for oligosaccharide assembly in onepot.376 The determination of RRVs was made with tolylthio glycoside donors activated in
the presence of an NIS/TfOH promoter system under standardized reaction conditions.
The reactivity data was then compiled into a computer program named Optimer376 that
was used to synthesize various oligosaccharides.516-518 Refer to Scheme 1.10 for a
relevant example of a reactivity-based oligosaccharide synthesis in one pot. Not being
strictly automated, this approach brought up an idea of standardizing the reactions and
using computers in quantifying and even predicting the reactivity of different building
blocks. Fraser-Reid,374 Ley,375,519,520 and others521 also created relative reactivity scales
for oligosaccharide synthesis.
Takahashi et al. investigated a number of platforms for the automation of
solution-based oligosaccharide synthesis in one-pot. While the Wong approach was
strictly chemoselective, in applications executed by Takahashi, selective activation of
different leaving groups was employed. In 2000, they adapted a semi-automated parallel
synthesis instrument Quest-210 by Argonaut Technologies, to the one-pot synthesis of
linear and branched oligosaccharides.508Thus, for the synthesis of trisaccharide 1.119
shown in Scheme 1.24, bromide donor 1.116 was selectively activated over thioglycoside
acceptor 1.117 in the presence of AgOTf. The anomeric thiophenyl leaving group of the
resulting disaccharide intermediate was then activated by the addition of NIS, TfOH, and
glycosyl acceptor 1.118 to afford trisaccharide 1.119 in 79% yield over two steps.
Takahashi and co-workers further extended this effort to a number of automation
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platforms, such as L-COS by Moritex, that allowed to automate temperature control,
stirring, and rate of reagent addition for deprotection and glycosylation steps.511,522512,523
The synthesizer could be supplemented with Combi Flash automated chromatograph to
purify the final products

Image used with permission from Professor John Rimoldi
Scheme 1.24. Solution phase automation of the oligosaccharide synthesis in one pot
using parallel synthesizer Quest 210
.
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1.3.2. Peptide synthesizer-based automation
The automated approach Seeberger and co-workers relied on is the acceptorbound one, where donor and promoter are in liquid phase.509 Since the early
developments are already discussed in detail in other review articles,25,498,510,523-525 we
will only briefly overview the key milestones and achievements. The main focus in this
discussion will be placed on the dedicated effort and progress towards the synthesis of
difficult glycosidic linkages. The instrument introduced by Seeberger and co-workers
was derived from an Applied Biosystems Inc. Model 433A peptide synthesizer. It was
modified to allow for performing reactions at low temperatures that were deemed
necessary for the oligosaccharide assembly.509 The solid support chosen was Merrifield
resin, well known in the peptide world, for its good chemical inertness and ideal swelling
properties in solvents utilized in glycan assembly. As it has been discussed previously,
the choice of the linker is critical since it should resist conditions required during the
synthesis. An olefin-type linker was chosen, for its versatility and good behavior in both
acidic and basic media, as well as the mild cleavage conditions. In the first synthesis
depicted in Scheme 1.25, octenediol-functionalized resin 1.121 was glycosylated with
TCAI donor 1.120 (10-fold excess) in the presence of TMSOTf. The ester group was
then cleaved using Zemplen conditions to generate the disaccharide acceptor. The
glycosylation and deprotection steps were repeated until the oligomers of the desired
length, up to decasaccharide, had been achieved. Each step was performed in two
iterations, to avoid the formation of deletion sequences, and hence maximize the yield
and simplify the final purification. The linker was the removed using Grubbs’ catalyst to
afford penta-, hepta- and decasaccharides 1.122a-c equipped with the anomeric pentenyl
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moiety. The high promise of the automated approach was evident immediately. Thus,
heptasaccharide 1.122b was synthesized in 24 h in 42% over-all yield. In comparison,
whereas their previous manual synthesis was less efficient (9% over-all yield in 14
days).443

Scheme 1.25. The synthesis of oligosaccharides 1.122a-c using a modified peptide
synthesizer

Matteo Panza | UMSL 2019 | Page 60

After this first milestone and with the intention of extending the scope of the new
technology, the subsequent efforts performed by Seeberger et al. focused on the synthesis
of oligosaccharides containing various challenging linkages.458,526-528 This included sialic
acids,529

furanosides,530

1,2-cis

glycosides,67

glycopeptides,460

and

branched

oligosaccharides.509 The expertise acquired in the development of this methodology for
the synthesis of various glycosidic linkages and sequences led to an impressive synthesis
of Globo-H hexasaccharide.67 As shown in Scheme 1.26, phosphate donor 1.123, was
used to glycosylate hydroxylated resin 1.121 using TMSOTf as a promoter. The
temporary Fmoc substituent at C-4 was removed using piperidine leading to the
formation of the polymer-bound disaccharide acceptor. Fmoc is commonly used in
oligosaccharide synthesis because it is highly stable in acidic conditions common for
glycosylation and it is easily removable in mildly basic conditions. In this particular
application, The cleavage product of Fmoc, dibenzofluorene, is a convenient marker to
monitor the progress of the reaction via colorimetric assay.531 The synthetic sequence
consists of glycosylation steps with two or three iterations, using either glycosyl
phosphate (1.123-1.126) or glycosyl PTFAI donors (1.127 and 1.128) followed by the
deprotection of the Fmoc group with piperidine.
The final product 1.129 was cleaved off the solid support using ethylene in the
presence of Grubbs’ catalyst532 in 30% yield. The stereoselectivity of the 1,2-cis
glycosylation step was enhanced by using diethyl ether, which is known to favor the
formation of axial products (vide supra). As aforementioned, Globo H is an important
synthetic target of high biomedical significance for the development of anti-cancer
vaccines.22,25,533-537 The biological importance of the Globo-H antigen is so widespread
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throughout the scientific community that many synthetic approaches have been
developed.63-66,68

Scheme 1.26. Automated synthesis of Globo H hexasaccharide
Seeberger and co-workers also developed reaction conditions to achieve βmannosylation on solid phase using an automated approach.538 They started from the
methodology developed by Crich539 involving 4,6-O-benzylidene protected mannosyl
donors bearing a sulfoxide leaving group. In the original procedure, the donor is pre-
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activated with Tf2O and then reacted with the nucleophile. To adjust the procedure to the
automated synthesis, the solvent adopted was dichloromethane, and the pre-activation
was abolished. Unfortunately, although the selectivity of the test reaction was high, the
yields were only moderate at best. On this basis, the next method of interest was the ocarboxybenzyl donor developed by Kim.152 After the initial study in the solution phase
that revealed high yields and selectivities, the selected donor was tested on solid phase to
synthesize a series of di- and trisaccharides. The stereoselectivity fluctuated from 3.5:1 to
9:1 in favor of the desired diastereomer, showing a partial erosion of the selectivity
compared to that achieved in reactions in solution.

Scheme 1.27. Automated synthesis of β-mannosides
Further, to facilitate the elongation of a sequence containing a β-mannosidic
linkage, the donor was equipped with a triisopropylsilyloxymethyl ether (Tom) at C-3.540
This protecting group is removed under the same mild conditions as those that make the
silyl protecting group ideal for synthetic application. The Tom substituent, however, is
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much less bulky than conventional silyl protecting groups, which is strategically
significant for β-mannosylation.541 The donor was successfully used in the synthesis of a
trisaccharide containing multiple β-linkages in excellent yield and good selectivity
(Scheme 1.27). Mannose trisaccharide 1.133 was isolated in 50% yield as a mixture of
anomers (8:1:1.3) and the pure β,β-linked product was isolated by HPLC. Van der Marel,
Codee, and their co-workers have successfully applied a similar approach to the synthesis
of ManA oligosaccharides.542

1.3.3. Fluorous-tag assisted automated synthesis
Fluorous tag-assisted technology has emerged as a new and attractive approach to
oligosaccharide synthesis with good prospects for automation. As discussed previously,
extensively fluorinated species and highly fluorinated protecting groups allow for the
separation of the fluorine-containing components, typically glycosyl acceptors, from the
non-fluorinated glycosyl donors, with the principle of different phase partitioning
between per-fluoroalkenes and methanol.355 On the other hand, Seeberger showed that
the chemistry of solution-based microreactors, developed in the late 1990’s, could be
applied to carbohydrate chemistry.543 The benefits of using a microreactor include:
safety, a much greater control of the reaction temperature, and compatibility with various
analytical techniques. Microreactors are amenable to automation and the syntheses can be
scaled up by increasing the number of reactors.
By merging these two technologies, fluorous-tagged synthesis and chemistry in
microreactors, the synthesis of a homotetramer 1.136 was accomplished as depicted in
Scheme 1.28.497 Three different syringe pumps delivered the solutions through the inlets
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into the mixing zone. The concentration can be controlled by the concentration of the
original solution and the flow-rate at which each reagent is delivered into the system. The
reaction occurs inside the reaction loop. Glycosyl phosphate donor 1.134 was first
glycosidated with fluorous tag 1.135 in the presence of TMSOTf.

Scheme 1.28. Fluorous tag supported synthesis of a tetrasaccharide 1.136 in a
microreactor
This was followed by the removal of the Fmoc group with piperidine and TBAF
to afford the fluorous monosaccharide acceptor. Tetrabutylammonium fluoride proved
necessary for removal of the 6-O-TMS by-products. The latter was glycosylated with
donor 1.134 and the deprotection-glycosylation sequence was repeated until the desired
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compound has been obtained. The product was then cleaved off from the fluorous support
by the treatment with Grubbs’ catalyst to provide tetrasaccharide 1.136. The reaction can
be followed by pairing the reactor with different detection systems including UV-vis
detectors, IR or mass spectrometers.

Image used with permission from Victoria Kohout (Professor Nicola Pohl’s group)
Scheme 1.29. Automated synthesis of pentamannose 1.140 using fluorous support
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The reaction times for the glycosylations were 20 sec for the formation of the
disaccharide, and 60 sec each for the tri- and tetrasaccharides.

The yields for the

reactions after purification were 97, 90, and 95% for the di-, tri-, and tetrasaccharides,
respectively.
The Pohl group applied the fluorous tag-assisted glycosylation approach to
developing an alternative automation technology. This was accomplished by using a
commercially available automated liquid handler and the fluorous solid phase extraction
(FSPE) technique (Scheme 1.29).513 The handler was modified to accommodate
cartridges for the FSPE. In this approach, the fluorous-tagged glycosyl acceptor 1.138
was glycosylated using an excess of TCAI donor 1.137 in the presence of TMSOTf as the
promoter. The obtained tagged disaccharide was then separated using an automated threestep FSPE. This consists of loading into a separation column, and elution of all fluorinefree components using 20% solution of water in methanol. At last, the retained
fluorinated molecules are released from the solid-phase using methanol or THF, which
are fluorophilic solvents.
This procedure can be automated by using commercially available devices
capable of applying a positive pressure at the top of the column or, alternatively, vacuum
at the exit of the eluate. After purification, the disaccharide was treated sequentially with
TBAF and hydrazine to remove TMS and Lev protecting groups, respectively. The
resulting triol acceptor 1.139 was tri-glycosylated using TCAI donor 1.120, to afford the
desired pentasaccharide 1.140 in an excellent yield of 92%.
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Figure 1.5. The split-valve set-up for the alternate-pump system
In an effort to pair an automated purification to the automated solution-phase
synthesizer, Pohl’s group worked on HPLC as the preferred instrument to accomplish this
purpose. An alternate-pump system that differs from a direct-pump design because it is
based on recycling the analyte through two identical columns using a 10-port switch
valve was utilized.544 The advantage of this alternate-pump design is that peak
broadening is avoided. The broadening is caused by the internal volume of the mobilephase solvent pump the analyte goes through, when pumped back into systems with
direct-pump design. The valve switches between two different positions, A and B, as
shown in Figure 1.5. Starting from position A, the compound elutes through the first
column and the UV detector. When the analyte reaches the half of the second column, the
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system switches to position B, so that the second column is directly connected with the
first one. When the compound travels back to column 1, halfway through column length,
the system switches back to position A and the system is now back to the original set up,
with the UV detector between column 1 and 2. Thus, the analyte passes through the
detector every odd-numbered column, so after every run through column 1, for its purity
to be assessed.
After choosing the purification set-up, the most suitable stationary phase was
selected. Three different phases were considered: the commonly used C5, a phenyl hexyl,
and a pentafluorophenyl (PFP) modified silica. The latter two were found superior in the
separation of both monosaccharides and oligosaccharides with methanol as organic
modifier. In particular, after numerous tests, the PFP-modified silica was found to be
more suitable for the separation of acylated monosaccharides and aromatic group
protected compounds, whereas the phenyl hexyl-modified silica worked better towards
acyl protected oligosaccharides, respectively.545 This new methodology was used to
purify the product of a reaction conducted in the automated synthesizer. The authors
detected that sugars equipped with achiral linkers proved to be the most challenging
compounds to purify through manual separation. In this case the product was successfully
purified using a PFP-modified stationary phase and seven effective columns.
Over the recent years, the Pohl group has applied the fluorous tag assisted
automated synthesis to the synthesis of a number of glycan sequences.546-549 Among this,
is the synthesis of manno oligosaccharides connected via challenging β-linkages. This
approach was based on the C-5 carboxylated mannosyl donor methodology developed by
van der Marel for manual reactions.307 At first, the synthesis of 1,4-linked β-
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oligomannosides was automated using alternative glycosylation, TBS-deprotection steps
to achieve the mannuronic hexasaccharide 1.144 sequence (Scheme 1.30).547 After each
glycosylation and deprotection step a FSPE is performed before reiterating the procedure
to elongate the chain.
As shown in Scheme 1.30, mannuronic acid donor 1.141 was used to glycosylate
fluorous-tagged glycosyl acceptor 1.142 in the presence of TMSOTf as the promoter. The
resulting disaccharide was treated with TBAF and acetic acid to remove the TBS
protecting group and was subsequently purified using the automated FSPE. The sequence
was repeated three times with the automated purification. The fourth iteration, followed
by the benchtop purification, afforded the tagged compound 1.142. The latter was
reinjected into the synthesizer, the TBS group was removed using tetrabutylammonium
fluoride, and the resulting compound 1.143 was purified using FSPE. At the end of the
assembly, the carboxyl groups are reduced with DIBAL-H using the automated platform
to afford the desired β-linked hexamannose 1.144. More recently, Tang and Pohl applied
a similar approach to the synthesis of other positional isomers of mannans.549 For the
synthesis of 1,2- and 1,3 linked oligomers, glycosyl donors bearing an easily removable
temporary PMB substituent at the respective positions were employed. At the end of the
sequencing the mannuronates were reduced with lithium triethylborohydride before the
final benzyl removal leading to excellent yields. In the case of the synthesis of 1,6-linked
mannans, the reduction of the carboxylic group is performed before the subsequent
glycosylation instead of the protecting group removal.549
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Scheme 1.30. The automated synthesis of β-mannuronan and β-mannan
Excellent stereoselectivity for the glycosylation of all positions has been
achieved; however, the elongation of the 1,2-, 1,3- and 1,6-linked oligomannans beyond
trisaccharides proved to be difficult. The reasons for this are not clear, but it could relate
to the increased steric demand as the size of the acceptor increases.
This approach was also applied to the synthesis of branched, all-mannosylated Nlinked glycan structures.546 The core N-glycan structure is characterized by the presence
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of a β-mannoside carrying two α-mannosides at O-3 and O-6 (refer to Figure 1.1). As
shown in Scheme 1.31, the formation of the difficult linkage is addressed using the
strategy of the C-5 carboxylate methodology (vide supra). The branching point has a
PMB to mask O-3 and the carboxylic group working both as directing and protecting
group.

Scheme 1.31. Automated sequence to obtain a branched oligomannan fragment
from N-glycans
The automated sequence consists of the glycosidation of donor 1.145 with the
fluorous tag 1.146. p-Methoxybenzyl group is removed in the presence of CAN, followed
by the automatic purification of the tagged monosaccharide using the FSPE. Further
benchtop purification to eliminate the undesired α-isomer afforded mannuronate 1.147 in
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78% yield. The latter was reduced to obtain free hydroxyl at the C-6 position and the
product was purified. The subsequent glycosylation performed with six equivalents of
donor allowed for bis-mannosylation. Benchtop Zemplen reaction afforded trisaccharide
1.148 in 50% yield. The synthesis was completed by removing the benzyl group and the
fluorous tag.

1.3.4

Glyconeer 2.1 as a dedicated oligosaccharide synthesizer

After proving that a peptide synthesizer-based apparatus may be a viable platform
for oligosaccharide synthesis, Seeberger and co-workers took one step further. In 2012,
they reported the “first fully automated solid-phase oligosaccharide synthesizer”.456 This
dedicated apparatus is a sophisticated system, consisting of a syringe pump-driven part
and a solenoid valve-driven part. The reaction vessel is double-jacketed to allow for the
circulation of the cryogenic fluid. It is connected to the inlet tubes to avoid splashing of
the solution injected and to allow for washing the vessel walls. The bottom of the vessel
is equipped with a porous glass filter and pipelines that can be directed to waste or to a
fraction collector. An exhaust opens only if a positive pressure of argon is used. This also
helps to assure the compete isolation from external atmosphere. The system is built with
two syringe pumps, but only one is used.
It is filled exclusively with 1,2-dichloroethane to avoid solvent contamination.
Four rotary valves are designated to regulate the delivery of building blocks and reagents
for activation and deprotection. The solenoid valves are used to deliver solvents, mix
reactions solutions, and manage the waste delivered from the reaction vessel.
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Scheme 1.32. Automated synthesis of N-glycan core using the dedicated synthesizer
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In addition to the parts already described, a cryostat operating between -50 °C and
-90 °C and a fraction collector are important features of the synthesizer. The instrument is
paired with a computer that helps to design, record and control glycosylation and
deprotection protocols. This set-up provides complete automation for reactions,
temperature control, cleavage, and collection of the final product. The complexity and the
number of channels available, combined with the positive pressure of Argon throughout
the whole system make the Glyconeer 2.1 the most complete and versatile synthesizer
currently available, allowing for achieving a significant variety of reaction conditions.
The versatility of the new system was tested by performing the synthesis of a range of
oligomers, including a high mannose type branched glycan 1.153 as illustrated in Scheme
1.32. The new linker 1.150 was also developed for this purpose. This linker helps to
assure better stability during the glycosylation conditions.
The chitobiose portion of the core pentasaccharide sequence was assembled first,
using glycosyl donor 1.149 for both units. After the two glycosylation-deprotection
cycles a challenging β-mannosyl residue was introduced by utilizing glycosyl donor
1.131 equipped with the 2-(hydroxycarbonyl)benzyl leaving group originally developed
by Kim and co-workers. Subsequent treatment with TBAF to remove the silyl protecting
group at C-3 and a selective opening of the benzylidene group afforded the desired 3,6diol, which was subjected to bis-mannosylation using glycosyl donor 1.151 to afford a
branched pentasaccharide. Cleavage from the solid support was performed using MeONa
affording the precursor 1.152 as a mixture of two anomers (α/β = 1/3) in 3.5% overall
yield. Preparative HPLC separation was used to isolate the desired product, which
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underwent global deprotection using hydrogenation to afford the final product in 78%
yield.

Scheme 1.33. Automated synthesis of manno triantamer 1.160
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Subsequently, relying on a similar technology, Seeberger et al obtained an α(1→6)-linked

oligomannan

sequence

containing

30

monosaccharide

residues

(triantamer).550 To achieve this challenging target, a modified Merrifield resin 1.155
carrying a photocleavable linker was used. The solid support was repeatedly glycosylated
using phosphate donor 1.154 in the presence of TMSOTf as a promoter (Scheme 1.33).
To avoid the formation of many deletion sequences and to make the final
separation easier, the unreacted hydroxyls were capped with Ac2O in pyridine. Piperidine
in dimethylformamide was used for the cleavage of the Fmoc protecting group from C-6
to afford the next generation glycosyl acceptor. The presence of benzoyl esters on the
other positions allowed for complete stereoselectivity of the glycosylation reactions and
high yields. The 29-mer resulting from 28 iterations of the glycosylation-cappingdeprotection sequence, was then glycosylated with donor 1.156, equipped with a spacer
to perform a very effective cap-and-tag purification.Therefore, upon removal of the
oligosaccharide 1.158 from the solid support, a conjugation step to magnetic beads
through the ε-aminocaproic ester spacer was performed. The purification step consisted
of a magnetic separation of the tagged 30-mer 1.159, followed by release using Zemplen
conditions also to remove benzoyl protecting groups. Finally, hydrogenation was
performed to free the terminal amine of the linker from the Cbz group, resulting in the
fully unprotected 30-mer 1.160, obtained in 1% yield, which corresponds to 96% yield
per synthetic step.
In the further development of the Glyconeer synthesizer, Seeberger et al
successfully synthesized mannosyl 50-mer 1.162 (penindamer), the longest sequence ever
obtained with a solid phase automated approach.551 The approach is similar to the one
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used for the synthesis of the 30-mer, although an important methodological advancement
has emerged with the implementation of the ethylthio glycoside as glycosyl donor. In this
application, the glycosyl donor 1.161 was activated with NIS in the presence of TfOH at 40 °C. The temperature was immediately ramped up to -20 °C and the reaction was
completed in 20 min. The study of the most suitable building block brought highlight to a
donor carrying a permanent benzoyl group at position 2, to assure neighboring group
participation and therefore high selectivity. C3 and C4 are protected with arming
benzyls370 and position C6 is carrying a temporary Fmoc group, removed with Et3N in
DMF every iteration. To facilitate the purification process, which revealed to be
challenging for deletion sequences longer than n-5, a capping step was introduced after
every glycosylation step. Furthermore, in the latest cycles, from 46 to 50, a second
glycosylation was added to the sequence to ensure even better conversion during the
elongation (Scheme 1.34). Since these additional steps are expensive in terms of time, a
25-mer was synthesized as a proof of concept, to show that the capping steps become
necessary only in the latest stages of the sequence. The approach proved to be successful
allowing an easy separation of the desired product from the shorter oligomers and a
higher average yield for each step. The purification was achieved by HPLC before the
deprotection steps and later on using dialysis and size exclusion chromatography.
For expanding the scope of the automated oligosaccharide synthesis, the
Seeberger group also worked on refining reaction conditions for the formation of other
challenging glycosidic linkages. For example, a number of efforts were dedicated to the
formation of sialylated oligosaccharides. Previously, sialic acid containing disaccharides
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were pre-synthesized and then used as building blocks in the convergent solid phase
synthesis.529

Image used with permission from Professor Todd Lowary
Scheme 1.34. Automated synthesis a 50-mer 1.162 using Glyconeer 2.1
More recently,499 the use of more sophisticated sialyl building blocks based on
the 4,5-oxazolidinone chemistry238-240 allowed for direct sialylation in the synthesizer.
These new sialyl donors were also equipped with chloroacetyl protecting groups at
position C-7 and C-8 and position C-9 was protected with Fmoc. A similar protecting
group pattern, along with the phosphate leaving group, showed good levels of reactivity
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in sialylation reactions in solution developed by Wong and Wu.552 After optimizing the
glycosylation conditions and reaction temperature this approach was successfully applied
to the automated synthesis of α-(2,6)-linked sialosides.

Scheme 1.35. Automation of the sialylation reaction
A representative example is shown in Scheme 1.35 wherein the target
disaccharide was synthesized from building blocks 1.161 and 1.162. The immobilized
disaccharide 1.165 was obtained from the reaction of the photocleavable linker 1.155
with donor 1.163 in the presence of TMSOTf.
Capping of the unreacted linker with acetic anhydride in pyridine, followed by
removal of the Fmoc protecting group with triethylamine (TEA) in dichloromethane
afforded the immobilized acceptor. Phosphate sialyl donor 1.164 was then activated in
the presence of TMSOTf. Finally, the photocleavage provided the target compound 1.165
in 10% overall yield. The yields for the formation of α-(2,3)-linkages were lower.
Another approach to sialooligosaccharides involved a chemoenzymatic synthesis.553
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According to their strategy a desired oligosaccharide sequence was assembled using the
synthesizer first. After the cleavage from the solid support, the target compound
underwent the entire protecting group removal followed by enzymatic sialylation. This
step was accomplished in the presence of α-(2,3)-sialyltransferase from Pasturella
Multocida that was originally introduced by the Chen group.554 As a result, the desired α(2,3)-linked products were isolated in in 78-89% yields.553

Scheme 1.36. Automation of 1,2-cis glycosylation
Seeberger and co-workers also studied the automated synthesis of 1,2-cis-linked
residues that are abundant both in microbial glycans and in the mammalian glycome. In
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particular, reactions assisted by the remote group participation were of particular interest
to this application. An overview of compounds 1.170-1.176, synthesized using the
Glyconeer 2.1, is depicted in Figure 1.6.

Figure 1.6. Representative 1,2-cis-linked oligosaccharides synthesized using
Glyconeer 2.1
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A systematic study of differently protected galactosyl and glucosyl donors was
performed.555

The highest stereoselectivity was obtained with the galactosyl donor

carrying acetates at the C-3 and C-4 positions. Glucosyl donor required esters at the C-3
or C-6, and depending on the desired propagation site, either a removable Fmoc
carbonate or more permanent acetate were used. A representative example is the all αlinked oligomer 1.169 depicted in Scheme 1.36, achieved from glucosyl donors 1.166,
1.167 and 1.168. Thus, donor 1.166 was glycosylated in the presence of NIS and triflic
acid to the photocleavable linker. The Fmoc protecting group was removed with
triethylamine in DMF to obtain the immobilized monosaccharide acceptor.

Scheme 1.37. Automated synthesis of β-manno-linked dodecasaccharide 1.179
The sequence was repeated to obtain the disaccharide, then donor 1.167 was
glycosylated in the previous conditions and Fmoc protecting group was removed,
affording the immobilized trisaccharide. Finally, donor 1.168 was reacted with the
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trisaccharide acceptor and photocleavage was performed to afford the final
tetrasaccharide 1.169 in 20% overall yield and with excellent α selectivity.
Among other useful methodologies for the synthesis of 1,2-cis-linked
oligosaccharides is the solid-phase synthesis of β-mannosides developed by Codee and
co-workers.542 Glyconeer 2.1 was used as a platform for automation of glycosidation of
mannuronic acid donor 1.177 equipped with a N-phenyltriflouroacetimidoyl leaving
group. Glycosylations promoted with TfOH at -40°C produced oligosaccharides in high
yields and complete β-selectivity. Thus, as depicted in Scheme 1.37, a 1,2-cis-linked
dodecasaccharide 1.179 was synthesized in 11% overall yield. Donor 1.177 was first
coupled to linker 1.178 and each glycosylation step was repeated twice with about 90%
coupling efficiency. The Lev protecting group removal was achieved with hydrazine
acetate in a mixture of pyridine and acetic acid. Upon completion of the assembly,
cleavage from the solid support was performed using a metathesis reaction with ethylene
in the presence of Grubbs I catalyst. Complete selectivity of the target compound was
proven by NMR.
Within a plethora of applications for the Glyconeer 2.1 automated synthesizer,
there has been the synthesis of a number of oligosaccharides containing furanosyl
residues. The first result accomplished was the synthesis of a series of linear and
branched oligoarabinofuranides,530 as depicted in Scheme 1.38. Thus, ethylthio glycosyl
donor 1.180 is glycosidated with linker acceptor 1.150, followed by removal of Fmoc
group at C-5 in the presence of piperidine in DMF. The donor 1.181, used for branching,
is coupled to the immobilized monosaccharide in the presence on NIS and triflic acid,
followed by treatment with piperidine in dimethylformamide to remove both Fmoc
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protecting groups. The resulting disaccharide was treated with donor 1.180 in the
presence of NIS and TfOH, followed by deprotection step, in two iterations, to obtain the
immobilized pentasaccharide. Finally, treatment with sodium methoxide in methanol and
catalytic hydrogenation afforded the target compound 1.182 in 63% yield. The synthesis
was completed in only 42 hours. The first application of the use of furanose building
blocks in solid phase was the synthesis of oligoxylanopyranosides.556 These structures are
based on a linear series of β-(1,4) linked xylosides with the furanoses as branches in
selected position. The oligosaccharides obtained in good yield are used to study the
binding preference of anti-xylan monoclonal antibody557 on microarray systems.558
The other two series of compounds synthesized by Seeberger and co-workers are
type I and II arabinogalactan (AG).559,560 These are present in plant cells and they can be
useful to study arabinogalactan-directed antibodies binding specificity. Type I is present
in pectic polysaccharide as a decoration of the main backbone and characterized by β(1,4) linkages connecting Gal units for the linear chain, and the branching is achieved by
α-(1,3) bonds between arabinofuranosides and galactosides.561
Type II, on the other hand, is present as a highly branched polysaccharide
attached to a hydroxyproline-rich peptide structure. The linear backbone of the glycan is
based on β-(1,3) linkages while the branching occurs through β-(1,6) bonds.562 The
arabinofuranoses present on the branching are connected by α-(1,3) linkages as in the
case of the Type I AG. The target compounds were obtained in good to excellent yields.
The effort in the assembly of various arabinofuranosides containing oligosaccharides
culminated in the formation of two complex structures containing the former and
mannopyranosides.563
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Scheme 1.38. Synthesis of the branched hexasaccharide composed of multiple
arabinofuranosyl residues
These oligosaccharides are present on the cell surface of the Mycobacterium
tuberculosis564 and constitute a synthetic challenge for their complexity. Three different
building blocks are required for the assembly of the product. They are all ethylthio
glycosides and protected with Fmoc on the position of elongation and branching. Another
important application of this dedicated system is to the synthesis of different families of
GAGs (glycosaminoglycans). These compounds are connected to a transmembrane core
protein, with the function of transducing signals to the interior of the cells from
extracellular environment.17
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The first target was chondroitin sulfate, containing β-D-glucuronic acid and Nacetyl-β-D-galactosamine, presenting various sites of acetylation and sulfation. The
advantage of the solid phase in the preparation of this polysaccharide is the establishing
of a general method that with a few building blocks allows reaching a wide number of
targets, hence the possibility of better understanding their biological relevance.

Scheme 1.39. Synthesis of a chondroitin sulfate
The selected chondroitin sulfate-A and chondroitin sulfate-C hexasaccharides are
similar in structure and differ only in the site of sulfation along the chain. As in cases
previously described here, donors contain the phosphate leaving group, the selected
protecting group for the chain elongation is Fmoc, allowing mild cleavage conditions,
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while Lev esters mask the hydroxyl used for the introduction of sulfates. The amino
group in the galactosyl building block 1.183 carries a trichloroacetate as a protecting
group and the linker 1.155, already utilized by Seeberger and co-workers, is UV labile.
The synthetic sequence is based on the coupling step with alternating GalNAc 1.183 and
GlcA 1.184 building blocks followed by deprotection of the Fmoc group. The acetylation
at the end of the chain, the Lev group removal and the sulfation are also performed using
solid phase protocols, affording the desired compound 1.185 in good yield (Scheme
1.39).
The second target was dermatan sulfate, which is a polysaccharide composed by a
disaccharide repeating unit, consisting of N-acetyl-β-D-galactosamine and

L-iduronic

acid.565 Seeberger et al. developed a synthesis of a di- and a tetrasaccharide using the
Fmoc protection at the oligosaccharide propagation position and the Lev ester at the
future sulfation sites. Galactosamine is readily available in a small number of steps while
iduronic acid requires a more complex synthesis.566 Both donors are equipped with
phosphate leaving group and the linker utilized is the photocleavable one found in many
other automated assemblies developed by the group. The yield of the two compounds
obtained, a disaccharide and a tetrasaccharide, are high and consistent even when the
larger acceptor is involved, averaging both 93% for each step.567
Other families of GAGs studied by Seeberger and co-workers include oligo-Nacetyllactosamine and keratan sulfate.563 The automated glycan assembly was employed
to achieve a fast and facile access to a large library of compounds. For this purpose, the
photocleavable linker and three orthogonal protecting groups (Fmoc, Lev and Nap) have
been utilized. The orthogonal protecting groups gave a streamlined access to keratan
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sulfate oligosaccharides with differential sulfation sites. The obtained products were
printed on microarrays and used to study the interaction with viral receptors. One of the
keratan sulfate tetrasaccharides was identiﬁed as a speciﬁc interaction partner of receptor
AAVrh10.

Scheme 1.40. The synthesis of hyaluronic acid fragments
Codee and co-workers reported the synthesis of different chains of hyaluronic
acid (HA), another common class of GAGs.542 HA is a major component of connective
tissue and extracellular matrix. Besides structural functions, HA has a role in
inflammatory response, cell-cell adhesion and recognition. Being able to access
fragments of HA would be beneficial for studying its interaction with protein CD44,
related to tumors proliferation. Common challenge for all GAG syntheses is the low
reactivity of building blocks that has been addressed by applying them in large excess. As
depicted in Scheme 1.40, the assembly started with PTFAI glucosamine donor 1.186 that
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was coupled with linker 1.178 in the presence of TfOH. The chain is then elongated with
the removal of the temporary Lev protecting group and subsequent glycosylation with
disaccharide donor 1.187. After repeating the glycosylation-deprotection cycle, the
products are released through olefin metathesis and purified using HPLC to afford the
desired hepta-, undeca- and pentadecasaccharide in 26, 32 and 18% yield, respectively.
To show the versatility and the wide range of application the automated glycan
assembly system is suitable for, Seeberger and co-workers developed a sequence where
peptide and oligosaccharide solid phase syntheses are coupled.460 Homogeneous
glycopeptides are extremely valuable, because regularly these compounds are isolated in
heterogenous mixtures that make difficult the determination of structure-activity
relationship. Normally the strategies for construction of a glycopeptide require the preformation of glycosylated amino acids in solution phase.368,568 The presented approach is
advantageous because it utilizes a simple building block, readily available and with
minimum synthetic requirements. Elongation of the peptide chain proceeds through Fmoc
approach, using HBTU as coupling reagent and piperidine to remove the protecting
group. Serine and threonine side chains are protected as tert-butyl or trityl ether to be
removed before the glycosylation step, achieved using TMSOTf.
To illustrate the versatility of the approach, three glycopeptides were synthesized,
including compounds with 1,2-cis linkages, requiring elongation on the glycan side and
with more than one glycosylation site. All the syntheses were performed in good yields
and selectivity and established the Glyconeer as a promising system to address the
challenges in glycopeptides assembly (Scheme 1.41). The possibility of accessing large
and complex oligosaccharides is particularly powerful in terms of understanding the
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specificity of various enzymes. The knowledge acquired through the synthesis of
furanose-containing oligosaccharides was useful to study the xylan-degrading enzyme
since the arabinoxylans are suitable for a large number of applications, including biofuels
and nutritional and pharmaceutical functions.

Scheme 1.41. Glycopeptide synthetic sequence
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The synthetic approach is based on the Fmoc strategy for the elongation of the linear
chain and using fully orthogonal Nap and 2-(azidomethyl)benzoyl (Azmb) for the
branching. After incubation with the enzyme, the fragments were studied using LCMS.569
A similar strategy has been used to study the hydrolysis of mixed-linked glucan
chains by lichenase enzyme. This family of glycans is composed by linear 1,3- and 1,4linked glucans, which form a gel-like material, important for the structural functions of
the cells. Although the synthetic approach is similar to the general one used by Seeberger
and co-workers, the formation of the 1,3- linkages was particularly challenging, requiring
two glycosylation steps to avoid the formation of the deletion sequence. Again, the
oligosaccharides were incubated with the enzyme and the digestion product analyzed via
LC-MS, revealing new important features of the behavior of the enzyme.570
The synthesis of oligosaccharide libraries has become one of the most useful
applications of Glyconeer 2.1. In addition to the aforementioned examples, Seeberger and
co-workers have recently synthesized libraries of homo- and heterooligomers of
mannose, glucose and glucosamine. The purpose of the library was to understand the
correlation between the oligomer conformation and their macroscopic properties.571
A combination of the automated glycan assembly and computational studies
revealed a significant structural diversity within a series of synthetic oligomers, even
within the ones comprising the same structural constituents albeit with the different
position of the glycosidic linkages.

The study clearly showcases the power of the

automated synthesis as a tool for a better understanding of the biological significance of
oligosaccharides.
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Scheme 1.42. The synthesis of a representative galactosylated xyloglucan for
generating of oligosaccharide libraries
Pfrengle and co-workers also contributed to the field by synthesizing numerous libraries
of plant-related oligosaccharides.556,569,572 Two significant examples include the assembly
of arabinoxylans and galactoxyloglucans, both being epitopes for monoclonal antibodies
that could be used as probes to study the cell wall properties. The approach for the
synthesis of both libraries is similar. The backbone is assembled using dibutyl phosphate
donors, and the branching is achieved using ethyl thioarabinofuranosides or galactosyl
phosphates. The xylogluco disaccharides were presynthesized prior the automation step
to bypass the challenge of introducing 1,2-cis linkage at the later stage of the synthesis.
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As depicted in Scheme 1.42, the assembly of the galactosylated xyloglucan 1.200
involved the reiteration of the glycosylation and deprotection steps with glucose building
block 1.197. The leaving group was activated with TMSOTf and the temporary Fmoc
group was removed with triethylamine in dimethylformamide. The immobilized
trisaccharide was then glycosylated with the preassembled disaccharide 1.198 to obtain
the xylose-decorated sequence. At last, the oligosaccharide was further elongated using
galactosyl donor 1.199 and the target was cleaved and deprotected to afford the desired
hexasaccharide 1.200 in 7% overall yield.

1.3.5. HPLC-assisted oligosaccharide synthesis
Demchenko, Stine, and their co-workers developed a new experimental set-up
based on an unmodified HPLC instrument. The system consisted of an Omnifit column
containing pre-swelled beads of the TentaGel-NH2 polymer. The column was then
connected to the HPLC system consisting of a ternary reciprocating pump, a UV detector
with variable range and a computer to operate the instrument through regular HPLC
management software.514 The glycosyl acceptor was already loaded on the resin prior to
the insertion into the column and two different solutions containing glycosyl donor and
promoter were mixed in the pump head and then activated donor was delivered to the
column. The reaction time needed for such a protocol was short, typically 30-60 minutes
and afterwards the system was purged with fresh solvent leaving the clean resin carrying
the disaccharide, which could be further elongated through deprotection-glycosylation
cycles. The efficacy and the versatility of the HPLC approach has to be proven, but the
first application revealed its potential.
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Scheme 1.43. HPLC-assisted automated oligosaccharide synthesis
As shown in Scheme 1.43, the synthesis of pentasaccharide 1.203 was
successfully accomplished starting from the TentaGel-NH2 resin preloaded with acceptor
1.202. However, the loading could also be performed directly using the HPLC sequence.
Donor 1.201, equipped with benzoyl ester in a neighboring position to ensure
stereoselectivity and Fmoc protecting group at C-6 for chain elongation, was pumped into
the system together with a solution of TMSOTf as promoter. After 1h of recirculation of
the solution, the system was washed with dichloromethane, followed by the deprotection
of Fmoc performed with piperidine in DMF for 5 minutes, and again a sequential purging
step using dichloromethane. The glycosylation-washing-deprotection-washing sequence
was repeated until oligosaccharide of the desired length was obtained. After that, the
product was cleaved from the solid support by using a recirculating solution of NaOMe in

Matteo Panza | UMSL 2019 | Page 95

methanol-dichloromethane to afford pentasaccharide 1.203 in 62% yield in 7 h total time
(vs 14 days for manual synthesis).

Scheme 1.44. The use of an autosampler as the mode for reagent delivery for the
HPLC-based automation
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The most recent contribution by Demchenko and Stine is the use of autosampler
in a new HPLC system as solution for delivering the promoter in the glycosylation
step.502 Autosamplers in modern HPLC have the advantage of being easily programmable
to enhance automation of the polymer-supported synthesis. The study covered many
aspects, starting from the efficiency of different solid phases, revealing JandaJel to be the
most attractive for HPLC-mediated synthesis. The effectiveness of different leaving
groups ranging from reactive O-imidates and phosphate to less reactive thioimidates and
thioglycosides was investigated. The chosen TCAI allowed to obtain pentasaccharide
1.206 in 67% yield over three glycosylation steps and two deprotection steps (Scheme
1.44).
To address some drawbacks of the solid phase synthesis using polymer supports,
Demchenko and Stine introduced the Surface-Tethered Iterative Carbohydrate Synthesis
(STICS, vide supra).438 For the purpose of the automation experiment small pieces of
nanoporous gold were integrated in the Omnifit column,437 and the synthesis was
conducted as in polymer-supported HPLC-based synthesis. The immobilization of the
glycosyl acceptor 1.208 on the support is achieved using sulfur-containing linkers, such
as lipoic acid, and the glycan assembly is performed. The HPLC pump was used to
circulate donor 1.207 through the Omnifit column containing nanoporous gold chips
(Scheme 45). To investigate the effect of the spacer, C4, C8 and C8OC8 were considered,
and the series of parallel experiments showed that longer chain spacers between the
glycosyl acceptor and the lipoic acid anchor increase the yield of disaccharide 1.209 from
60% to 90%.437
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Scheme 1.45. HPLC-assisted surface-tethered synthesis of disaccharides 1.209

1.3.6. Electrochemical activation platform for automation
Chalcogenoglycosides that can be activated by electrochemical methods573-578
served as a novel automation platform introduced by Nokami and co-workers.515 The
glycosylation step is based on electrochemical activation of thioglycoside donors with the
formation of the corresponding glycosyl triflate as the reactive intermediate. A dedicated
synthesizer was developed specifically for this application, using commercially available
components. Thus, the instrument was equipped with a chiller and a cooling bath, a
power supply for constant current electrolysis, and a syringe pump. The assembly and all
the hardware are controlled using the LabVIEW software. The reaction occurs in a Htype divided cell, with a carbon-felt anode and a platinum plate cathode. The glycosyl
donor is activated in the anodic chamber, and the acceptor is added using the syringe
pump.
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The annotated image is used with permission from Professor Toshiki Nokami
Scheme 1.46. Automated solution phase synthesis using electrochemical activation
In the original application, the synthesis of a series of β-(1→6)-linked Nacetylglucosamino glycans were assembled. As depicted in Scheme 46, the optimized
aryl thioglycoside donor 1.210 was preactivated via anodic oxidation at -80 °C and 1.0
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F/mol at 1.73 Volts for 40 minutes, resulting in the formation of the anomeric triflate
1.211 which reacted with the glycosyl acceptor 1.212 at -50-60 °C for 30 minutes. The
obtained disaccharide 1.213 was then ready for activation, since the reaction proceeds
with the growth of the glycan on the donor side, and the illustrated preactivationglycosylation steps were repeated to synthesize the pentasaccharide 1.214 in 31% overall
yield, with an average of 75% yield per cycle. The whole assembly required 10 hours.515
Given the potential of such a method, which has the advantages of both the
solution-phase and the automated synthesis, Nokami and co-workers recently developed
a few additional applications for the electrochemical activation of chalcogenides.579582

One target reported by Nokami was TGM-chitotriomycin,579,580,582 a molecule of

interest for the development of safer pesticides due to its selectivity in the inhibition of
fungal and entomic glucosaminidases. This 1,2-trans linked glucosamino glycan was
assembled using a similar approach affording a tetrasaccharide product in 41% overall
yield.
Another molecule of interest was a GPI anchor core trisaccharide, an
oligomannoside of interest to show the advantages of novel strategies for oligosaccharide
synthesis.581 The study started with the evaluation of the oxidation potential of different
building blocks, all characterized by a participating group at the C-2 or the C-6, such as
acetyl or pivaloyl. The studied compounds were compared to the 4-fluorophenyl 2,3,4,6tetra-O-benzyl-1-thio-α-D-mannopyranoside and to better understand the changes in the
potential DFT calculations were performed.
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Scheme 1.47. Electrochemical approach to the core trisaccharide of GPI anchors
To verify the selectivity of the selected donors a test was performed with the
assembly of different disaccharides using the electrochemical pre-activation strategy
(vide supra). Anodic oxidation was performed at -80 °C in the presence of Bu4NOTf with
1.00 F/mol of electricity. The proposed mechanism involves the formation of the
anomeric triflate, which is then displaced by the neighboring group to form an
acyloxonium ion, which undergoes substitution to afford the desired product. This was
applied to the assembly of the core trisaccharide of GPI anchor oligosaccharide as shown
in Scheme 1.47. The sequence was completed to provide trisaccharide 1.220 in 40%
overall yield.
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1.4.

Conclusions and outlook
To keep pace with the expanding areas of glycosciences, it is critical to make

glycans more accessible to the general chemical, biomedical and industrial audiences.
The advancement of automation strategies and their broader adoption will be crucial to
meeting this need. Fundamental new developments will be required both in the
generalization of the automation strategies and in the optimization of methods for
glycoside synthesis and oligosaccharide assembly needed for reliable implementation
into automation. Manual strategies for oligosaccharide synthesis in solution require
specialist knowledge of all aspects of carbohydrate chemistry and fine tuning of reactivity
levels and reaction conditions. Manual polymer- or tag-supported synthesis helps to
streamline the synthesis and purification, but still requires specialized knowledge of
carbohydrate synthesis. The automated platform developed by Seeberger introduces an
idea of operational simplicity; however, it requires a sophisticated and expensive
synthesizer, and dedicated and appropriately trained personnel.
More recent developments of automation platforms make use of common
laboratory equipment including parallel synthesizers syringe pumps, microreactors, and
HPLC components. These approaches offer a promise to deliver simple automation using
commonly available and relatively inexpensive equipment. The modular character these
synthesizers allows for endless opportunities to implement existing accessories including
reagent delivery modules and detecting systems that can be operated by standard
computer software. Some automation platforms already are capable of reaction
monitoring in real-time helping to reduce the amount of reagents needed and the reaction
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time. Although a viability of these new approaches and platforms has been demonstrated,
many, if not all, automation platforms are still in need of major refinement. Further
development of existing and new platforms for the automated synthesis is becoming a
significant area of research.
One of the greatest unsolved challenges is the need for dedicated automationamenable reaction conditions. Many aspects of the automated synthesis including
polymer supports and tags, large scale synthesis amenability, availability of affordable
“off-the-shelf” reagent kits, catalytic, stereoselective and operationally simple
glycosylations, streamlined synthesis or broader commercial availability of building
blocks still need to be improved to expedite the synthesis of glycans. Broad availability
of synthetic glycan sequences and libraries and/or affordable and accessible tools and
technologies for automation will greatly enhance study of the roles of carbohydrates in
biological and disease pathways. The produced libraries of synthetic compounds can be
readily integrated with the currently available glycan microarray technologies.
The full potential of automated techniques is yet to be explored, and the versatility
has to be improved to reach the diversity of manual, solution phase techniques. While
most automated platforms are still in development, manual synthesis in solution will
remain as an important tool to obtain complex oligosaccharides or particularly
challenging sequences.

1.5.

References

(1)
Stick, R. V.; Williams, S. J.: Carbohydrates: the essential molecules of life;
Second ed.; Elsevier: Amsterdam - Boston - Heidelberg, 2009.
(2)
Benoff, S. Carbohydrates and fertilization: an overview. Molecular Human
Reproduction 1997, 3, 599-637.

Matteo Panza | UMSL 2019 | Page 103

(3)
Varki, A.; Cummings, R. D.; Esko, J. D.; Freeze, H. H.; Bertozzi, C. R.; Stanley,
P.; Hart, G. W.; Etzler, M. E.: Essentials of glycobiology; Second ed.; CSH Laboratory
Press: New York, 2009.
(4)
Cipolla, L.; Arajo, A. C.; Bini, D.; Gabrielli, L.; Russo, L.; Shaikh, N. Discovery
and design of carbohydrate-based therapeutics. Expert Opin. Drug Discovery 2010, 5,
721-737.
(5)
Witczak, Z. J.: Carbohydrates as new and old targets for future drug design. In
Carbohydrates in Drug Design; Witczak, Z. J., Nieforth, K. A., Eds.; Marcel Dekker,
Inc.: New York, 1997; pp 1-37.
(6)
Carbohydrate-based drug discovery; Wong, C. H., Ed.; Wiley-VCH: Weinheim,
2003.
(7)
Carbohydrate drug design; Klyosov, A. A.; Witczak, Z. J.; Platt, D., Eds.; ACS:
Washington, 2006; Vol. 932.
(8)
Duus, J. O.; Gotfredsen, C. H.; Bock, K. Carbohydrate structural determination by
NMR spectroscopy: Modern methods and limitations. Chem. Rev. 2000, 100, 4589-4614.
(9)
Wormald, M. R.; Petrescu, A. J.; Pao, Y. L.; Glithero, A.; Elliott, T.; Dwek, R. A.
Conformational studies of oligosaccharides and glycopeptides: complementarity of
NMR, X-ray crystallography, and molecular modeling. Chem. Rev. 2002, 102, 371-386.
(10) Seah, H.; Basu, A.: Carbohydrate-carbohydrate interactions. In Encyclopedia of
Chemical Biology; Begley, T., Ed.; John Wiley & Sons, 2008.
(11) Jin, S.; Cheng, Y.; Reid, S.; Li, M.; Wang, B. Carbohydrate recognition by
boronolectins, small molecules, and lectins. Med. Res. Rev. 2010, 30, 171-257.
(12) Cheng, Y.; Li, M.; Wang, S.; Peng, H.; Reid, S.; Ni, N.; Fang, H.; Xu, W.; Wang,
B. Carbohydrate biomarkers for future disease detection and treatment. Sci. China Chem.
2010, 53, 3-20.
(13) Dube, D. H.; Bertozzi, C. R. Glycans in cancer and inflammation-potential for
therapeutics and diagnostics. Nature Rev. 2005, 4, 477-488.
(14) Murrey, H. E.; Hsieh-Wilson, L. C. The chemical neurobiology of carbohydrates.
Chem. Rev. 2008, 108, 1708-1731.
(15) Chaubard, J. L.; Krishnamurthy, C.; Yi, W.; Smith, D. F.; Hsieh-Wilson, L. C.
Chemoenzymatic probes for detecting and imaging fucose-alpha(1-2)-galactose glycan
biomarkers. J. Am. Chem. Soc. 2012, 134, 4489-4492.
(16) Poletti, L.; Lay, L. Chemical contributions to understanding heparin activity:
synthesis of related sulfated oligosaccharides. Eur. J. Org. Chem. 2003, 2999-3024.
(17) Linhardt, R. J.; Toida, T. Role of glycosaminoglycans in cellular communication.
Acc. Chem. Res. 2004, 37, 431-438.
(18) Kotra, L. P.; Mobashery, S. A renaissance of interest in aminoglycoside
antibiotics. Curr. Org. Chem. 2001, 5, 193-205.
(19) Ito, Y.; Manabe, S.: Other glycoconjugates: Synthesis of enediyne antibiotic
oligosaccharides. In Glycoscience: Chemistry and Chemical Biology; Fraser-Reid, B.,
Tatsuta, K., Thiem, J., Eds.; Springer: Berlin - Heidelberg - New York, 2001; Vol. 3; pp
2441-2470.
(20) Lucas, A. H.; Reason, D. C. Polysaccharide vaccines as probes of antibody
repertoires in man. Immunol. Rev. 1999, 171, 89-104.
(21) Kuberan, B.; Linhardt, R. J. Carbohydrate based vaccines. Curr. Org. Chem.
2000, 4, 653-677.

Matteo Panza | UMSL 2019 | Page 104

(22) Danishefsky, S. J.; Allen, J. R. From the laboratory to the clinic: a retrospective
on fully synthetic carbohydrate-based anticancer vaccines. Angew. Chem. Int. Ed. 2000,
39, 836-863.
(23) Pozsgay, V. Oligosaccharide-protein conjugates as vaccine candidates against
bacteria. Adv. Carbohydr. Chem. Biochem. 2001, 56, 153-199.
(24) Galonic, D. P.; Gin, D. Y. Chemical glycosylation in the synthesis of
glycoconjugate antitumour vaccines. Nature 2007, 446, 1000-1007.
(25) Seeberger, P. H.; Werz, D. B. Synthesis and medical applications of
oligosaccharides. Nature 2007, 446, 1046-1051.
(26) Alonzi, D. S.; Neville, D. C. A.; Lachmann, R. H.; Dwek, R. A.; Butters, T. D.
Glucosylated free oligosaccharides are biomarkers of endoplasmic-reticulum αglucosidase inhibition. Biochem. J. 2008, 409, 571-580.
(27) Janković, M. Glycans as biomarkers: status and perspectives. J. Med. Biochem.
2011, 30, 213-223.
(28) Drake, P. M.; Cho, W.; Li, B.; Prakobphol, A.; Johansen, E.; Anderson, N. L.;
Regnier, F. E.; Gibson, B. W.; Fisher, S. J. Sweetening the pot: adding glycosylation to
the biomarker discovery equation. Clin. Chem. 2010, 56, 223-236.
(29) Leymarie, N.; Zaia, J. Effective use of mass spectrometry for glycan and
glycopeptide structural analysis. Anal. Chem. 2012, 84, 3040-3048.
(30) Katrlík, J.; Švitel, J.; Gemeiner, P.; Kožár, T.; Tkac, J. Glycan and lectin
microarrays for glycomics and medicinal applications. Med. Res. Rev. 2010, 30, 394–418.
(31) Fujitani, N.; Furukawa, J.-i.; Araki, K.; Fujioka, T.; Takegawa, Y.; Piao, J.;
Nishioka, T.; Tamura, T.; Nikaido, T.; Ito, M.; Nakamura, Y.; Shinohara, Y. Total
cellular glycomics allows characterizing cells and streamlining the discovery process for
cellular biomarkers. Proc. Nat. Acad. Sci. 2013, 110, 2105-2110.
(32) Celso A. Reis, H. O., Luisa Silva, Catarina Gomes, Leonor David. Alterations in
glycosylation as biomarkers for cancer detection J. Clin. Pathol. 2010, 63, 322-329.
(33) Adamczyk, B.; Tharmalingam, T.; Rudd, P. M. Glycans as cancer biomarkers.
Biochim. Biophys. Acta 2012, 1280, 1347-1353.
(34) Ruhaak, L. R.; Miyamoto, S.; Lebrilla, C. B. Developments in the identification
of glycan biomarkers for the detection of cancer. Molec. Cell. Proteomics 2013, 12, 846855.
(35) Lebrilla, C. B.; An, H. J. The prospects of glycan biomarkers for the diagnosis of
diseases Molec. Biosystems 2009, 5, 17-20.
(36) Meany, D. L.; Zhang, Z.; Sokoll, L. J.; Zhang, H.; Chan, D. W. Glycoproteomics
for prostate cancer detection: changes in serum PSA glycosylation patterns. J. Proteome
Res. 2009, 8, 613-619.
(37) Futakawa, S.; Nara, K.; Miyajima, M.; Kuno, A.; Ito, H.; Kaji, H.; Shirotani, K.;
Honda, T.; Tohyama, Y.; Hoshi, K.; Hanzawa, Y.; Kitazume, S.; Imamaki, R.; Furukawa,
K.; Tasaki, K.; Arai, H.; Yuasa, T.; Abe, M.; Arai, H.; Narimatsu, H. A unique N-glycan
on human transferrin in CSF: a possible biomarker for iNPH. Neurobiol. Aging 2012, 33,
1807-1815.
(38) Coss, K. P.; Byrne, J. C.; Coman, D. J.; Adamczyk, B.; Abrahams, J. L.; Saldova,
R.; Brown, A. Y.; Walsh, O.; Hendroff, U.; Carolan, C.; Rudd, P. M.; Treacy, E. P. IgG
N-glycans as potential biomarkers for determining galactose tolerance in Classical
Galactosaemia. Molec. Genet. Metab. 2012, 105, 212-220.

Matteo Panza | UMSL 2019 | Page 105

(39) Moremen, K. W.; Tiemeyer, M.; Nairn, A. V. Vertebrate protein glycosylation:
diversity, synthesis and function. Nat. Rev. Mol Cell. Biol. 2012, 13, 448-462.
(40) Helenius, A.; Aebi, M. Intracellular functions of N-linked glycans. Science 2001,
291, 2364-2369.
(41) Wang, Z.; Chinoy, Z. S.; Ambre, S. G.; Peng, W.; McBride, R.; de Vries, R. P.;
Glushka, J.; Paulson, J. C.; Boons, G. J. A general strategy for the chemoenzymatic
synthesis of asymmetrically branched N-glycans. Science 2013, 341, 379-383.
(42) Walczak, M. A.; Hayashida, J.; Danishefsky, S. J. Building biologics by chemical
synthesis: practical preparation of di- and triantennary N-linked glycoconjugates. J. Am.
Chem. Soc. 2013, 135, 4700-4703.
(43) Aussedat, B.; Vohra, Y.; Park, P. K.; Fernandez-Tejada, A.; Alam, S. M.;
Dennison, S. M.; Jaeger, F. H.; Anasti, K.; Stewart, S.; Blinn, J. H.; Liao, H. X.;
Sodroski, J. G.; Haynes, B. F.; Danishefsky, S. J. Chemical synthesis of highly congested
gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines. J. Am.
Chem. Soc. 2013, 135, 13113-13120.
(44) Wu, X.; Grathwohl, M.; Schmidt, R. R. Efficient solid-phase synthesis of a
complex, branched N-glycan hexasaccharide: use of a novel linker and temporaryprotecting-group pattern. Angew. Chem. Int. Ed. 2002, 41, 4489-4493.
(45) Jonke, S.; Liu, K.-g.; Schmidt, R. R. Solid-phase oligosaccharide synthesis of a
small library of N-glycans. Chem. Eur. J. 2006, 12, 1274-1290.
(46) Eller, S.; Schuberth, R.; Gundel, G.; Seifert, J.; Unverzagt, C. Synthesis of
pentaantennary N-glycans with bisecting GlcNAc and core fucose. Angew. Chem. Int. Ed.
2007, 46, 4173-4175.
(47) Unverzagt, C.; Eller, S.; Mezzato, S.; Schuberth, R. A double regio- and
stereoselective glycosylation strategy for the synthesis of N-glycans. Chem. Eur. J. 2008,
14, 1304-1311.
(48) Huang, W.; Wang, D.; Yamada, M.; Wang, L. X. Chemoenzymatic synthesis and
lectin array characterization of a class of N-glycan clusters. J. Am. Chem. Soc. 2009, 131
17963-17971.
(49) Shivatare, S. S.; Chang, S. H.; Tsai, T. I.; Ren, C. T.; Chuang, H. Y.; Hsu, L.; Lin,
C. W.; Li, S. T.; Wu, C. Y.; Wong, C. H. Efficient convergent synthesis of bi-, tri-, and
tetra-antennary complex type N-glycans and their HIV-1 antigenicity. J. Am. Chem. Soc.
2013, 135, 15382-15391.
(50) Song, X.; Ju, H.; Zhao, C.; Lasanajak, Y. Novel strategy to release and tag Nglycans for functional glycomics. Bioconjug. Chem. 2014, 25, 1881-1887.
(51) Li, L.; Liu, Y.; Ma, C.; Qu, J.; Calderon, A. D.; Wu, B.; Wei, N.; Wang, X.; Guo,
Y.; Xiao, Z.; Song, J.; Sugiarto, G.; Li, Y.; Yu, H.; Chen, X.; Wang, P. G. Efficient
chemoenzymatic synthesis of an N-glycan isomer library. Chem. Sci. 2015, 6, 5652–
5661.
(52) Falguières, T.; Maak, M.; Weyhern, C. v.; Sarr, M.; Sastre, X.; Poupon, M.-F.;
Robine, S.; Johannes, L.; Janssen, K.-P. Human colorectal tumors and metastases express
Gb3 and can be targeted by an intestinal pathogen-based delivery tool Molec. Cancer
Therap. 2008, 7, 2498-2508.
(53) Kawano, T.; Sugawara, S.; Hosono, M.; Tatsuta, T.; Ogawa, Y.; Fujimura, T.;
Taka, H.; Murayama, K.; Nitta, K. Globotriaosylceramide-expressing Burkitt's

Matteo Panza | UMSL 2019 | Page 106

lymphoma cells are committed to early apoptotic status by rhamnose-binding lectin from
catfish eggs. Biol. Pharm. Bull. 2009, 32, 345-353.
(54) Johansson, D.; Kosovac, E.; Moharer, J.; Ljuslinder, I.; Brännström, T.;
Johansson, A.; Behnam-Motlagh, P. Expression of verotoxin-1 receptor Gb3 in breast
cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer 2009, 9.
(55) Aerts, J. M.; Groener, J. E.; Kuiper, S.; Donker-Koopman, W. E.; Strijland, A.;
Ottenhoff, R.; van Roomen, C.; Mirzaian, M.; Wijburg, F. A.; Linthorst, G. E.; Vedder,
A. C.; Rombach, S. M.; Cox-Brinkman, J.; Somerharju, P.; Boot, R. G.; Hollak, C. E.;
Brady, R. O.; Poorthuis, B. J. Elevated globotriaosylsphingosine is a hallmark of Fabry
disease Proc. Natl. Acad. Sci. 2008, 105, 2812-2817.
(56) Li, Y.; Zhou, D.; Xia, C.; Wang, P. G.; Levery, S. B. Sensitive quantitation of
isoglobotriaosylceramide in the presence of isobaric components using electrospray
ionization-ion trap mass spectrometry. Glycobiology 2008, 18, 166-176.
(57) Okuda, T.; Nakakita, S.-i.; Nakayama, K.-i. Structural characterization and
dynamics of globotetraosylceramide in vascular endothelial cells under TNF-α
stimulation. Glycoconjugate J. 2010, 27, 287-296.
(58) Nagano, K.; Yoshida, Y.; Isobe, T. Cell surface biomarkers of embryonic stem
cells. Proteomics 2008, 8, 4025–4035.
(59) Gottschling, S.; Jensen, K.; Warth, A.; Herth, F. J. F.; Thomas, M.; Schnabel, P.
A.; Herpel, E. Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer
and associated with poor prognosis Eur. Respirat. J. 2013, 41, 656-663.
(60) Malecki, M.; Anderson, M.; Beauchaine, M.; Seo, S.; Tambokane, X. TRA-160+, SSEA-4+, Oct4A+, Nanog+ clones of pluripotent stem cells in the embryonal
carcinomas of the ovaries. J. Stem Cell Res. Therapy 2012, 2.
(61) Ragupathi, G.; Koide, F.; Livingston, P. O.; Cho, Y. S.; Endo, A.; Wan, Q.;
Spassova, M. K.; Keding, S. J.; Allen, J.; Ouerfelli, O.; Wilson, R. M.; Danishefsky, S. J.
Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic
constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine
candidates. J. Am. Chem. Soc. 2006, 128, 2715-2725.
(62) Chang, W.-W.; Lee, C. H.; Lee, P.; Lin, J.; Hsu, C.-W.; Hung, J.-T.; Lin, J.-J.;
Yu, J.-C.; Shao, L.-e.; Yu, J.; Wong, C.-H.; Yu, A. L. Expression of Globo H and SSEA3
in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo
H synthesis. Proc. Nat. Acad. Sci. 2008, 105, 11667–11672
(63) Zhu, T.; Boons, G. J. A two-directional and highly convergent approach for the
synthesis of the tumor-associated antigen Globo-H. Angew. Chem., Int. Ed. Engl. 1999,
38, 3495-3497.
(64) Allen, J. R.; Allen, J. G.; Zhang, X. F.; Williams, L. J.; Zatorski, A.; Ragupathi,
G.; Livingston, P. O.; Danishefsky, S. J. A second generation synthesis of the
MBr1(Globo-H) breast tumor antigen: new application of the n-pentenyl glycoside
method for achieving complex carbohydrate protein linkages. Chem. Eur. J. 2000, 6,
1366-1375.
(65) Bosse, F.; Marcaurelle, L. A.; Seeberger, P. H. Linear synthesis of the tumorassociated carbohydrate antigens Globo-H, SSEA-3, and Gb3. J. Org. Chem. 2002, 67,
6659-6670.

Matteo Panza | UMSL 2019 | Page 107

(66) Wang, Z.; Zhou, L.; Ei-Boubbou, K.; Ye, X. S.; Huang, X. Multi-component onepot synthesis of the tumor-associated carbohydrate antigen Globo-H based on
preactivation of thioglycosyl donors. J. Org. Chem. 2007, 72, 6409-6420.
(67) Werz, D. B.; Castagner, B.; Seeberger, P. H. Automated synthesis of the tumorassociated carbohydrate antigens Gb-3 and Globo-H: incorporation of a-galactosidic
linkages. J. Am. Chem. Soc. 2007, 129, 2770-2771.
(68) Jeon, I.; Iyer, K.; Danishefsky, S. J. A practical total synthesis of Globo-H for use
in anticancer vaccines. J. Org. Chem. 2009, 74, 8452-8455.
(69) Handbook of chemical glycosylation: advances in stereoselectivity and
therapeutic relevance; Demchenko, A. V., Ed.; Wiley-VCH: Weinheim, Germany, 2008.
(70) Lemieux, R. U. Some implications in carbohydrate chemistry of theories relating
to the mechanisms of replacement reactions. Adv. Carbohydr. Chem. Biochem. 1954, 9,
1-57 and references therein.
(71) Capon, B. Mechanism in carbohydrate chemistry. Chem. Rev. 1969, 69, 407-496.
(72) Gervay, J.; Nguyen, T. N.; Hadd, M. J. Mechanistic studies on the stereoselective
formation of glycosyl iodides: first characterization of glycosyl iodides. Carbohydr. Res.
1997, 300, 119-125.
(73) Nukada, T.; Berces, A.; Zgierski, M. Z.; Whitfield, D. M. Exploring the
mechanism of neighboring group assisted glycosylation reactions. J. Am. Chem. Soc.
1998, 120, 13291-13295.
(74) Nguyen, H. M.; Chen, Y. N.; Duron, S. G.; Gin, D. Y. Sulfide-mediated
dehydrative glycosylation. J. Am. Chem. Soc. 2001, 123, 8766-8772.
(75) Ayala, L.; Lucero, C. G.; Romero, J. A. C.; Tabacco, S. A.; Woerpel, K. A.
Stereochemistry of nucleophilic substitution reactions depending upon substituent:
evidence for electrostatic stabilization of pseudoaxial conformers of oxocarbenium ions
by heteroatom substitution. J. Am. Chem. Soc. 2003, 125, 15521-15528.
(76) Crich, D.; Chandrasekera, N. S. Mechanism of 4,6-O-benzylidene-directed bmannosylation as determined by a-deuterium kinetic isotope effects. Angew. Chem. Int.
Ed. 2004, 43, 5386-5389 and references therein.
(77) Boebel, T. A.; Gin, D. Y. Probing the mechanism of sulfoxide-catalyzed
hemiacetal activation in dehydrative glycosylation. J. Org. Chem. 2005, 70, 5818-5826.
(78) Li, Z.; Gildersleeve, J. Mechanistic studies and methods to prevent aglycon
transfer of thioglycosides. J. Am. Chem. Soc. 2006, 128, 11612-11619.
(79) Jensen, H. H.; Bols, M. Stereoelectronic substituent effects. Acc. Chem. Res.
2006, 39, 259-265.
(80) Whitfield, D. M. Computational studies of the role of glycopyranosyl
oxacarbenium ions in glycobiology and glycochemistry. Adv. Carbohydr. Chem.
Biochem. 2009, 62, 83-159.
(81) Mydock, L. K.; Demchenko, A. V. Mechanism of chemical O-glycosylation: from
early studies to recent discoveries. Org. Biomol. Chem. 2010, 8, 497-510.
(82) Beaver, M. G.; Woerpel, K. A. Erosion of stereochemical control with increasing
nucleophilicity: O-glycosylation at the diffusion limit. J. Org. Chem. 2010, 75, 11071118.
(83) Crich, D. Mechanism of a chemical glycosylation reaction. Acc. Chem. Res. 2010,
43, 1144-1153.

Matteo Panza | UMSL 2019 | Page 108

(84) Pedersen, C. M.; Marinescu, L. G.; Bols, M. Glycosyl donors in ‘‘unusual’’
conformations – influence on reactivity and selectivity. C. R. Chimie 2010, 14, 17-43.
(85) Nokami, T.; Shibuya, A.; Manabe, S.; Ito, Y.; Yoshida, J. a- and b-Glycosyl
sulfonium ions: generation and reactivity. Chem. Eur. J. 2009, 15, 2252-2255.
(86) Huang, M.; Retailleau, P.; Bohe, L.; Crich, D. Cation clock permits distinction
between the mechanisms of a- and b-O- and b-C-glycosylation in the mannopyranose
series: evidence for the existence of a mannopyranosyl oxocarbenium ion. J. Am. Chem.
Soc. 2012, 134, 14746-14749.
(87) Huang, M.; Garrett, G. E.; Birlirakis, N.; Bohe, L.; Pratt, D. A.; Crich, D.
Dissecting the mechanisms of a class of chemical glycosylation using primary 13C kinetic
isotope effects. Nature: Chemistry 2012, 4, 663-667.
(88) Crich, D. Methodology development and physical organic chemistry: a powerful
combination for the advancement of glycochemistry. J. Org. Chem. 2011, 76, 9193-9209.
(89) Kaeothip, S.; Yasomanee, J. P.; Demchenko, A. V. Glycosidation of
thioglycosides in the presence of bromine: mechanism, reactivity, and stereoselectivity. J.
Org. Chem. 2012, 77, 291-299.
(90) Kononov, L. O.; Malysheva, N. N.; Orlova, A. V.; Zinin, A. I.; Laptinskaya, T.
V.; Kononova, E. G.; Kolotyrkina, N. G. Concentration dependence of glycosylation
outcome: a clue to reproducibility and understanding the reasons behind. Eur. J. Org.
Chem. 2012, 1926-1934.
(91) Whitfield, D. M. Plausible transition states for glycosylation reactions.
Carbohydr. Res. 2012, 356, 180-190.
(92) Whitfield, D. M. Complications of modeling glycosylation reactions: can the
anomeric conformation of a donor determine the glycopyranosyl oxacarbenium ring
conformation? Carbohydr. Res. 2012, 356, 191-195.
(93) Ranade, S. C.; Demchenko, A. V. Mechanism of chemical glycosylation: focus on
the mode of activation and departure of anomeric leaving groups. J. Carbohydr. Chem.
2013, 32, 1-43.
(94) Leng, W. L.; Yao, H.; He, J. X.; Liu, X. W. Venturing beyond Donor-Controlled
Glycosylation: New Perspectives toward Anomeric Selectivity. Acc. Chem. Res. 2018,
51, 628-639.
(95) Smoot, J. T.; Demchenko, A. V. Oligosaccharide synthesis: from conventional
methods to modern expeditious strategies. Adv. Carbohydr. Chem. Biochem. 2009, 62,
161-250.
(96) Fruchtel, J. S.; Jung, G. Organic chemistry on solid supports. Angew. Chem. Int.
Ed. Engl. 1996, 35, 17-42.
(97) Winter, M.: Supports for solid-phase organic synthesis. In Combinatorial peptide
and nonpeptide libraries: a handbook; Jung, G., Ed.; VCH: Wienheim, New York, Basel,
Cambridge, Tokyo, 1996; pp 465-510.
(98) Bochkov, A. F.; Zaikov, G. E.: Chemistry of the O-glycosidic bond: formation
and cleavage; Pergamon Press: Oxford - New York - Toronto - Sydney - Paris Frankfurt, 1979.
(99) Adero, P. O.; Amarasekara, H.; Wen, P.; Bohé, L.; Crich, D. The experimental
evidence in support of glycosylation mechanisms at the SN1–SN2 interface. Chem. Rev.
2018, in press.

Matteo Panza | UMSL 2019 | Page 109

(100) Nukada, T.; Berces, A.; Whitfield, D. M. Can the stereochemical outcome of
glycosylation reactions be controlled by the conformational preferences of the glycosyl
donor? Carbohydr. Res. 2002, 337, 765-774.
(101) Kochetkov, N. K.; Klimov, E. M.; Malysheva, N. N.; Demchenko, A. V. A new
stereospecific method for 1,2-cis-glycosylation. Carbohydr. Res. 1991, 212, 77-91.
(102) Kochetkov, N. K.; Klimov, E. M.; Malysheva, N. N.; Demchenko, A. V.
Stereospecific 1,2-cis-glycosylation: a modified thiocyanate method. Carbohydr. Res.
1992, 232, C1-C5.
(103) Cato, D.; Buskas, T.; Boons, G.-J. Highly efficient stereospecific preparation of
Tn and TF building blocks using thioglycosyl donors and the Ph2SO/Tf2O promotor
system. J. Carbohydr. Chem. 2005, 24, 503-516.
(104) Hoang, K. L. M.; Liu, X.-W. The intriguing dual-directing effect of 2cyanobenzyl ether for a highly stereospecific glycosylation reaction. Nat. Commun. 2014,
5, 5051.
(105) Issa, J. P.; Bennett, C. S. A reagent-controlled SN2-glycosylation for the direct
synthesis of beta-linked 2-deoxy-sugars. J. Am. Chem. Soc. 2014, 136, 5740-5744.
(106) Mydock, L. K.; Kamat, M. N.; Demchenko, A. V. Direct synthesis of
diastereomerically pure glycosyl sulfonium salts. Org. Lett. 2011, 13, 2928-2931.
(107) Michael, A. On the synthesis of helicin and phenolglucoside. Am. Chem. J. 1879,
1, 305-312.
(108) Fischer, E. Über die glucoside der alkohole. Ber. Dtsch. Chem. Ges. 1893, 26,
2400-2412.
(109) Koenigs, W.; Knorr, E. Über einige derivate des traubenzuckers und der
galactose. Ber. Deutsch. Chem. Ges. 1901, 34, 957-981.
(110) Igarashi, K. The Koenigs-Knorr reaction. Adv. Carbohydr. Chem. Biochem. 1977,
34, 243-283.
(111) Zemplen, G.; Gerecs, A. Action of mercury salts on acetohalogenosugars. IV.
Direct preparation of alkyl biosides of the a-series. Ber. Dtsch. Chem. Ges. 1930, 63B,
2720-2729.
(112) Helferich, B.; Wedemeyer, K. F. Preparation of glucosides from
acetobromoglucose. Ann. 1949, 563, 139-145.
(113) Helferich, B.; Zirner, J. Synthesis of tetra-O-acetyhexoses with a free 2-hydroxyl
group. Synthesis of disaccharides. Chem. Ber. 1962, 95, 2604-2611.
(114) Conrow, R. B.; Bernstein, S. Steroid conjugates. VI. An improved Koenigs-Knorr
synthesis of aryl glucuronides using cadmium carbonate, a new and effective catalyst. J.
Org. Chem. 1971, 36, 863-870.
(115) Helferich, B.; Schmitz-Hillebrecht, E. A new method for the synthesis of
glucosides of the phenols. Ber. Dtsch. Chem. Ges. 1933, 66B, 378-383.
(116) Toshima, K.; Tatsuta, K. Recent progress in O-glycosylation methods and its
application to natural-products synthesis. Chem. Rev. 1993, 93, 1503-1531.
(117) Davis, B. G. Recent developments in oligosaccharide synthesis. J. Chem. Soc.,
Perkin Trans. 1 2000, 2137-2160.
(118) Ferrier, R. J.; Hay, R. W.; Vethaviyasar, N. A potentially versatile synthesis of
glycosides. Carbohydr. Res. 1973, 27, 55-61.
(119) Nicolaou, K. C.; Seitz, S. P.; Papahatjis, D. P. A mild and general method for the
synthesis of O-glycosides. J. Am. Chem. Soc. 1983, 105, 2430-2434.

Matteo Panza | UMSL 2019 | Page 110

(120) Garegg, P. J.; Henrichson, C.; Norberg, T. A reinvestigation of glycosidation
reactions using 1-thioglycosides as glycosyl donors and thiophilic cations as promoters.
Carbohydr. Res. 1983, 116, 162-165.
(121) Oscarson, S.: General synthetic methods: Reactions at the anomeric center: Sglycosylation. In Glycoscience: Chemistry and Chemical Biology; Fraser-Reid, B.,
Tatsuta, K., Thiem, J., Eds.; Springer: Berlin - Heidelberg - New York, 2001; Vol. 1; pp
643-671.
(122) Bochkov, A. F.; Kochetkov, N. K. A new approach for the synthesis of
oligosaccharides. Carbohydr. Res. 1975, 39, 355-357.
(123) Kochetkov, N. K.; Backinowsky, L. V.; Tsvetkov, Y. E. Sugar thio orthoesters as
glycosylating agents. Tetrahedron Lett. 1977, 41, 3681-3684.
(124) Pougny, J. R.; Jacquinet, J. C.; Nassr, M.; Duchet, D.; Milat, M. L.; Sinay, P. A
novel synthesis of 1,2-cis-disaccharides. J. Am. Chem. Soc. 1977, 99, 6762-6763.
(125) Schmidt, R. R.; Michel, J. Facile synthesis of a- and b-O-glycosyl imidates;
Preparation of glycosides and disaccharides. Angew. Chem., Int. Ed. Engl. 1980, 19, 731732.
(126) Mukaiyama, T.; Nakatsuka, T.; Shoda, S. I. An efficient glucosylation of alcohol
using 1-thioglucoside derivative. Chem. Lett. 1979, 487-490.
(127) Hanessian, S.; Bacquet, C.; Lehong, N. Chemistry of the glycosidic linkage.
Exceptionally fast and efficient formation of glycosides by remote activation. Carbohydr.
Res. 1980, 80, c17-c22.
(128) Woodward, R. B.; Logusch, E.; Nambiar, K. P.; Sakan, K.; Ward, D. E.; AuYeung, B. W.; Balaram, P.; Browne, L. J.; Card, P. J.; Chen, C. H. Asymmetric total
synthesis of erythromycin. 3. Total synthesis of erythromycin. J. Am. Chem. Soc. 1981,
103, 3215-3217.
(129) Mukaiyama, T.; Murai, Y.; Shoda, S.-i. An efficient method for glucosylation of
hydroxy compounds using glucopyranosyl fluoride. Chem. Lett. 1981, 431-432.
(130) Boursier, M.; Descotes, G. Activation of the anomeric carbon of sugars by the
carbonate group and applications in glycosidic synthesis. Acad. Sci. 1989, 308, 919-921.
(131) Koide, K.; Ohno, M.; Kobayashi, S. A new glycosylation reaction based on a
"remote activation concept": glycosyl 2-pyridinecarboxylate as a novel glycosyl donor.
Tetrahedron Lett. 1991, 32, 7065-7068.
(132) Kunz, H.; Zimmer, J. Glycoside synthesis via electrophile-induced activation of
N-allyl carbamates. Tetrahedron Lett. 1993, 34, 2907-2910.
(133) Kochetkov, N. K.; Klimov, E. M.; Malysheva, N. N. Novel highly stereospecific
method of 1,2-cis-glycosylation. Synthesis of a-D-glucosyl-D-glucoses. Tetrahedron
Lett. 1989, 30, 5459-5462.
(134) Briner, K.; Vasella, A. Glycosylidene carbenes a new approach to glycoside
synthesis. Part 1. Preparation of glycosylidene-derived diaziridines and diazirines. Helv.
Chim. Acta 1989, 72, 1371-1382.
(135) Marra, A.; Sinay, P. A novel stereoselective synthesis of N-acetyl-aneuraminosyl-galactose disaccharide derivatives, using anomeric S-glycosyl xanthates.
Carbohydr. Res. 1990, 195, 303-308.
(136) Friesen, R. W.; Danishefsky, S. J. On the controlled oxidative coupling of glycals:
A new strategy for the rapid assembly of oligosaccharides. J. Am. Chem. Soc. 1989, 111,
6656-6660.

Matteo Panza | UMSL 2019 | Page 111

(137) Halcomb, R. L.; Danishefsky, S. J. On the direct epoxidation of glycals:
application of a reiterative strategy for the synthesis of b-linked oligosaccharides. J. Am.
Chem. Soc. 1989, 111, 6661-6666.
(138) Kondo, H.; Ichikawa, Y.; Wong, C. H. b-Sialyl phosphite and phosphoramidite:
synthesis and application to the chemoenzymatic synthesis of CMP-sialic acid and sialyl
oligosaccharides. J. Am. Chem. Soc. 1992, 114, 8748-8750.
(139) Martin, T. J.; Schmidt, R. R. Efficient sialylation with phosphite as leaving group.
Tetrahedron Lett. 1992, 33, 6123-6126.
(140) Kahne, D.; Walker, S.; Cheng, Y.; van Engen, D. Glycosylation of unreactive
substrates. J. Am. Chem. Soc. 1989, 111, 6881-6882.
(141) Brown, D. S.; Ley, S. V.; Vile, S. Preparation of cyclic ether acetals from 2benzenesulphonyl derivatives: a new mild glycosidation procedure. Tetrahedron Lett.
1988, 29, 4873-4876.
(142) Mehta, S.; Pinto, B. M. Phenylselenoglycosides as novel, versatile glycosyl
donors. selective activation over thioglycosides. Tetrahedron Lett. 1991, 32, 4435-4438.
(143) Fraser-Reid, B.; Konradsson, P.; Mootoo, D. R.; Udodong, U. Direct elaboration
of pent-4-enyl glycosides into disaccharides. J. Chem. Soc., Chem. Commun. 1988, 823825.
(144) Marra, A.; Esnault, J.; Veyrieres, A.; Sinay, P. Isopropenyl glycosides and
congeners as novel classes of glycosyl donors: theme and variations. J. Am. Chem. Soc.
1992, 114, 6354-6360.
(145) Boons, G. J.; Isles, S. Vinyl glycosides in oligosaccharide synthesis. Part 1: A
new latent-active glycosylation strategy. Tetrahedron Lett. 1994, 35, 3593-3596.
(146) Huchel, U.; Schmidt, C.; Schmidt, R. R. Synthesis of hetaryl glycosides and their
glycosyl donor properties. Eur. J. Org. Chem. 1998, 1353-1360 and references therein.
(147) Gervay, J.; Hadd, M. J. Anionic additions to glycosyl iodides: highly
stereoselective syntheses of b-C-, N-, and O-glycosides. J. Org. Chem. 1997, 62, 69616967.
(148) Plante, O. J.; Andrade, R. B.; Seeberger, P. H. Synthesis and use of glycosyl
phosphates as glycosyl donors. Org. Lett. 1999, 1, 211-214.
(149) Stick, R. V.; Tilbrook, D. M. G.; Williams, S. J. The selective activation of
telluro- over seleno- b-D-glucopyranosides as glycosyl donors: a reactivity scale for
various telluro, seleno and thio sugars. Aust. J. Chem. 1997, 50, 237-240.
(150) Hinklin, R. J.; Kiessling, L. L. Glycosyl sulfonylcarbamates: new glycosyl donor
with tunable reactivity. J. Am. Chem. Soc. 2001, 123, 3379-3380.
(151) Davis, B. G.; Ward, S. J.; Rendle, P. M. Glycosyldisulfides: a new class of
solution and solid phase glycosyl donors. Chem. Commun. 2001, 189-190.
(152) Kim, K. S.; Kim, J. H.; Lee, Y. J.; Lee, Y. J.; Park, J. 2-(Hydroxycarbonyl)benzyl
glycosides: a novel type of glycosyl donors for highly efficient b-mannopyranosylation
and oligosaccharide synthesis by latent-active glycosylation. J. Am. Chem. Soc. 2001,
123, 8477-8481.
(153) Demchenko, A. V.; Malysheva, N. N.; De Meo, C. S-Benzoxazolyl (SBox)
glycosides as novel, versatile glycosyl donors for stereoselective 1,2-cis glycosylation.
Org. Lett. 2003, 5, 455-458.

Matteo Panza | UMSL 2019 | Page 112

(154) Demchenko, A. V.; Pornsuriyasak, P.; De Meo, C.; Malysheva, N. N. Potent,
versatile, and stable: thiazolyl thioglycosides as glycosyl donors. Angew. Chem. Int. Ed.
2004, 43, 3069-3072.
(155) Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Iodine/triethylsilane as a
convenient promoter system for the activation of disarmed glycosyl trichloro- and N(phenyl)trifluoroacetimidates. Synlett 2002, 269-270.
(156) Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Efficient activation of
glycosyl N-(phenyl)trifluoroacetimidate donors with ytterbium(III) triflate in the
glycosylation reaction. Tetrahedron Lett. 2002, 43, 5573-5577.
(157) Li, Y.; Yang, Y.; Yu, B. An efficient glycosylation protocol with glycosyl orthoalkynylbenzoates as donors under the catalysis of Ph3PAuOTf Tetrahedron Lett. 2008,
49, 3604-3608.
(158) Mamidyala, S. K.; Finn, M. G. Glycosylation using unprotected alkynyl donors. J.
Org. Chem. 2009, 74, 8417-8420.
(159) Li, Y.; Yang, X.; Liu, Y.; Zhu, C.; Yang, Y.; Yu, B. Gold(I)-catalyzed
glycosylation with glycosyl ortho-alkynylbenzoates as donors: general scope and
application in the synthesis of a cyclic triterpene saponin. Chem. Eur. J. 2010, 16, 18711882.
(160) Yang, W.; Sun, J.; Lu, W.; Li, Y.; Shan, L.; Han, W.; Zhang, W.; Yu, B.
Synthesis of kaempferol 3-O-(3",6"-di-O-E-p-coumaroyl)-b-D-glucopyranoside, efficient
glycosylation of flavonol 3-OH with glycosyl o-alkynylbenzoates as donors. J. Org.
Chem. 2010, 75, 6879-6888.
(161) Li, Y.; Sun, J.; Yu, B. Efficient synthesis of lupane-type saponins via gold(I)catalyzed glycosylation with glycosyl ortho-alkynylbenzoates as donors. Org. Lett. 2011,
13, 5508-5511.
(162) Ma, Y.; Li, Z.; Shi, H.; Zhang, J.; Yu, B. Assembly of Digitoxin by gold(I)catalyzed glycosidation of glycosyl o-alkynylbenzoates. J. Org. Chem. 2011, 76, 97489756.
(163) Zhu, Y.; Yu, B. Characterization of the Isochromen-4-yl-gold(I) intermediate in
the gold(I)-catalyzed glycosidation of glycosyl ortho-alkynylbenzoates and enhacement
of the catalytic efficiency thereof. Angew. Chem. Int. Ed. 2011, 50, 8329-8332.
(164) Yang, F.; Wang, Q.; Yu, B. ortho-Alkynylphenyl thioglycosides as a new type of
glycosylation donors under the catalysis of Au(I) complexes. Tetrahedron Lett. 2012, 53,
5231-5234.
(165) Tang, Y.; Li, J.; Zhu, Y.; Li, Y.; Yu, B. Mechanistic insights into the gold(I)catalyzed activation of glycosyl ortho-alkynylbenzoates for glycosidation. Journal of the
American Chemical Society 2013, 135, 18396-18405.
(166) Mishra, B.; Neralkar, M.; Hotha, S. Stable alkynyl glycosyl carbonates: catalytic
anomeric activation and synthesis of a tridecasaccharide reminiscent of Mycobacterium
tuberculosis cell wall lipoarabinomannan. Angew. Chem. Int. Ed. 2016, 55, 7786.
(167) McKay, M. J.; Nguyen, H. M. Recent advances in transition metal-catalyzed
glycosylation. ACS Catal. 2012, 2, 1563-1595.
(168) Williams, R.; Galan, M. C. Recent advances in organocatalytic glycosylations.
Eur. J. Org. Chem. 2017, 6247–6264.

Matteo Panza | UMSL 2019 | Page 113

(169) Vibhute, A. M.; Dhaka, A.; Athiyarath, V.; Sureshan, K. M. A versatile
glycosylation strategy via Au (III) catalyzed activation of thioglycoside donors. Chem.
Sci. 2016, 7, 4259-4263.
(170) Balmond, E. I.; Coe, D. M.; Galan, M. C.; McGarrigle, E. M. a-Selective
organocatalytic synthesis of 2-deoxygalactosides. Angew. Chem. Int. Ed. 2012, 51, 91529155.
(171) Palo-Nieto, C.; Sau, A.; Galan, M. C. Gold(I)-catalyzed direct stereoselective
synthesis of deoxyglycosides from glycals. J. Am. Chem. Soc. 2017, 139, 14041-14044.
(172) Gin, D. Dehydrative glycosylation with 1-hydroxy donors (reprinted from
Glycochemistry: Principles, Synthesis, and Applications, pg 33- 52, 2001). J. Carbohydr.
Chem. 2002, 21, 645-665.
(173) Nogueira, J. M.; Issa, J. P.; Chu, A.-H. A.; Sisel, J. A.; Schum, R. S.; Bennett, C.
S. Halide effects on cyclopropenium cation promoted glycosylation with deoxy sugars:
highly α-selective glycosylations using a 3,3-dibromo-1,2-diphenylcyclopropene
promoter. Eur. J. Org. Chem. 2012, 2012, 4927-4930.
(174) Sun, L.; Wu, X.; Xiong, D. C.; Ye, X. S. Stereoselective Koenigs-Knorr
glycosylation catalyzed by urea. Angew. Chem. Int. Ed. 2016, 55, 8041-8044.
(175) Park, Y.; Harper, K. C.; Kuhl, N.; Kwan, E. E.; Liu, R. Y.; Jacobsen, E. N.
Macrocyclic bis-thioureas catalyze stereospecific glycosylation reactions. Science 2017,
355, 162-166.
(176) Ness, R. K.; Fletcher, H. G.; Hudson, C. S. New tribenzoyl-D-ribopyranosyl
halides and their reactions with methanol. J. Am. Chem. Soc. 1951, 73, 959-963.
(177) Ness, R. K.; Fletcher, H. G. Evidence that the supposed 3,5-di-O-benzoyl-1,2-O(1-hydroxybenzylidene)-a-D-ribose is actually 1,3,5-tri-O-benzoyl-a-D-ribose. J. Am.
Chem. Soc. 1956, 78, 4710-4714.
(178) Goodman, L. Neighboring-group participation in sugars. Adv. Carbohydr. Chem.
Biochem. 1967, 22, 109-175.
(179) Smoot, J. T.; Demchenko, A. V. How the arming participating moieties can
broaden the scope of chemoselective oligosaccharide synthesis by allowing the inverse
armed-disarmed approach J. Org. Chem. 2008, 73, 8838-8850.
(180) Smoot, J. T.; Pornsuriyasak, P.; Demchenko, A. V. Development of an arming
participating group for stereoselective glycosylation and chemoselective oligosaccharide
synthesis. Angew. Chem. Int. Ed. 2005, 44, 7123-7126.
(181) Buda, S.; Gołębiowska, P.; Mlynarski, J. Application of the 2-nitrobenzyl group
in glycosylation reactions: a valuable example of an arming participating group. Eur. J.
Org. Chem. 2013, 3988-3991.
(182) Tvaroska, I.; Bleha, T. Anomeric and exo-anomeric effects in carbohydrate
chemistry. Adv. Carbohydr. Chem. Biochem. 1989, 47, 45-123.
(183) Kim, J. H.; Yang, H.; Boons, G. J. Stereoselective glycosylation reactions with
chiral auxiliaries. Angew. Chem. Int. Ed. 2005, 44, 947-949.
(184) Kim, J. H.; Yang, H.; Park, J.; Boons, G. J. A general strategy for stereoselective
glycosylations. J. Am. Chem. Soc. 2005, 127, 12090-12097.
(185) Boltje, T. J.; Kim, J.-H.; Park, J.; Boons, G.-J. Stereoelectronic effects determine
oxacarbenium vs b-sulfonium ion mediated glycosylations. Org. Lett. 2011, 13, 284-287.

Matteo Panza | UMSL 2019 | Page 114

(186) Boltje, T. J.; Kim, J. H.; Park, J.; Boons, G. J. Chiral-auxiliary-mediated 1,2-cisglycosylations for the solid-supported synthesis of a biologically important branched αglucan. Nature Chemistry 2010, 2, 552-557.
(187) Fang, T.; Mo, K.-F.; Boons, G.-J. Stereoselective assembly of complex
oligosaccharides using anomeric sulfonium ions as glycosyl donors. J. Am. Chem. Soc.
2012, 134, 7545-7552.
(188) Mensink, R. A.; Boltje, T. J. Advances in Stereoselective 1,2-cis Glycosylation
using C-2 Auxiliaries. Chem. Eur. J. 2017, 23, 17637-17653.
(189) Fascione, M. A.; Adshead, S. J.; Stalford, S. A.; Kilner, C. A.; Leach, A. G.;
Turnbull, W. B. Stereoselective glycosylation using oxathiane glycosyl donors. Chem.
Commun. 2009, 5841-5843.
(190) Fascione, M. A.; Webb, N. J.; Kilner, C. A.; Warriner, S. L.; Turnbull, W. B.
Stereoselective glycosylations using oxathiane spiroketal glycosyl donors. Carbohydr.
Res. 2012, 348, 6-13.
(191) Cox, D. J.; Fairbanks, A. J. Stereoselective synthesis of a-glycosides by
neighboring group participation via an intermediate thiophenium ion. Tetrahedron:
Asymmetry 2009, 20, 773-780.
(192) van Boeckel, C. A. A.; Beetz, T.; van Aelst, S. F. Substituent effects on
carbohydrate coupling reactions promoted by insoluble silver salts. Tetrahedron 1984,
40, 4097-4107 and references therein.
(193) van Boeckel, C. A. A.; Beetz, T. Substituent effects in carbohydrate chemistry,
Part II. Coupling reactions involving gluco- and galacto-pyranosyl bromides promoted by
insoluble silver salts. Recl. Trav. Chim. Pays-Bas 1985, 104, 171-173.
(194) Ishikawa, T.; Fletcher, H. G. The synthesis and solvolysis of some Dglucopyranosyl bromides having a benzyl group at C-2. J. Org. Chem. 1969, 34, 563-571.
(195) Eby, R.; Schuerch, C. The use of 1-O-tosyl-D-glucopyranose derivatives in a-Dglucoside synthesis. Carbohydr. Res. 1974, 34, 79-90 and references therein.
(196) Mukaiyama, T.; Suenaga, M.; Chiba, H.; Jona, H. Highly a-selective
glycosylation with glycopyranosyl fluorides having diethylthiocarbamoyl group. Chem.
Lett. 2002, 56-57.
(197) Demchenko, A. V.; Rousson, E.; Boons, G. J. Stereoselective 1,2-cisgalactosylation assisted by remote neighboring group participation and solvent effects.
Tetrahedron Lett. 1999, 40, 6523-6526.
(198) Takatani, M.; Matsuo, I.; Ito, Y. Pentafluoropropionyl and trifluoroacetyl groups
for temporary hydroxyl group protection in oligomannoside synthesis. Carbohydr. Res.
2003, 338, 1073-1081.
(199) Corey, E. J.; Carpino, P. Enantiospecific total synthesis of pseudopterosins A and
E. J. Am. Chem. Soc. 1989, 111, 5472-5473.
(200) Gerbst, A. G.; Ustuzhanina, N. E.; Grachev, A. A.; Tsvetkov, D. E.; Khatuntseva,
E. A.; Nifant'ev, N. E. Effect of the nature of protecting group at O-4 on stereoselectivity
of glycosylation by 4-O-substituted 2,3-di-O- benzylfucosyl bromides. Mendeleev
Commun. 1999, 114-116.
(201) Yamanoi, T.; Nakamura, K.; Takeyama, H.; Yanagihara, K.; Inazu, T. New
synthetic methods and reagents for complex carbohydrates. 8. stereoselective amannopyranoside
and
b-mannopyranoside
formation
from
glycosyl

Matteo Panza | UMSL 2019 | Page 115

dimethylphosphinothioates with the C-2 axial benzyloxyl group. Bull. Chem. Soc. Jpn.
1994, 67, 1359-1366.
(202) De Meo, C.; Kamat, M. N.; Demchenko, A. V. Remote participation-assisted
synthesis of b-mannosides. Eur. J. Org. Chem. 2005, 706-711.
(203) Ustyuzhanina, N.; Komarova, B.; Zlotina, N.; Krylov, V.; Gerbst, A. G.;
Tsvetkov, Y.; Nifantiev, N. E. Stereoselective a-glycosylation with 3-O-acetylated Dgluco donors. Synlett 2006, 6, 921-923.
(204) Baek, J. Y.; Lee, B. Y.; Jo, M. G.; Kim, K. S. b-Directing effect of electronwithdrawing groups at O-3, O-4, and O-6 positions and a-directing effect by remote
participation of 3-O-acyl and 6-O-acetyl groups of donors in mannopyranosylations. J.
Am. Chem. Soc. 2009, 131, 17705-17713.
(205) Komarova, B. S.; Orekhova, M. V.; Tsvetkov, Y. E.; Nifantiev, N. E. Is an acyl
group at O-3 in glucosyl donors able to control a-stereoselectivity of glycosylation? The
role of conformational mobility and the protecting group at O-6. Carbohydr. Res. 2014,
384, 70–86.
(206) Crich, D.; Cai, W.; Dai, Z. Highly diastereoselective a-mannopyranosylation in
the absence of participating protecting groups. J. Org. Chem. 2000, 65, 1291-1297.
(207) Crich, D.; Jayalath, P.; Hutton, T. K. Enhanced diastereoselectivity in Bmannopyranosylation through the use of sterically minimal propargyl ether protecting
groups. J. Org. Chem. 2006, 71, 3064-3070.
(208) Zulueta, M. M.; Lin, S. Y.; Lin, Y. T.; Huang, C. J.; Wang, C. C.; Ku, C. C.; Shi,
Z.; Chyan, C. L.; Irene, D.; Lim, L. H.; Tsai, T. I.; Hu, Y. P.; Arco, S. D.; Wong, C. H.;
Hung, S. C. a-Glycosylation by D-glucosamine-derived donors: synthesis of heparosan
and heparin analogues that interact with mycobacterial heparin-binding hemagglutinin. J.
Am. Chem. Soc. 2012, 134, 8988-8995.
(209) Kalikanda, J.; Li, Z. Study of the stereoselectivity of 2-azido-2-deoxygalactosyl
donors: remote protecting group effects and temperature dependency. J. Org. Chem.
2011, 76, 5207-5218.
(210) Ngoje, G.; Li, Z. Study of the stereoselectivity of 2-azido-2-deoxyglucosyl
donors: protecting group effects. Org. Biomol. Chem. 2013, 11, 1879-1886.
(211) Yasomanee, J. P.; Demchenko, A. V. The effect of remote picolinyl and picoloyl
substituents on the stereoselectivity of chemical glycosylation. J. Am. Chem. Soc. 2012,
134, 20097-20102.
(212) Yasomanee, J. P.; Demchenko, A. V. Hydrogen bond-mediated aglycone delivery
(HAD): a highly stereoselective synthesis of 1,2-cis α-D-glucosides from common
glycosyl donors in the presence of bromine. Chem. Eur. J. 2015, 21, 6572-6581.
(213) Pistorio, S. G.; Yasomanee, J. P.; Demchenko, A. V. Hydrogen bond-mediated
aglycone delivery: focus on β-mannosylation. Org. Lett. 2014, 16, 716-719.
(214) Yasomanee, J. P.; Demchenko, A. V. Hydrogen bond-mediated aglycone
delivery: the synthesis of linear and branched α-glucans. Angew. Chem. Int. Ed. 2014, 53,
10453–10456.
(215) Ruei, J.-H.; Venukumar, P.; Ingle, A. B.; Mong, K.-K. T. C6 Picoloyl protection:
a remote stereodirecting group for 2-deoxy-b-glycoside formation. Chem. Commun.
2015, 51, 5394-5397.
(216) Escopy, S.; Geringer, S. A.; De Meo, C. Combined effect of the picoloyl
protecting group and triflic acid in sialylation. Org. Lett. 2017, 19, 2638-2641.

Matteo Panza | UMSL 2019 | Page 116

(217) Wu, Y. F.; Tsai, Y. F. Assistance of the C-7,8-picoloyl moiety for directing the
glycosyl acceptors into the alpha-orientation for the glycosylation of sialyl donors. Org.
Lett. 2017, 19, 4171-4174.
(218) Liu, Q.-W.; Bin, H.-C.; Yang, J.-S. β‑Arabinofuranosylation using 5‑O‑(2quinolinecarbonyl) substituted ethyl thioglycoside donors. Org. Lett. 2013, 15, 39743977.
(219) Crich, D.; Cai, W. Chemistry of 4,6-O-benzylidene-D-glucopyranosyl triflates:
Contrasting behavior between the gluco and manno series. J. Org. Chem. 1999, 64, 49264930.
(220) Crich, D.; Sun, S. Direct synthesis of b-mannopyranosides by the sulfoxide
method. J. Org. Chem. 1997, 62, 1198-1199.
(221) Crich, D.; Sun, S. Are glycosyl triflates intermediates in the sulfoxide
glycosylation method?
a chemical and 1H, 13C, and 19F NMR spectroscopic
investigation. J. Am. Chem. Soc. 1997, 119, 11217-11223.
(222) Fraser-Reid, B.; Wu, Z.; Andrews, C. W.; Skowronski, E. Torsional effects in
glycoside reactivity: saccharide couplings mediated by acetal protecting groups. J. Am.
Chem. Soc. 1991, 113, 1434-1435.
(223) Jensen, H. H.; Nordstrom, L. U.; Bols, M. The disarming effect of the 4,6-acetal
group on glycoside reactivity: torsional or electronic? J. Am. Chem. Soc. 2004, 126,
9205-9213.
(224) Benakli, K.; Zha, C.; Kerns, R. J. Oxazolidinone protected 2-amino-2-deoxy-Dglucose derivatives as versatile intermediates in stereoselective oligosaccharide synthesis
and the formation of a-linked glycosides. J. Am. Chem. Soc. 2001, 123, 9461-9462.
(225) Kerns, R. J.; Zha, C.; Benakli, K.; Liang, Y.-Z. Extended applications and
potential limitations of ring-fused 2,3-oxazolidinone thioglycosides in glycoconjugate
synthesis. Tetrahedron Lett. 2003, 44, 8069-8072.
(226) Wei, P.; Kerns, R. J. Factors affecting stereocontrol during glycosidation of 2,3oxazolidinone-protected 1-tolylthio-N-acetyl-D-glucosamine. J. Org. Chem. 2005, 70,
4195-4198.
(227) Wei, P.; Kerns, R. J. Chemoselective deprotection and functional group
interconversion of ring-fused 2N,3O-oxazolidinones of N-acetyl-D-glucosamine.
Tetrahedron Lett. 2005, 46, 6901-6905.
(228) Boysen, M.; Gemma, E.; Lahmann, M.; Oscarson, S. Ethyl 2-acetamido-4,6-di-Obenzyl-2,3-N,O-carbonyl-2-deoxy-1-thio-b-D-glycopyranoside as a versatile GlcNAc
donor. Chem. Commun. 2005, 24, 3044-3046.
(229) Geng, Y.; Zhang, L.-H.; Ye, X.-S. Stereoselectivity investigation on glycosylation
of oxazolidinone protected 2-amino-2-deoxy-D-glucose donors based on pre-activation
protocol. Tetrahedron 2008, 64, 4949-4958.
(230) Geng, Y.; Zhang, L.-H.; Ye, X.-S. Pre-activation protocol leading to highly
stereoselectivity-controllable glycosylations of oxazolidinone protected glucosamines.
Chem. Commun. 2008, 597–599.
(231) Yang, L.; Ye, X. S. A highly a-selective glycosylation for the convenient
synthesis of repeating a-(1-->4)-linked N-acetyl-galactosamine units. Carbohydr. Res.
2010, 345, 1713-1721.

Matteo Panza | UMSL 2019 | Page 117

(232) Geng, Y.; Qin, Q.; Ye, X.-S. Lewis acids as α-directing additives in
glycosylations by using 2,3-O-carbonate-protected glucose and galactose thioglycoside
donors based on preactivation protocol. J. Org. Chem. 2012, 77, 5255-5270.
(233) Manabe, S.; Ishii, K.; Ito, Y. N-Benzyl-2,3-oxazolidinone as a glycosyl donor for
selective a-glycosylation and one-pot oligosaccharide synthesis involving 1,2-cisglycosylation. J. Am. Chem. Soc. 2006, 128, 10666-10667.
(234) Manabe, S.; Ishii, K.; Ito, Y. N-Benzyl-2,3-trans-carbamate-bearing glycosyl
donors for 1,2-cis-selective glycosylation reactions. Eur. J. Org. Chem. 2011, 497-516.
(235) Crich, D.; Picione, J. Direct synthesis of the b-L-rhamnopyranosides. Org. Lett.
2003, 5, 781-784.
(236) Crich, D.; Jayalath, P. Stereocontrolled formation of b-glucosides and related
linkages in the absence of neighboring group participation: influence of a trans-fused 2,3O-carbonate group. J. Org. Chem. 2005, 70, 7252-7259.
(237) Lu, Y.-S.; Li, Q.; Zhang, L.-H.; Ye, X.-S. Highly direct a-selective glycosylations
of 3,4-O-carbonate-protected 2-deoxy and 2,6-dideoxythioglycosides by preactivation
protocol. Org. Lett. 2008, 10, 3445-3448.
(238) Tanaka, H.; Nishiura, Y.; Takahashi, T. Stereoselective synthesis of oligo-a-(2-8)sialic acids. J. Am. Chem. Soc. 2006, 128, 7124-7125.
(239) Farris, M. D.; De Meo, C. Application of 4,5-O,N-oxazolidinone protected
thiophenyl sialosyl donor to the synthesis of a-sialosides. Tetrahedron Lett. 2007, 48,
1225-1227.
(240) Crich, D.; Li, W. O-Sialylation with N-acetyl-5-N,4-O-carbonyl-protected
thiosialoside donors in dichloromethane: facile and selective cleavage of the
oxazolidinone ring. J. Org. Chem. 2007, 72, 2387-2391.
(241) Paulsen, H.: Selectivity and reactivity in oligosaccharide synthesis. In Selectivity a Goal for Synthetic Efficiency; Bartmann, W., Trost, B. M., Eds.; Verlag Chemie:
Weinheim, 1984; pp 169-190.
(242) Uriel, C.; Gomez, A. M.; Lopez, J. C.; Fraser-Reid, B. Reciprocal donor-acceptor
selectivity: the influence of the donor O-2 substituent in the regioselective mannosylation
of myo-inositol orthopentanoate. Eur. J. Org. Chem. 2009, 403-411.
(243) Jayaprakash, K. N.; Lu, J.; Fraser-Reid, B. Synthesis of a lipomannan component
of the cell-wall complex of Mycobacterium tuberculosis is based on Paulsen's concept of
donor/acceptor "match". Angew. Chem. Int. Ed. 2005, 44, 5894-5898.
(244) Uriel, C.; Gomez, A. M.; Lopez, J. C.; Fraser-Reid, B. Further insight into
'matching' of donors and acceptors via reciprocal donor acceptor selectivity (RDAS)
studies. Synlett 2003, 2203-2207.
(245) Mach, M.; Schlueter, U.; Mathew, F.; Fraser-Reid, B.; Hazen, K. C. Comparing
n-pentenyl orthoesters and n-pentenyl glycosides as alternative glycosyl donors.
Tetrahedron 2002, 58, 7345-7354.
(246) Fraser-Reid, B.; Lopez, J. C.; Radhakrishnan, K. V.; Nandakumar, M. V.; Gomez,
A. M.; Uriel, C. One pot/two donors /one diol give one differentiated trisaccharide:
powerful evidence for reciprocal donor-acceptor selectivity (RDAS). Chem. Commun.
2002, 2104-2105.
(247) Spijker, N. M.; van Boeckel, C. A. A. Double stereodifferentiation in
carbohydrate coupling reactions: the mismatched interaction of donor and acceptor as an

Matteo Panza | UMSL 2019 | Page 118

unprecedented factor governing the a/b-ratio of glycoside formation. Angew. Chem. Int.
Edit. Engl. 1991, 30, 180-183.
(248) Kimura, T.; Sekine, M.; Takahashi, D.; Toshima, K. Chiral Brønsted acid
mediated glycosylation with recognition of alcohol chirality. Angew. Chem. Int. Ed.
2013, 52, 12131-12134.
(249) Andersson, F.; Fugedi, P.; Garegg, P. J.; Nashed, M. Synthesis of 1,2-cis-linked
glycosides using dimethyl(methylthio)sulfonium triflate as promoter and thioglycosides
as glycosyl donors. Tetrahedron Lett. 1986, 27, 3919-3922.
(250) Manabe, S.; Ito, Y.; Ogawa, T. Solvent effect in glycosylation reaction on
polymer support. Synlett 1998, 628-630.
(251) Schmidt, R. R.; Rucker, E. Stereoselective glycosidations of uronic acids.
Tetrahedron Lett. 1980, 21, 1421-1424.
(252) Dohi, H.; Nishida, Y.; Tanaka, H.; Kobayashi, K. O-Methoxycarbonylphenyl 1thio-b-D-galactopyranoside, a non-malodorous thio glycosylation donor for the synthesis
of globosyl a-(1-4)-linkages. Synlett 2001, 1446-1448.
(253) Wulff, G.; Rohle, G. Results and problems of O-glycoside synthesis. Angew.
Chem., Int. Edit. Engl. 1974, 13, 157-170.
(254) Demchenko, A.; Stauch, T.; Boons, G. J. Solvent and other effects on the
stereoselectivity of thioglycoside glycosidations. Synlett 1997, 818-820.
(255) Ishiwata, A.; Munemura, Y.; Ito, Y. Synergistic solvent effect in 1,2-cisglycosides formation. Tetrahedron 2008, 64, 92-102.
(256) Chao, C. S.; Lin, C. Y.; Mulani, S.; Hung, W. C.; Mong, K. K. Neighboringgroup participation by C-2 ether functions in glycosylations directed by nitrile solvents.
Chem. Eur. J. 2011, 17, 12193-12202.
(257) Knoben, H.; Schuluter, U.; Redlich, H. Synthesis of N-unsubstituted, mono- and
di-substituted carbohydrate-1-O-carbamates and their behaviour in glycoside syntheses.
Carbohydr. Res. 2004, 339, 2821-2833.
(258) Jayakanthan, K.; Vankar, Y. D. Glycosyl trichloroacetylcarbamate: a new
glycosyl donor for O-glycosylation. Carbohydr. Res. 2005, 340, 2688-2692.
(259) Shirahata, T.; Matsuo, J.-i.; Teruya, S.; Hirata, N.; Kurimoto, T.; Akimoto, N.;
Sunazuka, T.; Kaji, E.; Omura, S. Improved catalytic and stereoselective glycosylation
with glycosyl N-trichloroacetylcarbamate: application to various 1-hydroxy sugars.
Carbohydr. Res. 2010, 345, 740-749.
(260) Wasonga, G.; Zeng, Y.; Huang, X. Pre-activation based stereoselective
glycosylations: stereochemical control by additives and solvent. Sci. China Chem. 2011,
54, 66-73.
(261) Satoh, H.; Hansen, H. S.; Manabe, S.; van Gunsteren, W. F.; Hunenberger, P. H.
Theoretical investigation of solvent effects on glycosylation reactions: stereoselectivity
controlled by preferential conformations of the intermediate oxacarbenium-counterion
complex. J. Chem. Theory Comput. 2010, 6, 1783-1797.
(262) Liu, C.-Y. I.; Mulani, S.; Mong, K.-K. T. Iterative one-pot α-glycosylation
strategy: application to oligosaccharide synthesis. Adv. Synth. Catal. 2012, 354, 32993310.
(263) Zhu, X.; Schmidt, R. R.: Glycoside synthesis from 1-oxygen-substituted glycosyl
imidates. In Handbook of Chemical Glycosylation; Demchenko, A. V., Ed.; Wiley-VCH:
Weinheim, Germany, 2008; pp 143-185.

Matteo Panza | UMSL 2019 | Page 119

(264) Schmidt, R. R.; Jung, K. H.: Trichloroacetimidates. In Carbohydrates in
Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH: Weinheim,
New York, 2000; Vol. 1; pp 5-59.
(265) Yu, B.; Sun, J. Glycosylation with glycosyl N-phenyltrifluoroacetimidates
(PTFAI) and a perspective of the future development of new glycosylation methods.
Chem. Commun. 2010, 46, 4668-4678.
(266) Nakamura, S.; Nambu, H.; Hashimoto, S.: Phosphates, phosphites and other O-P
derivatives. In Handbook of Chemical Glycosylation; Demchenko, A. V., Ed.; WileyVCH: Weinheim, Germany, 2008; pp 223-259.
(267) Yang, J.; Cooper-Vanosdell, C.; Mensah, E. A.; Nguyen, H. M. Cationic
palladium(II)-catalyzed stereoselective glycosylation with glycosyl trichloroacetimidates.
J. Org. Chem. 2008, 73, 794-800.
(268) Mensah, E. A.; Azzarelli, J. M.; Nguyen, H. M. Palladium-controlled β-selective
glycosylation in the absence of the C(2)-ester participatory group. J. Org. Chem. 2009,
74, 1650-1657.
(269) Goswami, M.; Ellern, A.; Pohl, N. L. Bismuth(V)-mediated thioglycoside
activation. Angew. Chem. Int. Ed. Engl. 2013, 52, 8441-8445.
(270) Kabotso, D. E. K.; Pohl, N. L. B. Pentavalent bismuth as a universal promoter for
S-containing glycosyl donors with a thiol additive. Org. Lett. 2017, 19, 4516-4519.
(271) Hotha, S.; Kashyap, S. Propargyl glycosides as stable glycosyl donors: anomeric
activation and glycosyl syntheses. J. Am. Chem. Soc. 2006, 128, 9620-9621.
(272) Sureshkumar, G.; Hotha, S. Propargyl 1,2-orthoesters as glycosyl donors:
stereoselective synthesis of 1,2-trans glycosides and disaccharides. Tetrahedron Lett.
2007, 48, 6564-6568.
(273) Hashmi, A. S. K. Gold-catalyzed organic reactions. Chem. Rev. 2007, 107, 31803211.
(274) Yu, B. Gold(I)-Catalyzed Glycosylation with Glycosyl o-Alkynylbenzoates as
Donors. Acc. Chem. Res. 2018, 51, 507-516.
(275) Reisman, S. E.; Doyle, A. G.; Jacobsen, E. N. Enantioselective thiourea-catalyzed
additions to oxocarbenium ions. J. Am. Chem. Soc. 2008, 130, 7198–7199.
(276) Geng, Y.; Kumar, A.; Faidallah, H. M.; Albar, H. A.; Mhkalid, I. A.; Schmidt, R.
R. Cooperative catalysis in glycosidation reactions with O-glycosyl trichloroacetimidates
as glycosyl donors. Angew. Chem. Int. Ed. 2013, 52, 10089 –10092.
(277) Romero, J. A. C.; Tabacco, S. A.; Woerpel, K. A. Stereochemical reversal of
nuclephilic substitution reactions depending upon substituent: reactions of heteroatomsubstituted six-membered-ring oxocarbenium ions through pseudoaxial conformers. J.
Am. Chem. Soc. 2000, 122, 168-169.
(278) Baghdasarian, G.; Woerpel, K. A. Electrostatic effects on the reactions of
cyclohexanone oxocarbenium ions. J. Org. Chem. 2006, 71, 6851-6858.
(279) Billings, S. B.; Woerpel, K. A. Nucleophilic substitution reactions of sulfursubstituted cyclohexanone acetals: an analysis of the factors controlling stereoselectivity.
J. Org. Chem. 2006, 71, 5171-5178.
(280) Yang, M. T.; Woerpel, K. A. The effect of electrostatic interactions on
conformational equlibria of multiply substituted tetrahydropyran oxocarbenium ions. J.
Org. Chem. 2009, 74, 545-553.

Matteo Panza | UMSL 2019 | Page 120

(281) Bérces, A.; Enright, G.; Nukada, T.; Whitfield, D. M. The conformational origin
of the barrier to the formation of neighboring group assistance in glycosylation reactions:
a dynamical density functional theory study. J. Am. Chem. Soc. 2001, 123, 5460-5464.
(282) Nukada, T.; Berces, A.; Wang, L.; Zgierski, M. Z.; Whitfield, D. M. The twoconformer hypothesis: 2,3,4,6-tetra-O-methyl-mannopyranosyl and -glucopyranosyl
oxacarbenium ions. Carbohydr. Res. 2005, 340, 841-852.
(283) Jensen, H. H.; Lyngbye, L.; Bols, M. A free-energy relationship between the rate
of acidic hydrolysis of glycosides and the pKa of isofagomines. Angew. Chem. Int. Ed.
2001, 113, 3555-3557.
(284) Jensen, H. H.; Bols, M. Steric effects are not the cause of the rate difference in
hydrolysis of stereoisomeric glycosides. Org. Lett. 2003, 5, 3419-3421.
(285) Jensen, H. H.; Pedersen, C. M.; Bols, M. Going to extremes: “super” armed
glycosyl donors in glycosylation chemistry. Chem. Eur. J. 2007, 13, 7576-7582.
(286) Pedersen, C. M.; Nordstrom, L. U.; Bols, M. “Super armed” glycosyl donors:
conformational arming of thioglycosides by silylation. J. Am. Chem. Soc. 2007, 129,
9222-9235.
(287) Pedersen, C. M.; Marinescu, L. G.; Bols, M. Conformationally armed glycosyl
donors: reactivity quantification, new donors and one pot reactions. Chem. Commun.
2008, 2465-2467.
(288) Heuckendorff, M.; Pedersen, C. M.; Bols, M. Quantifying electronic effects of
common carbohydrate protecting groups in a piperidine model system. Chem. Eur. J.
2010, 16, 13982-13994.
(289) Beaver, M. G.; Billings, S. B.; Woerpel, K. A. C-Glycosylation reactions of
sulfur-substituted glycosyl donors: Evidence against the role of neighboring-group
participation. J. Am. Chem. Soc. 2008, 130, 2082-2086.
(290) Garcia, A.; Sanzone, J. R.; Woerpel, K. A. Participation of alkoxy groups in
reactions of acetals: violation of the reactivity/selectivity principle in a Curtin-Hammett
kinetic scenario. Angew. Chem. Int. Ed. Engl. 2015, 54, 12087-12090.
(291) Shenoy, S. R.; Woerpel, K. A. Investigations into the role of ion pairing in
reactions of heteroatom-substituted cyclic oxocarbenium ions. Org. Lett. 2005, 7, 11571160.
(292) Doores, K. J.; Davis, B. G. Reagent switchable stereoselective beta(1,2)
mannoside mannosylation: OH-2 of mannose is a privileged acceptor. Org. Biomol.
Chem. 2008, 6, 2692-2696.
(293) Pornsuriyasak, P.; Vetter, C.; Kaeothip, S.; Kovermann, M.; Balbach, J.;
Steinborn, D.; Demchenko, A. V. Coordination chemistry approach to the long-standing
challenge of anomeric stereoselectivity. Chem. Commun. 2009, 6379-6381.
(294) Lu, S. R.; Lai, Y. H.; Chen, J. H.; Liu, C. Y.; Mong, K. K. Dimethylformamide:
an unusual glycosylation modulator. Angew. Chem. Int. Ed. 2011, 50, 7315-7320.
(295) Mulani, S. K.; Hung, W. C.; Ingle, A. B.; Shiau, K. S.; Mong, K. K. Modulating
glycosylation with exogenous nucleophiles: an overview. Org. Biomol. Chem. 2014, 12,
1184-1197.
(296) Kayastha, A. K.; Jia, X. G.; Yasomanee, J. P.; Demchenko, A. V. 6-O-Picolinyl
and 6-O-picoloyl building blocks as glycosyl donors with switchable stereoselectivity.
Org. Lett. 2015, 17, 4448-4451.

Matteo Panza | UMSL 2019 | Page 121

(297) Xiang, S.; Hoang Kle, M.; He, J.; Tan, Y. J.; Liu, X. W. Reversing the
stereoselectivity of a palladium-catalyzed O-glycosylation through an inner-sphere or
outer-sphere pathway. Angew. Chem. Int. Ed. 2015, 54, 604-607.
(298) Yasomanee, J. P.; Parameswar, A. R.; Pornsuriyasak, P.; Rath, N. P.; Demchenko,
A. V. 2,3-Di-O-picolinyl building blocks as glycosyl donors with switchable
stereoselectivity. Org. Biomol. Chem. 2016, 14, 3159-3169.
(299) Wang, L.; Overkleeft, H. S.; van der Marel, G. A.; Codee, J. D. C. Reagent
controlled stereoselective synthesis of alpha-glucans. J. Am. Chem. Soc. 2018, 140, 46324638.
(300) Veyrieres, A.: Special problems in glycosylation reactions: 2-deoxy sugars. In
Carbohydrates in Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; WileyVCH: Weinheim, New York, 2000; Vol. 1; pp 367-406.
(301) Marzabadi, C. H.; Franck, R. W. The synthesis of 2-deoxyglycosides: 1988-1999.
Tetrahedron 2000, 56, 8385-8417.
(302) Bennett, C. S.; Galan, M. C. Methods for 2-deoxyglycoside synthesis. Chem. Rev.
2018, this issue, in press.
(303) Varki, A. Biological roles of oligosaccharides: all of the theories are correct.
Glycobiology 1993, 3, 97-130.
(304) Sasaki, K.; Tohda, K. Recent topics in β-stereoselective mannosylation.
Tetrahedron Lett. 2018, 59, 496-503.
(305) Crich, D. Chemistry of glycosyl triflates: synthesis of b-mannopyranosides
(Reprinted from Glycochemistry: Principles, Synthesis, and Applications, pg 53-75,
2001). J. Carbohydr. Chem. 2002, 21, 667-690.
(306) El Ashry, E. S. H.; Rashed, N.; Ibrahim, E. S. I. Strategies of synthetic
methodologies for constructing b-mannosidic linkage. Curr. Org. Synth. 2005, 2, 175213.
(307) van den Bos, L. J.; Dinkelaar, J.; Overkleeft, H. S.; van der Marel, G. A.
Stereocontrolled synthesis of b-D-mannuronic acid esters: synthesis of an alginate
trisaccharide. J. Am. Chem. Soc. 2006, 128, 13066-13067.
(308) Codee, J. D. C.; van den Bos, L. J.; de Jong, A.-R.; Dinkelaar, J.; Lodder, G.;
Overkleeft, H. S.; van der Marel, G. A. The stereodirecting effect of the glycosyl C5carboxylate ester: stereoselective synthesis of b-mannuronic acid alginates. J. Org. Chem.
2009, 74, 38-47.
(309) Walvoort, M. T. C.; Lodder, G.; Mazurek, J.; Overkleeft, H. S.; Codee, J. D. C.;
van der Marel, G. A. Equatorial anomeric triflates from mannuronic acid esters. J. Am.
Chem. Soc. 2009, 131, 12080-12081.
(310) Walvoort, M. T. C.; Lodder, G.; Overkleeft, H. S.; Codee, J. D. C.; van der Marel,
G. A. Mannosazide methyl uronate donors. Glycosylating properties and use in the
construction of β-ManNAcA-containing oligosaccharides. J. Org. Chem. 2010, 75, 7990–
8002.
(311) Jung, K. H.; Muller, M.; Schmidt, R. R. Intramolecular O-glycoside bond
formation. Chem. Rev. 2000, 100, 4423-4442.
(312) Madsen, J.; Bols, M.: Intramolecular glycosylation reaction. In Carbohydrates in
Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH: Weinheim,
New York, 2000; Vol. 1; pp 449-466.

Matteo Panza | UMSL 2019 | Page 122

(313) Ziegler, T.: The twenty first century view of chemical O-glycosylation. In
Handbook of Chemical Glycosylation; Demchenko, A. V., Ed.; Wiley-VCH Verlag
GmbH & Co: Weinheim, Germany, 2008; pp 469-496.
(314) Fairbanks, A. J. Intramolecular aglycon delivery (IAD): The solution to 1,2-cis
stereocontrol for oligosaccharide synthesis? Synlett 2003, 1945-1958.
(315) Ishiwata, A.; Lee, Y. J.; Ito, Y. Recent advances in stereoselective glycosylation
through intramolecular aglycon delivery. Org. Biomol. Chem. 2010, 8, 3596-3608.
(316) Cumpstey, I. Intramolecular aglycon delivery. Carbohydr. Res. 2008, 343, 15531573.
(317) Bols, M.; Skrydstrup, T. Silicon-tethered reactions. Chem. Rev. 1995, 95, 1253–
1277.
(318) Jia, X. G.; Demchenko, A. V. Intramolecular glycosylation. Beilstein J. Org.
Chem. 2017, 13, 2028-2048.
(319) Barresi, F.; Hindsgaul, O. Synthesis of b-mannosides by intramolecular aglycon
delivery. J. Am. Chem. Soc. 1991, 113, 9376-9377.
(320) Stork, G.; Kim, G. Stereocontrolled synthesis of disaccharides via the temporary
silicon connection. J. Am. Chem. Soc. 1992, 114, 1087-1088.
(321) Bols, M. Stereocontrolled synthesis of a-glucosides by intramolecular
glycosidation. J. Chem. Soc., Chem. Commun. 1992, 913-914.
(322) Seward, C. M. P.; Cumpstey, I.; Aloui, M.; Ennis, S. C.; Redgrave, A. J.;
Fairbanks, A. J. Stereoselective cis glycosylation of 2-O-allyl protected glycosyl donors
by intramolecular aglycon delivery (IAD). Chem. Commun. 2000, 1409-1410.
(323) Ishiwata, A.; Munemura, Y.; Ito, Y. NAP ether mediated intramolecular aglycone
delivery: a unified strategy for 1,2-cis-glycosylation. Eur. J. Org. Chem. 2008, 42504263.
(324) Yong, J. L.; Ishiwata, A.; Ito, Y. Stereoselective synthesis of β-Lrhamnopyranosides. J. Am. Chem. Soc. 2008, 130, 6330-6331.
(325) Ishiwata, A.; Ito, Y. Development of highly efficient and stereocontrolled Oglycosylation methodologies and its application to the construction of bacterial glycans.
Trends Glycosci. Glycotechnol. 2009, 21, 266-289.
(326) Ishiwata, A.; Kaeothip, S.; Takeda, Y.; Ito, Y. Synthesis of the highly
glycosylated hydrophilic motif of extensins. Angew. Chem. Int. Ed. 2014, 53, 9812-9816.
(327) Ishiwata, A.; Ito, Y. Synthesis of docosasaccharide arabinan motif of
mycobacterial cell wall. J. Am. Chem. Soc. 2011, 133, 2275-2291.
(328) Ishiwata, A.; Sakurai, A.; Nishimiya, Y.; Tsuda, S.; Ito, Y. Synthetic study and
structural analysis of the antifreeze agent xylomannan from Upis ceramboides. J. Am.
Chem. Soc. 2011, 133, 19524-19535.
(329) Ishiwata, A.; Ito, Y. Intramolecular aglycon delivery and its application to
stereoselective synthesis of glycans. Yuki Gosei Kagaku Kyokaishi/J. Synth. Org. Chem.
2012, 70, 382-394.
(330) Kaeothip, S.; Ishiwata, A.; Ito, Y. Stereoselective synthesis of Arabidopsis
CLAVATA3 (CLV3) glycopeptide, unique protein post-translational modifications of
secreted peptide hormone in plant. Org. Biomol. Chem. 2013, 11, 5892-5907.
(331) Ishiwata, A.; Ito, Y.: Synthesis of bacterial cell envelope components. In
Glycochemical Synthesis: Strategies and Applications, 2015; pp 361-406.

Matteo Panza | UMSL 2019 | Page 123

(332) Gelin, M.; Ferrieres, V.; Plusquellec, D. A general and diastereoselective
synthesis of 1,2-cis-hexofuranosides from 1,2-trans-thiofuranosyl donors. Eur. J. Org.
Chem. 2000, 1423-1431.
(333) Lowary, T. L. D-Arabinofuranosides from mycobacteria: Synthesis and
conformation (Reprinted from Glycochemistry: Principles, Synthesis, and Applications,
pg 133-162, 2001). J. Carbohydr. Chem. 2002, 21, 691-722.
(334) Gadikota, R. R.; Callam, C. S.; Lowary, T. L. Stereocontrolled synthesis of 2,3anhydro-b-D-lyxofuranosyl glycosides. Org. Lett. 2001, 3, 607-610.
(335) Bai, Y.; Lowary, T. L. 2,3-Anhydrosugars in glycoside bond synthesis.
Application to a-D-galactofuranosides. J. Org. Chem. 2006, 71, 9658-9671.
(336) Zhu, X.; Kawatkar, S.; Rao, Y.; Boons, G. J. Practical approach for the
stereoselective introduction of b-arabinofuranosides. J. Am. Chem. Soc. 2006, 128,
11948-11957.
(337) Crich, D.; Pedersen, C. M.; Bowers, A. A.; Wink, D. J. On the use of 3,5-Obenzylidene and 3,5-O-(di-tert-butylsilylene)-2-O-benzylarabinothiofuranosides and their
sulfoxides as glycosyl donors for the synthesis of β-arabinofuranosides: importance of
the activation method. J. Org. Chem. 2007, 72, 1553-1565.
(338) Ishiwata, A.; Akao, H.; Ito, Y. Stereoselective synthesis of a fragment of
mycobacterial arabinan. Org. Lett. 2006, 8, 5525-5528.
(339) Boons, G. J.; Demchenko, A. V. Recent advances in O-sialylation. Chem. Rev.
2000, 100, 4539-4565.
(340) Ress, D. K.; Linhardt, R. J. Sialic acid donors: chemical synthesis and
glycosylation. Curr. Org. Synth. 2004, 1, 31-46.
(341) Ikeda, K.; Sato, M.; Torisawa, Y. Some aspects of sialic acid modification. Curr.
Med. Chem. 2004, 3, 339-350.
(342) De Meo, C. Synthesis of N-5-derivatives of neuraminic acid and their application
as sialosyl donors. ACS Symp. Ser. 2007, 960, 118-131.
(343) De Meo, C.; Boons, G. J.; Demchenko, A. V.: Synthesis of glycosides of sialic
acid: chemical aspects (scope and limitations). In Comprehensive Glycoscience - From
Chemistry to Systems Biology; Kamerling, J. P., Ed.; Elsevier, 2007.
(344) Muthana, S.; Cao, H.; Chen, X. Recent progress in chemical and chemoenzymatic
synthesis of carbohydrates. Curr. Opin. Chem. Biol. 2009, 13, 573-581.
(345) Mandhapati, A. R.; Rajender, S.; Shaw, J.; Crich, D. The isothiocyanato moiety:
an ideal protecting group for the stereoselective synthesis of sialic acid glycosides and
subsequent diversification. Angew. Chem. Int. Ed. 2015, 54, 1275-1278.
(346) Paquet, F.; Sinay, P. Intramolecular oximercuration-demercuration reaction: A
new stereocontrolled approach to sialic acid containing disaccharides. Tetrahedron Lett.
1984, 25, 3071-3074.
(347) Ohtake, H.; Ichiba, N.; Ikegami, S. A highly stereoselective construction of bglycosyl linkages by reductive cleavage of cyclic sugar ortho esters. J. Org. Chem. 2000,
65, 8171-8179.
(348) Babu, R. S.; Zhou, M.; O'Doherty, G. A. De novo synthesis of oligosaccharides
using a palladium-catalyzed glycosylation reaction. J. Am. Chem. Soc. 2004, 126, 34283429.
(349) Zhou, M.; O’Doherty, G. A. De novo approach to 2-deoxy-a-glycosides:
asymmetric syntheses of digoxose and digitoxin. J. Org. Chem. 2007, 72, 2485-2493.

Matteo Panza | UMSL 2019 | Page 124

(350) Guo, H.; O’Doherty, G. A. De novo asymmetric synthesis of anthrax
tetrasaccharide and related tetrasaccharide. J. Org. Chem. 2008, 73, 5211-5220.
(351) Zhou, M.; O’Doherty, G. A. The de novo synthesis of oligosaccharides:
application to the medicinal chemical study of Digitoxin. Curr. Topics Med. Chem. 2008,
8, 114-125.
(352) Demchenko, A. V. Strategic approach to the chemical synthesis of
oligosaccharides. Lett. Org. Chem. 2005, 2, 580-589.
(353) Love, K. R.; Andrade, R. B.; Seeberger, P. H. Linear synthesis of a protected htype II pentasaccharide using glycosyl phosphate building blocks. J. Org. Chem. 2001,
66, 8165-8176.
(354) Seeberger, P. H.; Haase, W. C. Solid-phase oligosaccharide synthesis and
combinatorial carbohydrate libraries. Chem. Rev. 2000, 100, 4349-4393.
(355) Miura, T.; Goto, K.; Waragai, H.; Matsumoto, H.; Hirose, Y.; Ohmae, M.; Ishida,
H.; Satoh, A.; Inazu, T. Rapid oligosaccharide synthesis using a fluorous protective
group. J. Org. Chem. 2004, 69, 5348-5353.
(356) Koto, S.; Uchida, T.; Zen, S. Syntheses of isomaltose, isomaltotetraose, and
isomaltooctaose. Bull. Chem. Soc. Jpn. 1973, 46, 2520-2523.
(357) Paulsen, H. Advances in selective chemical syntheses of complex
oligosaccharides. Angew. Chem. Int. Edit. Engl. 1982, 21, 155-173.
(358) Ogawa, T.; Yamamoto, H.; Nukada, T.; Kitajima, T.; Sugimoto, M. Synthetic
approach to glycan chains of a glycoprotein and proteoglycan. Pure Appl. Chem. 1984,
56, 779-795.
(359) Sardar, M. Y. R.; Mandhapati, A. R.; Park, S.; Wever, W. J.; Cummings, R. D.;
Chaikof, E. L. Convergent Synthesis of Sialyl LewisX- O-Core-1 Threonine. J. Org.
Chem. 2018, 83, 4963-4972.
(360) Goto, K.; Sawa, M.; Tamai, H.; Imamura, A.; Ando, H.; Ishida, H.; Kiso, M. The
total synthesis of starfish ganglioside GP3 bearing a unique sialyl glycan architecture.
Chem. Eur. J. 2016, 22, 8323 –8331.
(361) Demchenko, A. V.; Boons, G. J. A highly convergent synthesis of a complex
oligosaccharide derived from group B type III Streptococcus. J. Org. Chem. 2001, 66,
2547-2554.
(362) Backinowsky, L. V.; Abronina, P. I.; Shashkov, A. S.; Grachev, A. A.;
Kochetkov, N. K.; Nepogodiev, S. A.; Stoddart, J. F. An efficient approach towards the
convergent synthesis of "fully-carbohydrate" mannodendrimers. Chem. Eur. J. 2002, 8,
4412-4423.
(363) Xue, J.; Guo, Z. Convergent synthesis of a GPI containing an acylated inositol. J.
Am. Chem. Soc. 2003, 125, 16334-16339.
(364) Liu, X.; Kwon, Y. U.; Seeberger, P. H. Convergent synthesis of a fully lipidated
glycosylphosphatidylinositol anchor of Plasmodium falciparum. J. Am. Chem. Soc. 2005,
127, 5004-5005.
(365) Wang, Z. G.; Warren, J. D.; Dudkin, V. Y.; Zhang, X.; Iserloh, U.; Visser, M.;
Eckhardt, M.; Seeberger, P. H.; Danishefsky, S. J. A highly convergent synthesis of an Nlinked glycopeptide presenting the H-type 2 human blood group determinant.
Tetrahedron 2006, 62, 4954-4978.
(366) Crich, D.; Wu, B.; Jayalath, P. Convergent synthesis of a b-(1--3)-mannohexaose.
J. Org. Chem. 2007, 72, 6806-6815.

Matteo Panza | UMSL 2019 | Page 125

(367) Rao, Y.; Boons, G.-J. A highly convergent chemical synthesis of conformational
epitopes of rhamnogalactan II. Angew. Chem. Int. Ed. 2007, 46, 6148-6151.
(368) Vohra, Y.; Buskas, T.; Boons, G.-J. Rapid assembly of oligosaccharides: a highly
convergent strategy for the assembly of a glycosylated amino acid derived from PSGL-1.
J. Org. Chem. 2009, 74, 6064-6071.
(369) Wu, Y.; Xiong, D. C.; Chen, S. C.; Wang, Y. S.; Ye, X. S. Total synthesis of
mycobacterial arabinogalactan containing 92 monosaccharide units. Nat. Commun. 2017,
8, 14851.
(370) Mootoo, D. R.; Konradsson, P.; Udodong, U.; Fraser-Reid, B. "Armed" and
"disarmed" n-pentenyl glycosides in saccharide couplings leading to oligosaccharides. J.
Am. Chem. Soc. 1988, 110, 5583-5584.
(371) Fraser-Reid, B.; Udodong, U. E.; Wu, Z. F.; Ottosson, H.; Merritt, J. R.; Rao, C.
S.; Roberts, C.; Madsen, R. n-Pentenyl glycosides in organic chemistry: a contemporary
example of serendipity. Synlett 1992, 927-942 and references therein.
(372) Fraser-Reid, B.; Jayaprakash, K. N.; López, J. C.; Gómez, A. M.; Uriel, C.:
Protecting groups in carbohydrate chemistry profoundly influence all selectivities in
glycosyl couplings. In ACS Symp. Ser. (Frontiers in Modern Carbohydrate Chemistry)
Demchenko, A. V., Ed.; ACS Symp. Ser; Oxford Univ. Press, 2007; Vol. 960; pp 91-117.
(373) Bandara, M. D.; Yasomanee, J. P.; Demchenko, A. V.: Application of armed,
disarmed, superarmed and superdisarmed building blocks in stereocontrolled
glycosylation and expeditious oligosaccharide synthesis. In Selective Glycosylations:
Synthetic Methods and Catalysts; Bennett, C. S., Ed.; Wiley, 2017; pp 29-58.
(374) Wilson, B. G.; Fraser-Reid, B. n-Pentenyl glycoside based methodology for
determining the relative reactivities of variously protected pairs of glycosides. J. Org.
Chem. 1995, 60, 317-320.
(375) Douglas, N. L.; Ley, S. V.; Lucking, U.; Warriner, S. L. Tuning glycoside
reactivity: new tool for efficient oligosaccharides synthesis. J. Chem. Soc., Perkin Trans.
1 1998, 51-65.
(376) Zhang, Z.; Ollmann, I. R.; Ye, X. S.; Wischnat, R.; Baasov, T.; Wong, C. H.
Programmable one-pot oligosaccharide synthesis. J. Am. Chem. Soc. 1999, 121, 734-753.
(377) Fridman, M.; Solomon, D.; Yogev, S.; Baasov, T. One-pot synthesis of
glucosamine oligosaccharides. Org. Lett. 2002, 4, 281-283.
(378) Zhu, T.; Boons, G. J. Thioglycosides protected as trans-2,3-cyclic carbonates in
chemoselective glycosylations. Org. Lett. 2001, 3, 4201-4203.
(379) Kamat, M. N.; Demchenko, A. V. Revisiting the armed-disarmed concept
rationale: chemoselective activation of the S-benzoxazolyl glycosides in oligosaccharide
synthesis. Org. Lett. 2005, 7, 3215-3218.
(380) Mydock, L. K.; Demchenko, A. V. Superarming the S-benzoxazolyl glycosyl
donors by simple 2-O-benzoyl-3,4,6-tri-O-benzyl protection. Org. Lett. 2008, 10, 21032106.
(381) Mydock, L. K.; Demchenko, A. V. Application of the superarmed glycosyl donor
to chemoselective oligosaccharide synthesis. Org. Lett. 2008, 10, 2107-2110.
(382) Premathilake, H. D.; Mydock, L. K.; Demchenko, A. V. Superarming common
glycosyl donors by simple 2-O-benzoyl-3,4,6-tri-O-benzyl protection. J. Org. Chem.
2010, 75, 1095-1100.

Matteo Panza | UMSL 2019 | Page 126

(383) Heuckendorff, M.; Premathilake, H. D.; Pornsuriyasak, P.; Madsen, A. Ø.;
Pedersen, C. M.; Bols, M.; Demchenko, A. V. Superarming of glycosyl donors by
combined neighboring and conformational effects. Org. Lett. 2013, 15, 4904–4907.
(384) Bandara, M. D.; Yasomanee, J. P.; Rath, N. P.; Pedersen, C. M.; Bols, M.;
Demchenko, A. V. Conformationally superarmed S-ethyl glycosyl donors as effective
building blocks for chemoselective oligosaccharide synthesis in one pot. Org. Biomol.
Chem. 2017, 15, 559-563.
(385) Kaeothip, S.; Demchenko, A. V. On orthogonal and selective activation of
glycosyl thioimidates and thioglycosides: application to oligosaccharide assembly. J.
Org. Chem. 2011, 76, 7388-7398.
(386) Paulsen, H. Progress in oligosaccharide synthesis through a new orthogonal
glycosylation strategy. Angew. Chem. Int. Ed. Engl. 1995, 34, 1432-1434.
(387) Kanie, O.: Orthogonal strategy in oligosaccharide synthesis. In Carbohydrates in
Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH: Weinheim,
New York, 2000; Vol. 1; pp 407-426.
(388) Kanie, O.; Ito, Y.; Ogawa, T. Orthogonal glycosylation strategy in
oligosaccharide synthesis. J. Am. Chem. Soc. 1994, 116, 12073-12074.
(389) Demchenko, A. V.; De Meo, C. semi-Orthogonality of O-pentenyl and S-ethyl
glycosides: application for the oligosaccharide synthesis. Tetrahedron Lett. 2002, 43,
8819-8822.
(390) Lopez, J. C.; Agocs, A.; Uriel, C.; Gomez, A. M.; Fraser-Reid, B. Iterative,
orthogonal strategy for oligosaccharide synthesis based on the regioselective
glycosylation of polyol acceptors with partially unprotected n-pentenyl-orthoesters:
further evidence for reciprocal donor acceptor selectivity (RDAS). Chem. Commun.
2005, 5088-5090.
(391) Ako, T.; Daikoku, S.; Ohtsuka, I.; Kato, R.; Kanie, O. A method of orthogonal
oligosaccharide synthesis leading to a combinatorial library based on stationary solidphase reaction. Chem. Asian J. 2006, 1, 798-813.
(392) Kanie, O.; Ohtsuka, I.; Ako, T.; Daikoku, S.; Kanie, Y.; Kato, R. Orthogonal
glycosylation reactions on solid phase and synthesis of a library consisting of a complete
set of fucosyl galactose isomers. Angew. Chem. Int. Ed. 2006, 45, 3851-3854.
(393) Pornsuriyasak, P.; Demchenko, A. V. S-Thiazolinyl (STaz) glycosides as versatile
building blocks for convergent selective, chemoselective, and orthogonal oligosaccharide
synthesis. Chem. Eur. J. 2006, 12, 6630-6646.
(394) Lopez, J. C.; Uriel, C.; Guillamon-Martin, A.; Valverde, S.; Gomez, A. M.
IPy2BF4-Mediated transformation of n-pentenyl glycosides to glycosyl fluorides: a new
pair of semiorthogonal glycosyl donors. Org. Lett. 2007, 9, 2759-2762.
(395) Kaeothip, S.; Pornsuriyasak, P.; Rath, N. P.; Demchenko, A. V. Unexpected
orthogonality of S-benzoxazolyl and S-thiazolinyl derivatives: application to expeditious
oligosaccharide assembly. Org. Lett. 2009, 11, 799-802.
(396) Vidadala, S. R.; Thadke, S. A.; Hotha, S. Orthogonal activation of propagyl and
n-pentenyl glycosides and 1,2-orthoesters. J. Org. Chem. 2009, 74, 9233-9236.
(397) Fujikawa, K.; Vijaya Ganesh, N.; Tan, Y. H.; Stine, K. J.; Demchenko, A. V.
Reverse orthogonal approach to oligosaccharide synthesis. Chem. Commun. 2011, 1060210604.

Matteo Panza | UMSL 2019 | Page 127

(398) Kaeothip, S.; Demchenko, A. V. Expeditious oligosaccharide synthesis via
selective and orthogonal activation. Carbohydr. Res. 2011, 346, 1371-1388.
(399) Hasty, S. J.; Bandara, M. D.; Rath, N. P.; Demchenko, A. V. S-Benzimidazolyl
(SBiz) imidates as a platform for oligosaccharide synthesis via active-latent, armeddisarmed, selective and orthogonal activations. J. Org. Chem. 2017, 82, 1904-1911.
(400) Roy, R.; Andersson, F. O.; Letellier, M. "Active" and "latent" thioglycosyl donors
in oligosaccharide synthesis. Application to the synthesis of a-sialosides. Tetrahedron
Lett. 1992, 33, 6053-6056.
(401) Nicolaou, K. C.; Dolle, R. E.; Papahatjis, D. P.; Randall, J. L. Practical synthesis
of oligosaccharides. Partial synthesis of avermectin B1a. J. Am. Chem. Soc. 1984, 106,
4189-4192.
(402) Nicolaou, K. C.; Caulfield, T.; Kataoka, H.; Kumazawa, T. A practical and
enantioselective synthesis of glycosphingolipids and related compounds. Total synthesis
of globotriaosylceramide (Gb3). J. Am. Chem. Soc. 1988, 110, 7910-7912.
(403) Yamago, S.; Yamada, T.; Hara, O.; Ito, H.; Mino, Y.; Yoshida, J. A new, iterative
strategy of oligosaccharide synthesis based on highly reactive b-bromoglycosides derived
from selenoglycosides. Org. Lett. 2001, 3, 3867-3870.
(404) Murray, R. W.; Jeyaraman, R. Dioxiranes: synthesis and reactions of
methyldioxiranes. J. Org. Chem. 1985, 50, 2847-2853.
(405) Danishefsky, S. J.; Bilodeau, M. T. Glycals in organic synthesis: the evolution of
comprehensive strategies for the assembly of oligosaccharides and glycoconjugates of
biological consequence. Angew. Chem. Int. Ed. Engl. 1996, 35, 1380-1419.
(406) Deshpande, P. P.; Kim, H. M.; Zatorski, A.; Park, T. K.; Ragupathi, G.;
Livingston, P. O.; Live, D.; Danishefsky, S. J. Strategy in oligosaccharide synthesis: an
application to a concise total synthesis of the KH-1(adenocarcinoma) antigen. J. Am.
Chem. Soc. 1998, 120, 1600-1614.
(407) Gammon, D. W.; Sels, B. F.: Other methods for glycoside synthesis: dehydro and
anhydro derivatives. In Handbook of Chemical Glycosylation; Demchenko, A. V., Ed.;
Wiley-VCH: Weinheim, Germany, 2008; pp 416-448.
(408) Huang, X.; Huang, L.; Wang, H.; Ye, X. S. Iterative one-pot synthesis of
oligosaccharides. Angew. Chem. Int. Ed. 2004, 43, 5221-5224.
(409) Wang, Y.; Yan, Q.; Wu, J.; Zhang, L. H.; Ye, X. S. A new one-pot synthesis of αGal epitope derivatives involved in the hyperacute rejection response in
xenotransplantation. Tetrahedron 2005, 61, 4313-4321.
(410) Yang, B.; Yang, W.; Ramadan, S.; Huang, X. Pre-activation-vased stereoselective
glycosylations. Eur. J. Org. Chem. 2018, 2018, 1075-1096.
(411) Wang, C.; Wang, H.; Huang, X.; Zhang, L. H.; Ye, X. S. Benzenesulfinyl
morpholine: a new promoter for one-pot oligosaccharide synthesis using thioglycosides
by pre-activation strategy. Synlett 2006, 2846-2850.
(412) Zeng, Y.; Wang, Z.; Whitfield, D.; Huang, X. Installation of electron-donating
protective groups, a strategy for glycosylating unreactive thioglycosyl acceptors using the
preactivation-based glycosylation method. J. Org. Chem. 2008, 73, 7952-7962.
(413) Peng, P.; Ye, X.-S. O,O-Dimethylthiophosphonosulfenyl bromide-silver triflate:
A new powerful promoter system for the preactivation of thioglycosides. Org. Biomol.
Chem. 2011, 9, 616-622.

Matteo Panza | UMSL 2019 | Page 128

(414) Yang, L.; Qin, Q.; Ye, X.-S. Preactivation: an alternative strategy in
stereoselective glycosylation and oligosaccharide synthesis. Asian J. Org. Chem. 2013, 2,
30-49.
(415) Bouhall, S. K.; Sucheck, S. J. In situ preactivation strategies for the expeditious
synthesis of oligosaccharides: A review. J. Carbohydr. Chem. 2014, 33, 347-367.
(416) Peng, P.; Xiong, D. C.; Ye, X. S. ortho-Methylphenylthioglycosides as glycosyl
building blocks for preactivation-based oligosaccharide synthesis. Carbohydr. Res. 2014,
384, 1-8.
(417) Zhu, T.; Boons, G. J. Two-directional, convergent synthesis of a pentasaccharide
that is involved in the hyperacute rejection response in xenotransplantation from pig to
man. J. Chem. Soc., Perkin Trans. 1 1998, 857-862.
(418) Boons, G. J.; Bowers, S.; Coe, D. M. Trityl ethers in oligosaccharide synthesis: a
novel strategy for the convergent assembly of oligosaccharides. Tetrahedron Lett. 1997,
38, 3773-3776.
(419) Zhu, T.; Boons, G. J. A two directional glycosylation strategy for the convergent
assembly of oligosaccharides. Tetrahedron Lett. 1998, 39, 2187-2190.
(420) Zhu, T.; Boons, G. J. A two-directional approach for the solid-phase synthesis of
trisaccharide libraries. Angew. Chem. Int. Ed. 1998, 37, 1898-1900.
(421) Wang, Y.; Ye, X. S.; Zhang, L. H. Oligosaccharide assembly by one-pot multistep strategy. Org. Biomol. Chem. 2007, 5, 2189-2200.
(422) Parameswar, A. R.; Demchenko, A. V.: One-pot oligosaccharide synthesis. In
Progress in the synthesis of complex carbohydrate chains of plant and microbial
polysaccharides; Nifantiev, N. E., Ed.; Transworld Res. Network: Kerala, 2009; pp 463488.
(423) Kulkarni, S. S.; Wang, C.-C.; Sabbavarapu, N. M.; Podilapu, A. R.; Liao, P.-H.;
Hung, S.-C. “One-pot” protection, glycosylation, and protection−glycosylation strategies
of carbohydrates. Chem. Rev. 2018, in press.
(424) Raghavan, S.; Kahne, D. A one-step synthesis of ciclamycin trisaccharide. J. Am.
Chem. Soc. 1993, 115, 1580-1581.
(425) Pornsuriyasak, P.; Demchenko, A. V. Glycosyl thioimidates in a highly
convergent one-pot strategy for oligosaccharide synthesis. Tetrahedron: Asymmetry
2005, 16, 433-439.
(426) Valverde, S.; Garcia, M.; Gomez, A. M.; Lopez, J. C. A combined
intramolecular–intermolecular one-pot glycosylation approach for the synthesis of a
branched trisaccharide. Chem. Commun. 2000, 813-814.
(427) Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. Solid-phase organic reactions:
a review of the recent literature. Tetrahedron 1996, 52, 4527-4554.
(428) Brown, R. C. D. Recent developments in solid-phase organic synthesis. J. Chem.
Soc., Perkin Trans. 1 1998, 3293-3320.
(429) Merrifield, B. The role of the support in solid phase peptide synthesis Br. Polym.
J. 1984, 16, 173-178.
(430) Solid-phase organic synthesis; Toy, P. H.; Lam, Y., Eds.; John Wiley & Sons,
Inc. : Hoboken, 2012.
(431) Merrifield, R. B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide.
J. Am. Chem. Soc. 1963, 85, 2149-2154.

Matteo Panza | UMSL 2019 | Page 129

(432) Frechet, J. M.; Schuerch, C. Solid-phase synthesis of oligosaccharides. I.
Preparation of the solid support. Poly[p-(1-propen-3-ol-1-yl)styrene]. J. Am. Chem. Soc.
1971, 93, 492-496.
(433) Kunz, H.; Schultz, M.: Glycopeptide synthesis in solution and on the solid phase.
In Carbohydrates in Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.;
Wiley-VCH: Weinheim, New York, 2000; Vol. 1; pp 267-304.
(434) Schmidt, R. R.; Jonke, S.; Liu, K.: New aspects of glycoside bond formation:
solid-phase oligosaccharide synthesis In ACS Symp. Ser. (Frontiers in Modern
Carbohydrate Chemistry) Demchenko, A. V., Ed.; ACS Symp. Ser; Oxford Univ. Press,
2007; Vol. 960; pp 209-237.
(435) Toy, P. H.; Janda, K. D. New supports for solid-phase organic synthesis:
development of polystyrene resins containing tetrahydrofuran derived cross-linkers.
Tetrahedron Lett. 1999, 40, 6329-6332.
(436) Heckel, A.; Mross, E.; Jung, K. H.; Rademann, J.; Schmidt, R. R. Oligosaccharide
synthesis on controlled-pore glass as solid phase material. Synlett 1998, 171-173.
(437) Vijaya Ganesh, N.; Fujikawa, K.; Tan, Y. H.; Nigudkar, S. S.; Stine, K. J.;
Demchenko, A. V. Surface-tethered iterative carbohydrate synthesis: a spacer study. J.
Org. Chem. 2013, 78, 6849-6857.
(438) Pornsuriyasak, P.; Ranade, S. C.; Li, A.; Parlato, M. C.; Sims, C. R.; Shulga, O.
V.; Stine, K. J.; Demchenko, A. V. STICS: surface-tethered iterative carbohydrate
synthesis. Chem. Commun. 2009, 1834-1836.
(439) Bennett, C. S. Principles of modern solid-phase oligosaccharide synthesis. Org.
Biomol. Chem. 2014, 12, 1686-1698.
(440) Douglas, S. P.; Withfield, D. M.; Krepinsky, J. J. Polymer-supported solution
synthesis of oligosaccharides using a novel versatile linker for the synthesis of Dmannopentaose, a structural unit of Dmannans of pathogenic yeasts. J. Am. Chem. Soc.
1995, 117, 2116-2117.
(441) Rodebaugh, R.; Fraser-Reid, B.; Geysen, H. M. A new o-nitrobenzyl
photocleavable linker for solid phase synthesis. Tetrahedron Lett. 1997, 38, 7653-7656.
(442) Weigelt, D.; Magnusson, G. A linker for solid phase carbohydrate synthesis,
permitting the introduction of variable anomeric functionality in the release step.
Tetrahedron Lett. 1998, 39, 2839-2842.
(443) Andrade, R. B.; Plante, O. J.; Melean, L. G.; Seeberger, P. H. Solid-phase
oligosaccharide synthesis: preparation of complex structures using a novel linker and
different glycosylating agents. Org. Lett. 1999, 1, 1811-1814.
(444) Fukase, K.; Nakai, Y.; Egusa, K.; Porco, J. A.; Kusumoto, S. A novel oxidatively
removable linker and its application to a-selective solid-phase oligosaccharide synthesis
on a macroporous polystyrene support. Synlett 1999, 1074-1078.
(445) James, I. W. Linkers for solid phase organic synthesis. Tetrahedron 1999, 55,
4855-4946.
(446) Guillier, F.; Orain, D.; Bradley, M. Linkers and cleavage strategies in solid-phase
organic synthesis and combinatorial chemistry. Chem. Rev. 2000, 100, 2091-2157.
(447) Brase, S.; Dahmen, S.: Linkers for solid-phase synthesis. In Handbook of
Combinatorial Chemistry, 2002; Vol. 1; pp 59-169.

Matteo Panza | UMSL 2019 | Page 130

(448) Hunt, D. K.; Seeberger, P. H. Linker influence on the stereochemical outcome of
glycosylations utilizing solid support-bound glycosyl phosphates. Org. Lett. 2002, 4,
2751-2754.
(449) Mogemark, M.; Gustafson, L.; Bengtsson, C.; Elofsson, M.; Kihlberg, J. A
fluorinated selenide linker for solid-phase synthesis of n-pentenyl glycosides. Org. Lett.
2004, 6, 4885-4888.
(450) Boas, U.; Brask, J.; Jensen, K. J. Backbone amide linker in solid-phase synthesis.
Chem. Rev. 2009, 109, 2092-2118.
(451) Mar Kayser, M.; de Paz, J. L.; Nieto, P. M. Polymer-supported synthesis of
oligosaccharides using a diisopropylsiloxane linker and trichloroacetimidate donors. Eur.
J. Org. Chem. 2010, 2010, 2138-2147.
(452) Czechura, P.; Guedes, N.; Kopitzki, S.; Vazquez, N.; Martin-Lomas, M.;
Reichardt, N. C. A new linker for solid-phase synthesis of heparan sulfate precursors by
sequential assembly of monosaccharide building blocks. Chem. Commun. 2011, 47,
2390-2392.
(453) Scott, P. J. H.: Linker strategies in modern solid-phase organic synthesis. In SolidPhase Organic Synthesis; Toy, P. H., Lam, Y., Eds.; John Wiley & Sons, Inc. : Hoboken,
2012; pp 3-82.
(454) de Jong, A. R.; Volbeda, A. G.; Hagen, B.; van den Elst, H.; Overkleeft, H. S.;
van der Marel, G. A.; Codée, J. D. C. A second-generation tandem ring-closing
metathesis cleavable linker for solid-phase oligosaccharide synthesis. Eur. J. Org. Chem.
2013, 2013, 6644-6655.
(455) Pornsuriyasak, P.; Jia, X. G.; Kaeothip, S.; Demchenko, A. V. Templated
oligosaccharide synthesis: the linker effect on the stereoselectivity of glycosylation. Org.
Lett. 2016, 18, 2316-2319.
(456) Krock, L.; Esposito, D.; Castagner, B.; Wang, C.-C.; Bindschadler, P.; Seeberger,
P. H. Streamlined access to conjugation-ready glycans by automated synthesis. Chem.
Sci. 2012, 3, 1617-1622.
(457) Yin, J.; Eller, S.; Collot, M.; Seeberger, P. H. Acylsulfonamide safety-catch
linker: promise and limitations for solid-phase oligosaccharide synthesis. Beilstein. J.
Org. Chem. 2012, 8, 2067-2071.
(458) Eller, S.; Collot, M.; Yin, J.; Hahm, H. S.; Seeberger, P. H. Automated solidphase synthesis of chondroitin sulfate glycosaminoglycans. Angew. Chem. Int. Ed. 2013,
52, 5858-5861.
(459) Wilsdorf, M.; Schmidt, D.; Bartetzko, M. P.; Dallabernardina, P.; Schuhmacher,
F.; Seeberger, P. H.; Pfrengle, F. A traceless photocleavable linker for the automated
glycan assembly of carbohydrates with free reducing ends. Chem. Commun. 2016, 52,
10187-10189.
(460) Hurevich, M.; Seeberger, P. H. Automated glycopeptide assembly by combined
solid-phase peptide and oligosaccharide synthesis. Chem. Commun. 2014, 50, 1851-1853.
(461) Roussel, F.; Takhi, M.; Schmidt, R. R. Solid-phase synthesis of a branched
hexasaccharide using a highly efficient synthetic strategy. J. Org. Chem. 2001, 66, 85408548.
(462) Randolph, J. T.; McClure, K. F.; Danishefsky, S. J. Major simplifications in
oligosaccharide syntheses arising from a solid-phase based method: an application to the
synthesis of the Lewis b antigen. J. Am. Chem. Soc. 1995, 117, 5712-5719.

Matteo Panza | UMSL 2019 | Page 131

(463) Zheng, C.; Seeberger, P. H.; Danishefsky, S. J. Amidoglycosylation of polymerbound glycals: a complete solid-phase synthesis of the oligosaccharide domain of the
Lewis b blood group determinant. Angew. Chem. Int. Ed. 1998, 37, 786-789.
(464) Parlato, M. C.; Kamat, M. N.; Wang, H.; Stine, K. J.; Demchenko, A. V.
Application of glycosyl thioimidates in solid-phase oligosaccharide synthesis. J. Org.
Chem. 2008, 73, 1716-1725.
(465) Ito, Y.; Kanie, O.; Ogawa, T. Orthogonal glycosylation strategy for rapid
assembly of oligosaccharides on a polymer support. Angew. Chem. Int. Ed. 1996, 35,
2510-2512.
(466) Tennant-Eyles, R. J.; Davis, B. G.; Fairbanks, A. J. Peptide templated glycosidic
bond formation: a new strategy for oligosaccharide synthesis. Chem. Commun. 1999,
1037-1038.
(467) Tennant-Eyles, R. J.; Davis, B. G.; Fairbanks, A. J. Peptide templated
glycosylation reactions. Tetrahedron: Asymmetry 2000, 11, 231-243.
(468) Tennant-Eyles, R. J.; Davis, B. G.; Fairbanks, A. J. Solid phase peptide templated
glycosidic bond formation. Tetrahedron: Asymmetry 2003, 14, 1201-1210.
(469) Greenwell, D. R.; Ibnouzaki, A. F.; Warriner, S. L. Peptide-templated saccharide
synthesis on a solid support. Angew. Chem. Int. Ed. 2002, 41, 1215-1218.
(470) Shulga, O. V.; Jefferson, K.; Khan, A. R.; D’Souza, V. T.; Liu, J.; Demchenko, A.
V.; Stine, K. J. Preparation and characterization of porous gold and its application as a
platform for immobilization of acetylcholine esterase. Chem. Mater. 2007, 19, 39023911.
(471) Tan, Y. H.; Davis, J. A.; Fujikawa, K.; Ganesh, N. V.; Demchenko, A. V.; Stine,
K. J. Surface area and pore size characteristics of nanoporous gold subjected to thermal,
mechanical, or surface modification studied using gas adsorption isotherms, cyclic
voltammetry, thermogravimetric analysis, and scanning electron microscopy. J. Mater.
Chem. 2012, 22, 6733-6745.
(472) Bhattarai, J. K.; Sharma, A.; Fujikawa, K.; Demchenko, A. V.; Stine, K. J.
Electrochemical synthesis of nanostructured gold film for the study of carbohydratelectin interactions using localized surface plasmon resonance spectroscopy. Carbohydr.
Res. 2015, 405, 55-65.
(473) Kim, S. H. Nanoporous gold: Preparation and applications to catalysis and
sensors. Curr. Appl. Phys. 2018, 18, 810-818.
(474) Gravert, D. J.; Janda, K. D. Organic synthesis on soluble polymer supports:
liquid-phase methodologies. Chem. Rev. 1997, 97, 489-509.
(475) Tanaka, K.; Fukase, K.: Oligosaccharide synthesis on solid, soluble polymer, and
tag supports. In Solid-Phase Organic Synthesis; Toy, P. H., Lam, Y., Eds.; John Wiley &
Sons, Inc. : Hoboken, 2012; pp 489-530.
(476) Ando, H.; Manabe, S.; Nakahara, Y.; Ito, Y. Solid-phase capture - release strategy
applied to oligosaccharide synthesis on a soluble polymer support. Angew. Chem. Int. Ed.
2001, 40, 4725-4728.
(477) Yan, F.; Gilbert, M.; Wakarchuk, W. W.; Brisson, J. R.; Whitfield, D. M.
Chemoenzymatic iterative synthesis of difficult linkages of oligosaccharides on soluble
polymeric supports. Org. Lett. 2001, 3, 3265-3268.
(478) Ojeda, R.; de Paz, J. L.; Martin-Lomas, M. Synthesis of heparin-like
oligosaccharides on a soluble polymer support. Chem. Commun. 2003, 2486-2487.

Matteo Panza | UMSL 2019 | Page 132

(479) Majumdar, D.; Zhu, T.; Boons, G.-J. Synthesis of oligosaccharides on soluble
high molecular-weight-branched polymers in combination with purification by
nanofiltration. Org. Lett. 2003, 5, 3591-3594.
(480) Zhu, T.; Boons, G.-J. A novel and efficient synthesis of a dimeric Lex
oligosaccharide on polymeric support. J. Am. Chem. Soc. 2000, 122, 10222-10223.
(481) Huo, C.; Chan, T. H. A novel liquid-phase strategy for organic synthesis using
organic ions as soluble supports. Chem. Soc. Rev. 2010, 39, 2977-3006.
(482) Galan, M. C.; Corfield, A. P. Ionic liquids in oligosaccharide synthesis: Towards
mucin-type glycan probes. Biochem. Soc. Trans. 2010, 38, 1368-1373.
(483) Pathak, A. K.; Yerneni, C. K.; Young, Z.; Pathak, V. Oligomannan synthesis
using ionic liquid supported glycosylation. Org. Lett. 2008, 10, 145-148.
(484) Yerneni, C. K.; Pathak, V.; Pathak, A. K. Imidazolium cation supported solutionphase assembly of homolinear α(1→6)−linked octamannoside: an efficient alternate
approach for oligosaccharide synthesis. J. Org. Chem. 2009, 74, 6307-6310.
(485) Pépin, M.; Hubert-Roux, M.; Martin, C.; Guillen, F.; Lange, C.; Gouhier, G. First
examples of α-(1→4)-glycosylation reactions on ionic liquid supports. Eur. J. Org.
Chem. 2010, 6366-6371.
(486) Krishnamurthy, V. R.; Dougherty, A.; Kamat, M.; Song, X.; Cummings, R. D.;
Chaikof, E. L. Synthesis of an Fmoc-threonine bearing core-2 glycan: a building block
for PSGL-1 via Fmoc-assisted solid-phase peptide synthesis. Carbohydr. Res. 2010, 345,
1541-1547.
(487) Zhong, W.; Boons, G.-J.: Glycoside synthesis from 1-sulfur/selenium-substituted
derivatives: thioglycosides in oligosaccharide synthesis. In Handbook of Chemical
Glycosylation; Demchenko, A. V., Ed.; Wiley-VCH: Weinheim, Germany, 2008; pp 261303.
(488) Codee, J. D. C.; Litjens, R. E. J. N.; van den Bos, L. J.; Overkleeft, H. S.; van der
Marel, G. A. Thioglycosides in sequential glycosylation strategies. Chem. Soc. Rev. 2005,
34, 769-782.
(489) Oscarson, S.: Thioglycosides. In Carbohydrates in Chemistry and Biology; Ernst,
B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH: Weinheim, New York, 2000; Vol. 1; pp 93116.
(490) Garegg, P. J. Thioglycosides as glycosyl donors in oligosaccharide synthesis. Adv.
Carbohydr. Chem. Biochem. 1997, 52, 179-205.
(491) Schmidt, R. R.; Jung, K. H.: Oligosaccharide synthesis with trichloroacetimidates.
In Preparative Carbohydrate Chemistry; Hanessian, S., Ed.; Marcel Dekker, Inc.: New
York, 1997; pp 283-312.
(492) Schmidt, R. R.; Kinzy, W. Anomeric-oxygen activation for glycoside synthesis:
the trichloroacetimidate method. Adv. Carbohydr. Chem. Biochem. 1994, 50, 21-123.
(493) Crotti, S.; Adamo, R. New strategies for the synthesis of bio-medically relevant
oligosaccharides: recent updates on 1,2-cis-O-glycosylation and α-O-sialylation. Curr.
Org. Synth. 2013, 10, 501-524.
(494) Yu, B.; Sun, J.; Yang, X. Assembly of naturally occurring glycosides, evolved
tactics, and glycosylation methods. Acc. Chem. Res. 2012, 45, 1227-1236.
(495) Garcia, B. A.; Gin, D. Y. Dehydrative glycosylation with activated diphenyl
sulfonium reagents. Scope, mode of C(1)-hemiacetal activation, and detection of reactive
glycosyl intermediates. J. Am. Chem. Soc. 2000, 122, 4269-4279.

Matteo Panza | UMSL 2019 | Page 133

(496) Ravidà, A.; Liu, X.; Kovacs, L.; Seeberger, P. H. Synthesis of glycosyl
phosphates from 1,2-orthoesters and application to in situ glycosylation reactions. Org.
Lett. 2006, 8, 1815-1818.
(497) Carrel, F. R.; Geyer, K.; Codée, J. D. C.; Seeberger, P. H. Oligosaccharide
synthesis in microreactors. Org. Lett. 2007, 9, 2285-2288.
(498) Seeberger, P. H. Automated oligosaccharide synthesis. Chem. Soc. Rev. 2008, 37,
19-28.
(499) Lai, C. H.; Hahm, H. S.; Liang, C. F.; Seeberger, P. H. Automated solid-phase
synthesis of oligosaccharides containing sialic acids. Beilstein. J. Org. Chem. 2015, 11,
617-621.
(500) Nigudkar, S. S.; Parameswar, A. R.; Pornsuriyasak, P.; Stine, K. J.; Demchenko,
A. V. O-Benzoxazolyl imidates as versatile glycosyl donors for chemical glycosylation.
Org. Biomol. Chem. 2013, 11, 4068-4076.
(501) Nigudkar, S. S.; Wang, T.; Pistorio, S. G.; Yasomanee, J. P.; Stine, K. J.;
Demchenko, A. V. OFox imidates as versatile glycosyl donors for chemical
glycosylation. Org. Biomol. Chem. 2017, 15, 348-359.
(502) Pistorio, S. G.; Nigudkar, S. S.; Stine, K. J.; Demchenko, A. V. HPLC-assisted
automated oligosaccharide synthesis: the implementation of the autosampler as a mode of
the reagent delivery. J. Org. Chem. 2016, 81, 8796-8805.
(503) Seeberger, P. H. The logic of automated glycan assembly. Acc. Chem. Res. 2015,
48, 1450-1463.
(504) Ley, S. V. The Engineering of Chemical Synthesis: Humans and Machines
Working in Harmony. Angew. Chem. Int. Ed. 2018, 57, 5182-5183.
(505) Trobe, M.; Burke, M. D. The molecular industrial revolution: automated synthesis
of small molecules. Angew. Chem. Int. Ed. 2018, 57, 4192-4214.
(506) Koeller, K. M.; Wong, C. H. Synthesis of complex carbohydrates and
glycoconjugates: Enzyme-based and programmable one-pot strategies. Chem. Rev. 2000,
100, 4465-4493.
(507) Sears, P.; Wong, C. H. Toward automated synthesis of oligosaccharides and
glycoproteins. Science 2001, 291, 2344-2350.
(508) Takahashi, T.; Adachi, M.; Matsuda, A.; Doi, T. Combinatorial synthesis of
trisaccharides via solution-phase one-pot glycosylation. Tetrahedron Lett. 2000, 41,
2599-2603.
(509) Plante, O. J.; Palmacci, E. R.; Seeberger, P. H. Automated solid-phase synthesis
of oligosaccharides. Science 2001, 291, 1523-1527.
(510) Plante, O. J.; Palmacci, E. R.; Seeberger, P. H. Development of an automated
oligosaccharide synthesizer. Adv. Carbohydr. Chem. Biochem. 2003, 58, 35-54.
(511) Tanaka, H.; Matoba, N.; Tsukamoto, H.; Takimoto, H.; Yamada, H.; Takahashi,
T. Automated parallel synthesis of a protected oligosaccharide library based upon the
structure of dimeric Lewis X by one-pot sequential glycosylation. Synlett 2005, 824-828.
(512) Machida, K.; Hirose, Y.; Fuse, S.; Sugawara, T.; Takahashi, T. Development and
application of a solution-phase automated synthesizer, 'ChemKonzert'. Chem. Pharm.
Bull. 2010, 58, 87-93.
(513) Jaipuri, F. A.; Pohl, N. L. Toward solution-phase automated iterative synthesis:
fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomers.
Org. Biomol. Chem. 2008, 6, 2686-2691.

Matteo Panza | UMSL 2019 | Page 134

(514) Vijaya Ganesh, N.; Fujikawa, K.; Tan, Y. H.; Stine, K. J.; Demchenko, A. V.
HPLC-assisted automated oligosaccharide synthesis. Org. Lett. 2012, 14, 3036-3039.
(515) Nokami, T.; Hayashi, R.; Saigusa, Y.; Shimizu, A.; Liu, C.-Y.; Mong, K.-K. T.;
Yoshida, J.-i. Automated solution-phase synthesis of oligosaccharides via iterative
electrochemical assembly of thioglycosides. Org. Lett. 2013, 15, 4520-4523.
(516) Hsu, C. H.; Hung, S. C.; Wu, C. Y.; Wong, C. H. Toward automated
oligosaccharide synthesis. Angew. Chem. Int. Ed. 2011, 50, 11872-11923.
(517) Huang, T. Y.; Zulueta, M. M. L.; Hung, S. C. One-pot strategies for the synthesis
of the tetrasaccharide linkage region of proteoglycans. Org. Lett. 2011, 13, 1506-1509.
(518) Huang, Y. L.; Hung, J. T.; Cheung, S. K.; Lee, H. Y.; Chu, K. C.; Li, S. T.; Lin,
Y. C.; Ren, C. T.; Cheng, T. J.; Hsu, T. L.; Yu, A. L.; Wu, C. Y.; Wong, C. H.
Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer. Proc. Nat.
Acad. Sci. 2013, 110, 2517-2522.
(519) Grice, P.; Ley, S. V.; Pietruszka, J.; Priepke, H. W. M.; Walther, E. P. E. Tuning
the reactivity of glycosides: efficient one-pot oligosaccharide synthesis. Synlett 1995,
781-784.
(520) Baeschlin, D. K.; Chaperon, A. R.; Charbonneau, V.; Green, L. G.; Ley, S. V.;
Lucking, U.; Walther, E. Rapid assembly of oligosaccharides: Total synthesis of a
glycosylphosphatidylinositol anchor of trypanosoma brucei. Angew. Chem. Int. Edit.
1998, 37, 3423-3428.
(521) Reactivity tuning in oligosaccharide assembly; Fraser-Reid, B.; Lopez, J. C., Eds.;
Springer-Verlag: Berlin-Heidelberg, 2011; Vol. 301.
(522) Tanaka, H.; Yamada, H.; Takahashi, T. Rapid synthesis of oligosaccharides based
on one-pot glycosylation. Trends Glycosci. Glycotechnol. 2007, 19, 183-193.
(523) Seeberger, P. H. Automated carbohydrate synthesis to drive chemical glycomics.
Chem. Commun. 2003, 115-1121.
(524) Seeberger, P. H.; Werz, D. B. Automated synthesis of oligosacchraides as a basis
for drug discovery. Nature Rev. 2005, 4, 751-763.
(525) Lepenies, B.; Yin, J.; Seeberger, P. H. Applications of synthetic carbohydrates to
chemical biology. Curr. Opin. Chem. Biol. 2010, 14, 404-411.
(526) Palmacci, E. R.; Plante, O. J.; Hewitt, M. C.; Seeberger, P. H. Automated
synthesis of oligosaccharides. Helv. Chim. Acta 2003, 86, 3975-3990.
(527) Melean, L. G.; Love, K. R.; Seeberger, P. H. Toward the automated solid-phase
synthesis of oligoglucosamines: Systematic evaluation of glycosyl phosphate and
glycosyl trichloroacetimidate building blocks. Carbohydr. Res. 2002, 337, 1893-1916.
(528) Kanemitsu, T.; Seeberger, P. H. Use of olefin cross-metathesis to release azidecontaining sugars from solid support. Org. Lett. 2003, 5, 4541-4544.
(529) Esposito, D.; Hurevich, M.; Castagner, B.; Wang, C. C.; Seeberger, P. H.
Automated synthesis of sialylated oligosaccharides. Beilstein J. Org. Chem. 2012, 8,
1601-1609.
(530) Kandasamy, J.; Hurevich, M.; Seeberger, P. H. Automated solid phase synthesis
of oligoarabinofuranosides. Chem. Commun. 2013, 49, 4453-4455.
(531) Love, K. R.; Seeberger, P. H. Automated solid-phase synthesis of protected
tumor-associated antigen and blood group determinant oligosaccharides. Angew. Chem.
Int. Ed. 2004, 43, 602-605.

Matteo Panza | UMSL 2019 | Page 135

(532) Grubbs, R. H.; Miller, S. J.; Fu, G. C. Ring-closing metathesis and related
processes in organic synthesis. Acc. Chem. Res. 1995, 28, 446-452.
(533) Hakomori, S. Glycosphingolipids in cellular interaction, differentiation, and
oncogenesis. Ann. Rev. Biochem. 1981, 50, 733-764.
(534) Hakomori, S. Tumor-associated carbohydrate antigens. Annu. Rev. Immunol.
1984, 2, 103-126.
(535) Hakomori, S. Cancer-associated glycosphingolipid antigens: their structure,
organization and function. Acta Anat. 1998, 161, 79-90.
(536) Hakomori, S. Structure and function of glycosphingolipids and sphingolipids:
recollections and future trends. Biochim. Biophys. Acta 2008, 1780, 325-346.
(537) Guo, Z.; Wang, Q. Recent development in carbohydrate-based cancer vaccines.
Curr. Opinion in Chem. Biology 2009, 13, 608-617.
(538) Codée, J. D. C.; Kröck, L.; Castagner, B.; Seeberger, P. H. Automated solid-phase
synthesis of protected oligosaccharides containing β-mannosidic linkages. Chem. Eur. J.
2008, 14, 3987-3994.
(539) Crich, D.; Sun, S. Direct formation of b-mannopyranosides and other hindered
glycosides from thioglycosides. J. Am. Chem. Soc. 1998, 120, 435-436.
(540) Pitsch, S.; Weiss, P. A.; Wu, X.; Ackermann, D.; Honegger, T. Fast and reliable
automated synthesis of RNA and partially 2′-O- protected precursors (`Caged RNA')
based on two novel, orthogonal 2′-O-protecting groups, preliminary communication.
Helv. Chim. Acta 1999, 82, 1753-1761.
(541) Crich, D.; Jayalath, P. 2-O-Propargyl ethers: readily cleavable, minimally
intrusive protecting groups for β-mannosyl donors. Org. Lett. 2005, 7, 2277-2280.
(542) Walvoort, M. T. C.; van den Elst, H.; Plante, O. J.; Krock, L.; Seeberger, P. H.;
Overkleeft, H. S.; van der Marel, G. A.; Codee, J. D. C. Automated solid-phase synthesis
of b-mannuronic acid alginates. Angew. Chem. Int. Ed. 2012, 51, 4393-4396.
(543) Ratner, D. M.; Murphy, E. R.; Jhunjhunwala, M.; Snyder, D. A.; Jensen, K. F.;
Seeberger, P. H. Microreactor-based reaction optimization in organic chemistry glycosylation as a challenge. Chem. Commun. 2005, 578-580.
(544) Alley, W. R.; Mann, B. F.; Hruska, V.; Novotny, M. V. Isolation and purification
of glycoconjugates from complex biological sources by recycling high-performance
liquid chromatography. Anal. Chem. 2013, 85, 10408-10416.
(545) Nagy, G.; Peng, T.; Kabotso, D. E. K.; Novotny, M. V.; Pohl, N. L. B. Protocol
for the purification of protected carbohydrates: toward coupling automated synthesis to
alternate-pump recycling high-performance liquid chromatography. Chem. Commun.
2016, 52, 13253-13256.
(546) Tang, S.-L.; Linz, L. B.; Bonning, B. C.; Pohl, N. L. B. Automated solution-phase
synthesis of insect glycans to probe the binding affinity of pea enation mosaic virus. J.
Org. Chem. 2015, 80, 10482-10489.
(547) Tang, S.-L.; Pohl, N. L. B. Automated solution-phase synthesis of β‑1,4mannuronate and β‑1,4-mannan. Org. Lett. 2015, 17, 2642-2645.
(548) Bhaduri, S.; Pohl, N. L. B. Fluorous-tag assisted syntheses of sulfated keratan
sulfate oligosaccharide fragments. Org. Lett. 2016, 18, 1414-1417.
(549) Tang, S.-L.; Pohl, N. L. B. Automated fluorous-assisted solution-phase synthesis
of β-1,2-, 1,3-, and 1,6-mannan oligomers. Carbohydr. Res. 2016, 430, 8-15.

Matteo Panza | UMSL 2019 | Page 136

(550) Calin, O.; Eller, S.; Seeberger, P. H. Automated polysaccharide synthesis:
assembly of a 30mer mannoside. Angew. Chem. Int. Ed. 2013, 52, 5862-5865.
(551) Naresh, K.; Schumacher, F.; Hahm, H. S.; Seeberger, P. H. Pushing the limits of
automated glycan assembly: synthesis of a 50mer polymannoside. Chem. Commun. 2017,
53, 9085-9088.
(552) Chu, K.-C.; Ren, C.-T.; Lu, C.-P.; Hsu, C.-H.; Sun, T.-H.; Han, J.-L.; Pal, B.;
Chao, T.-A.; Lin, Y.-F.; Wu, S.-H.; Wong, C.-H.; Wu, C.-Y. Efficient and stereoselective
synthesis of α(2→9) oligosialic acids: from monomers to dodecamers. Angew. Chem. Int.
Ed. 2011, 50, 9391-9395.
(553) Fair, R. J.; Hahm, H. S.; Seeberger, P. H. Combination of automated solid-phase
and enzymatic oligosaccharide synthesis provides access to alpha(2,3)-sialylated glycans.
Chem. Commun. 2015, 51, 6183-6185.
(554) Yu, H.; Chokhawala, H.; Karpel, R.; Yu, H.; Wu, B.; Zhang, J.; Zhang, Y.; Jia,
Q.; Chen, X. A multifunctional Pasteurella multocida sialyltransferase: a powerful tool
for the synthesis of sialoside libraries. J. Am. Chem. Soc. 2005, 127, 17618-17619.
(555) Hahm, H. S.; Hurevich, M.; Seeberger, P. H. Automated assembly of
oligosaccharides containing multiple cis-glycosidic linkages. Nat. Commun. 2016, 7,
12482.
(556) Schmidt, D.; Schuhmacher, F.; Geissner, A.; Seeberger, P. H.; Pfrengle, F.
Automated synthesis of arabinoxylan-oligosaccharides enables characterization of
antibodies that recognize plant cell wall glycans. Chem. Eur. J. 2015, 21, 5709-5713.
(557) Pattathil, S.; Avci, U.; Baldwin, D.; Swennes, A. G.; McGill, J. A.; Popper, Z.;
Bootten, T.; Albert, A.; Davis, R. H.; Chennareddy, C.; Dong, R.; Shea, B.; Rossi, R.;
Leoff, C.; Freshour, G.; Narra, R.; Neil, M.; York, W. S.; Hahn, M. G. A comprehensive
toolkit of plant cell wall glycan-directed monoclonal antibodies. Plant Physiol. 2010,
153, 514.
(558) Rillahan, C. D.; Paulson, J. C. Glycan microarrays for decoding the glycome.
Ann. Rev. Biochem. 2011, 80, 797-823.
(559) Mohnen, D. Pectin structure and biosynthesis. Curr. Opin. Plant Biol. 2008, 11,
266-277.
(560) Tan, L.; Showalter, A.; Egelund, J.; Hernandez-Sanchez, A.; Doblin, M.; Bacic,
A. Arabinogalactan-proteins and the research challenges for these enigmatic plant cell
surface proteoglycans. Frontiers in Plant Science 2012, 3, 140.
(561) Bartetzko, M. P.; Schuhmacher, F.; Seeberger, P. H.; Pfrengle, F. Determining
substrate specificities of β1,4-endogalactanases using plant arabinogalactan
oligosaccharides synthesized by automated glycan assembly. J. Org. Chem. 2017, 82,
1842-1850.
(562) Bartetzko, M. P.; Schuhmacher, F.; Hahm, H. S.; Seeberger, P. H.; Pfrengle, F.
Automated glycan assembly of oligosaccharides related to arabinogalactan proteins. Org.
Lett. 2015, 17, 4344-4347.
(563) Hahm, H. S.; Schlegel, M. K.; Hurevich, M.; Eller, S.; Schuhmacher, F.;
Hofmann, J.; Pagel, K.; Seeberger, P. H. Automated glycan assembly using the
Glyconeer 2.1 synthesizer. Proc. Natl. Acad. Sci. 2017, 114, E3385-E3389.
(564) Brennan, P. J.; Nikaido, H. The envelope of Mycobacteria. Ann. Rev. Biochem.
1995, 64, 29-63.

Matteo Panza | UMSL 2019 | Page 137

(565) Osborne, S. A.; Daniel, R. A.; Desilva, K.; Seymour, R. B. Antithrombin activity
and disaccharide composition of dermatan sulfate from different bovine tissues.
Glycobiology 2008, 18, 225-234.
(566) Bindschädler, P.; Adibekian, A.; Grünstein, D.; Seeberger, P. H. De novo
synthesis of differentially protected l-iduronic acid glycosylating agents. Carbohydr. Res.
2010, 345, 948-955.
(567) Kandasamy, J.; Schuhmacher, F.; Hahm, H. S.; Klein, J. C.; Seeberger, P. H.
Modular automated solid phase synthesis of dermatan sulfate oligosaccharides. Chem.
Commun. 2014, 50, 1875-1877.
(568) Koeller, K. M.; Smith, M. E. B.; Huang, R.-F.; Wong, C.-H. Chemoenzymatic
synthesis of a PSGL-1 N-terminal glycopeptide containing tyrosine sulfate and α-Olinked sialyl Lewis X. J. Am. Chem. Soc. 2000, 122, 4241-4242.
(569) Senf, D.; Ruprecht, C.; de Kruijff, G. H. M.; Simonetti, S. O.; Schuhmacher, F.;
Seeberger, P. H.; Pfrengle, F. Active site mapping of xylan-deconstructing enzymes with
arabinoxylan oligosaccharides produced by automated glycan assembly. Chem. Eur. J.
2017, 23, 3197-3205.
(570) Dallabernardina, P.; Schuhmacher, F.; Seeberger, P. H.; Pfrengle, F. Mixedlinkage glucan oligosaccharides produced by automated glycan assembly serve as tools to
determine the substrate specificity of lichenase. Chem. Eur. J. 2017, 23, 3191-3196.
(571) Delbianco, M.; Kononov, A.; Poveda, A.; Yu, Y.; Diercks, T.; Jimenez-Barbero,
J.; Seeberger, P. H. Well-defined oligo- and polysaccharides as ideal probes for structural
studies. J. Am. Chem. Soc. 2018, 140, 5421-5426.
(572) Dallabernardina, P.; Ruprecht, C.; Smith, P. J.; Hahn, M. G.; Urbanowicz, B. R.;
Pfrengle, F. Automated glycan assembly of galactosylated xyloglucan oligosaccharides
and their recognition by plant cell wall glycan-directed antibodies. Org. Biomol. Chem.
2017, 15, 9996-10000.
(573) Amatore, C.; Jutand, A.; Mallet, J. M.; Meyer, G.; Sinay, P. Electrochemical
glycosylation using phenyl S-glycosides. J. Chem. Soc., Chem. Commun. 1990, 718-719.
(574) Balavoine, G.; Berteina, S.; Gref, A.; Fischer, J. C.; Lubineau, A. Thio glycosides
as potential glycosyl donors in electrochemical glycosidation reactions. Part 1. Their
preparation and reactivity toward simple alcohols. J. Carbohydr. Chem. 1995, 14, 12171236.
(575) Yamago, S.; Kokubo, K.; Yoshida, J.-i. O-Glycosidation of telluroglycoside by
electrochemical oxidation. Chem. Lett. 1997, 26, 111-112.
(576) Yamago, S.; Kokubo, K.; Hara, O.; Masuda, S.; Yoshida, J. Electrochemistry of
chalcogenoglycosides. Rational design of iterative glycosylation based on reactivity
control of glycosyl donors and acceptors by oxidation potentials. J. Org. Chem. 2002, 67,
8584-8592.
(577) France, R. R.; Compton, R. G.; Davis, B. G.; Fairbanks, A. J.; Rees, N. V.;
Wadhawan, J. D. Selective electrochemical glycosylation by reactivity tuning. Org.
Biomol. Chem. 2004, 2, 2195-2202.
(578) Nokami, T.; Shibuya, A.; Tsuyama, H.; Suga, S.; Bowers, A. A.; Crich, D.;
Yoshida, J. Electrochemical generation of glycosyl triflate pools. J. Am. Chem. Soc.
2007, 129, 10922-10928.
(579) Nokami, T.; Isoda, Y.; Sasaki, N.; Takaiso, A.; Hayase, S.; Itoh, T.; Hayashi, R.;
Shimizu, A.; Yoshida, J.-i. Automated electrochemical assembly of the protected

Matteo Panza | UMSL 2019 | Page 138

potential TMG-chitotriomycin precursor based on rational optimization of the
carbohydrate building block Org. Lett. 2015, 17, 1525−1528.
(580) Isoda, Y.; Sasaki, N.; Kitamura, K.; Takahashi, S.; Manmode, S.; Takeda-Okuda,
N.; Tamura, J. I.; Nokami, T.; Itoh, T. Total synthesis of TMG-chitotriomycin based on
an automated electrochemical assembly of a disaccharide building block. Beilstein J.
Org. Chem. 2017, 13, 919-924.
(581) Manmode, S.; Sato, T.; Sasaki, N.; Notsu, I.; Hayase, S.; Nokami, T.; Itoh, T.
Rational optimization of the mannoside building block for automated electrochemical
assembly of the core trisaccharide of GPI anchor oligosaccharides. Carbohydr. Res.
2017, 450, 44-48.
(582) Sasaki, N.; Nokami, T.; Itoh, T. Synthesis of a TMG-chitotriomycin precursor
based on electrolyte-free electrochemical glycosylation using an ionic liquid tag. Chem.
Lett. 2017, 46, 683-685.

CHAPTER 2

Bromine-promoted glycosidation of
conformationally superarmed
thioglycosides

Panza, M.; Civera, M.; Yasomanee, J. P.; Belvisi, L.; Demchenko, A. V. Brominepromoted glycosidation of conformationally superarmed thioglycosides. Chem. Eur. J.,
2019, 25, 11831-11836

Matteo Panza | UMSL 2019 | Page 140

2.1. Introduction
While understanding the structure and functions of carbohydrates is difficult,1-3 it
is glycosylation that is flawlessly executed by enzymes4-5 has proven a particularly
challenging reaction to chemists. With the aid of modern methods, strategies, and
technologies, the formation of many glycosidic bonds can now be achieved.6-10 The
development of glycosylation reactions that will offer new capabilities for obtaining
complex glycans with exclusive stereoselectivity and enhanced purity remains an
important area of research in the field of synthetic chemistry. The goal of controlling
glycosylation has been pursued in many ways, with main focus recently shifting to studying
stereoelectronics and conformation of the starting material and key reaction intermediates.
Although some model studies have helped to establish general trends,11-18 practical
application of the stereoelectronic and conformational factors to stereocontrol of
glycosylations is still limited.
Fraser-Reid’s seminal work on the armed-disarmed approach showed that the
building block reactivity can be modulated through the choice of protecting groups.19-20 In
recent years, the scope of the original armed-disarmed concept has been expanded, and a
number of reactivity levels that extend beyond the traditional armed-disarmed boundary
have been established.21 Following other early work in the area,22-24 our group reported that
2-O-benzyl-3,4,6-tri-O-benzoyl protected donors are less reactive (superdisarmed) than
their disarmed per-Bz counterparts.25 This unexpected protecting group effect was
explained by the existence of the O2/O5 cooperative effect that takes into consideration the
stabilization of reaction intermediates, rather than only the electronics of the starting
material. While studying the activation of superdisarmed thioglycosides with Br2, we
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developed conditions at which the β-bromide was the only intermediate leading to products
(Scheme 2.1A).26 The oxacarbenium ion either did not form or had no contribution to the
formation of glycosides. As a result, the nucleophilic displacement of the β-bromide
intermediate took place in the concerted fashion leading to exclusive α-stereoselectivity of
all glycosylations. Since the α-bromide remained totally unreactive in this reaction, αthioglycoside precursor was fond to be a more suitable precursor to generate the desired βbromide intermediate stereoselectively (Scheme 2.1B). This strategic adjustment led to
improved yields, however, unreactive glycosyl acceptors still produced only moderate
yields.

Scheme 2.1. Previous glycosidations of thioglycosides with Br2
To enhance the reaction rates and achieve more practical yields, we also
investigated per-benzylated armed thioglycosides (Scheme 2.1C). Although those reactive
donors could indeed be glycosidated quite rapidly in the presence of Br2 providing good
yields, a decreased stereoselectivity was encountered.26 These reactions proceeded via the
intermediacy of the α-bromide that was sufficiently reactive in the armed series to couple
with an acceptor. Low temperature NMR experiments27 showed that the β-bromide was
also present at the early stage of the reaction. However, it was thought to be an insignificant
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intermediate en route to the product formation due to its rapid anomerization into the αcounterpart
Described herein is our dedicated effort to extend the bromine-promoted
glycosylation reaction to the investigation of glycosyl donors of the superarmed series.
There are two known concepts for superarming glycosyl donors. The first concept, wherein
the enhancement of reactivity was achieved by changing the equatorial-rich

4

C1

conformation to an axial-rich skew-boat conformation by creating steric congestion with tbutyldimethylsilyl (TBS) protecting groups at the C-2, 3 and 4, was introduced by Bols
and co-workers.28-32 The second concept introduced by our group involves the electronic
superarming using conventions of the O2/O5 cooperative effect. According to this effect,
intermediates obtained from the 2-O-benzoyl-3,4,6-tri-O-benzyl-protected glycosyl donors
are stabilized both anchimerically by the ester substituent at O-2 and electronically by the
O-5 that is surrounded by electron-rich ethers.33-35 Bols’ and our groups have also jointly
developed glycosyl donors with combined conformational and anchimeric superarming.3637

However, none of the superarmed donors developed to date can be applied to the

stereoselective synthesis of 1,2-cis glycosides. The development of highly reactive
(superarmed) α-stereoselective glycosyl donors would be very useful for all investigators
working on synthesizing 1,2-cis-linked glycans in solution and solid supports.38

2.2. Results and discussion
With a goal of investigating superarmed glycosyl donors in application to 1,2-cis
glycosylation, we began studying conformational properties of a series of β-ethylthio
glycosides β-2.1-2.3, prepared from a common diol precursor β-2.1.39 1H spectrum was
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recorded at rt and the coupling constants were consistent with those expected for the
standard 4C1 chair conformation, typical for D-glucose derivatives.40-42 We have also
recorded a 13C {1H} NMR spectrum, and the list of signals is included in Table 2.1. Diol
precursor β-2.1 was then protected with TBS groups at C-3 and C-4 positions to obtain
compound β-2.2. 1H and

13

C NMR spectra were recorded at rt. The coupling constants

obtained from the 1H spectrum clearly showed an increasing distortion in the conformation
of β-2.2 from the standard 4C1 conformation observed for β-2.1. The

HH

J values were

consistent with the previously reported values for similar compounds.21, 28-30 The difference
was particularly noticeable in the values for J2,3 and J3,4. Thus, J2,3 decreases noticeably
from 9.2 in β-2.1 to 3.9 Hz in β-2.2 and J3,4 decreases from 9.2 Hz in β-2.1 to 5.0 Hz in β2.2. This change was also associated with a shift of the anomeric proton downfield from
4.51 in β-2.1 to 4.79 ppm in β-2.2. This shift could be a sign of a particular distribution of
functional groups around the ring. The remaining ring protons H-2-5 are all shifted
downfield when TBS groups are added.
A further conformational change was observed for 3,4-di-O-triisopropylsilyl
(TIPS) glucoside β-2.3 as judged by the coupling constants of J2,3 = J3,4 = J4,5 = 0 Hz. The
value could be related to compound β-2.3 adopting an axial-rich conformation to release
the steric strain caused by bulky silyl groups at C-3,4. All ring proton signals H-2-5 in β2.3 experience even greater downfield Δδ shift than those recorded for β-2.2, while the
shifts for the H-6 protons are not affected by the 3,4-O-silylation.
Interesting trends have also been observed by comparing the 13C {1H} NMR spectra
of compounds β-2.1-2.3. The chemical shifts of C-1, C-2 and C-5 were found to be
particularly diagnostic of the conformational changes undergone by the ring. The trend
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identified is in shifting of the C-1 and C-3 signals upfield, whereas C-2, C-4 and C-5 shift
downfield. For example, the C-1 signal moves from 85.06 for β-2.1 to 82.81 of β-2.2 and
to 81.23 ppm for β-2.3. In contrast, C-5 shifts from 77.82 to 79.41 to 80.79 ppm in the
same sequence of compounds.

1H

Signal

β-2.1

H/C-1

4.51 (d)

J1,2 = 9.7

85.06

H/C-2

3.28 (dd)

J2,3 = 9.2

80.87

H/C-3

3.63 (dd)

J3,4 = 8.7

77.95

H/C-4

3.47 (dd)

J4,5 = 9.2

70.13

H/C-5

ND

77.82

J6a,6b = 12.1

64.16

H/C-1

3.55-3.59 (m)
4.57 (br d)
4.69-6.62 (m)
4.79 (d)

J1,2 = 8.3

82.81

H/C-2

3.42 (dd)

J2,3 = 3.9

82.50

H/C-3

3.91-3.86 (m)

J3,4 = 5.0

76.45

H/C-4

3.80 (t)

71.68

H/C-5

3.97-3.91 (m)

J4,5 =5.0
J5,6a = 7.4
J5,6b = 4.9
J6a,6b = 11.3

65.52

J1,2 = 8.5

81.23

H/C-6
β-2.2

J, Hz

NMR, ppm

79.41

H/C-1

4.41 (dd)
4.61 (dd)
5.05 (d)

H/C-2

3.60 (d)

J2,3 = 0

83.09

H/C-3

4.16 (bs)

J3,4 = 0

70.89

H/C-4

4.27 (bs)

75.71

H/C-5

4.24 (t)

J4,5 =0
J5,6a = 6.9
J5,6b = 6.9

H/C-6

4.50 (dd)
4.62 (dd)

J6a,6b = 11.0

66.13

H/C-6
β-2.3

NMR, ppm

13C

Cmpd

80.79

Table 2.1. NMR data for thioglycosides β-2.1-2.3
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Due to the significant changes in the coupling constants, ring distortion was
anticipated. Computational experiments were set up to investigate whether the in silico
data would support the experimental data, in collaboration with the laboratory of Prof.
Laura Belvisi. The calculations were conducted by Dr. Monica Civera. A series of
computational studies was performed on the compounds β-2.1-2.3. Computational models
of thioglycosides β-2.2 and β-2.3 were built by implementing the following workflow. 1)
Monte Carlo/Energy Minimization (MC/EM) conformational search was carried out at the
molecular mechanics level (OPLS2005 force field) leaving all dihedral angles free to move.
2) Representative minimum-energy geometries of MC/EM search was optimized at the
DFT B3LYP/6-31G* level of theory. 3) The obtained stationary points were confirmed as
minima by calculating vibrational frequencies at the same level of theory and their
thermochemical properties, including the final denoted total Gibbs free energy, were
computed. DFT minimum energy structures and relative energy differences, resulting from
these computational studies, are summarized in Table 2.2.
Cmpd Conformation Relative energy
β-2.2

4

C1 chair

0.00 kcal mol-1

1

C4 chair

0.75 kcal mol-1

3,O

B boat

2

β-2.3

1.32 kcal mol-1

SO skew-boat

2.53 kcal mol-1

3

S1 skew-boat

0.00 kcal mol-1

1

C4 chair

2.24 kcal mol-1

2

SO skew-boat

4.72 kcal mol-1
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Table 2.2. DFT B3LYP/6-31G* minimum energy structures of thioglycosides β-2.2
and β-2.3 with relative Gibbs free energies
In the case of compound β-2.2, the standard 4C1 chair conformation is the most
stable, whereas the axial-rich 1C4 chair and 3,OB boat conformations lie 0.75 and 1.32 kcal
mol-1, respectively, above the minimum energy structure, likely contributing to the
conformational equilibrium. Interestingly, the axial-rich skew-boat conformation 3S1 was
located by DFT calculations as the lowest energy minimum of the 3,4-OTIPS glucoside β2.3 (Figure 2.1), followed by the 1C4 chair at 2.24 kcal mol-1. The computational data
achieved for thioglycosides β-2.2 and β-2.3 match well the experimental trend, with the
calculated coupling constant values of the most stable skew-boat conformation of β-2.3
being very close to the experimental ones (See appendix, Table A-1 and A-2)

Figure 2.1. DFT-optimized 3S1 skew-boat conformation of the 3,4-OTIPS
thioglucoside β-2.3 (hydrogens and phenyl groups have been omitted for clarity in
the ball and stick 3D-representation)
To study the reactivity of thioglycoside β-2.2, the respective bromide 2.4 was
generated by the reaction with Br2 following previously established reaction conditions.26
We theorized that the activation of superarmed donors with Br2 will allow us to investigate
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whether the conformational superarming may offer additional stabilization modes to the
anticipated β-bromide intermediate. When donors in the traditional 4C1 conformation are
used for the synthesis of β-bromides, the latter are able to undergo conformational changes
to adopt the axial or pseudoaxial orientation (Figure 2.2).43 Since this adopted
conformation is unstable, the β-bromide equilibrates into the thermodynamically stable αcounterpart and hence returns to its original 4C1 conformation. Conversely, if the starting
donor is already present as a skew-boat, as determined for the conformationally superarmed
donors, the formation of β-bromide will additionally reinforce the all-axial conformation.
If the axial β-bromide is stabilized by the anomeric effect, as in compounds with the
preferred 1C4 conformation (Figure 2.2), it will be both kinetically and thermodynamically
stable and will not equilibrate (or will equilibrate much slower) into the α-counterpart. The
analogy is found in Matsuda and Shuto’s study of xylose derivatives and their observation
of altered anomeric effect and reversed stereoselectivity in glycosylations.44-45 However,
the hexose chair is much more difficult to flip due to the CH2OR substituent at C-5 that has
a strong propensity to reside equatorially.46

Figure 2.2. Conformation and stereoselectivity of β-bromides
Thus, bromide 2.4 obtained from 3,4-O-TBS donor β-2.2 was studied using a 300
MHz NMR as depicted in Scheme 2.2. Molecular bromine was injected into a frozen
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solution of the donor in CDCl3. The mixture was allowed to melt at -50 °C and then 1H
NMR spectra were recorded at different time points. The starting material has been
completely consumed within the first 5 min of the reaction monitoring, as judged by
disappearance of the diagnostic signal for H-2 at 3.42 ppm. The presence of both α- and βbromides 2.4 was also detected at this timepoint. The signal for H-1 at 6.50 ppm is
diagnostic, but it cannot be used for quantifying the ratios of bromides because it coincides
for both anomers. In this respect, reaction monitoring using more diagnostic signals at 3.94
ppm for H-2, H-3 of β-2.4 and at 3.25 ppm for H-2 of α-2.4 was proven most convenient.
As shown in Scheme 2.2, the anomeric mixture of bromides 2.4 has almost
completely converted into the α-anomer at 30 min timepoint. Also evident at this timepoint
is the presence of a decomposed by-product due to the anticipated partial loss of TBS
protecting groups. This was an indication that the chosen starting β-thioglycoside is
probably not the most suitable precursor for generating the β-bromide, even with the
assistance of the TBS groups. It should be noted that we also attempted to convert
thioglycoside β-2.3 into the corresponding bromide. Unfortunately, this attempt was largely
unsuccessful due to a very rapid cleavage of TIPS groups the presence of Br2, perhaps due
to a significant weakening of the O-Si bonds due to the steric congestion that these
compounds experience.
In the attempt of achieving a more stereocontrolled formation of the reactive βbromide intermediate, we turned our attention to investigating α-configured SEt donor. The
analogy can be found in our previous study wherein superdisarmed α-SEt precursor
produced the corresponding β-bromide predominantly.26 Starting from diol α-2.1, we
obtained TBS and TIPS protected thioglycosides, α-2.2 and α-2.3, respectively. The
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coupling constants calculated from their proton NMR spectra clearly demonstrated the
conformational changes taking place. Thus, in the series of compounds α-2.1, α-2.2 and α2.3, the J2,3 value decreases from 9.5 to 7.4 to 3.7 Hz. Coupling constants J3,4 and J4,5
behave similarly showing a steady decrease (Table 2.3). Differently from the β-series, no
dramatic signal shifts were observed in the 1H and 13C NMR spectra of the α-series. As a
matter of fact, the chemical shift difference between α-2.1 and α-2.2 is minimal, with
somewhat more significant changes observed for α-2.3. This observation may be an
indication of notable changes taking place upon transition from TBS to sterically more
demanding TIPS groups.

Scheme 2.2. Conversion of 3,4-di-O-TBS β-SEt glucoside β-2.2 into α,β-bromides 2.4
The computational data for α-thioglycosides was also consistent with the
experimental observations. Computational models of thioglycosides α-2.2 and α-2.3 were
built by implementing the same protocol as that applied to the β-series. Only 4C1 and 1C4
chair conformations were located as minimum energy structures, showing the importance

Matteo Panza | UMSL 2019 | Page 150

of the axial-rich 1C4 chair geometry for compound α-2.3 always higher than that for α-2.2,
according to both relative SCF DFT/B3LYP and Gibbs free energies (see appendix, Tables
A-3 and A-4).
To study the reactivity of this series of compounds, the NMR monitoring of the
formation of anomeric bromide 2.4 from thioglycoside α-2.2 was conducted. The
procedure used herein was the same as that applied to the β-counterpart of 2.2 (vide supra).
After 5 minutes, only β-bromide 2.4 was detected. At the 10-minute timepoint, the
intermediate is still largely β-2.4, and only a small peak at δ ≈ 3.3 ppm is indicating the
beginning of the anomerization process to α-2.4. Only after 2 hours, the reactive bromide
β-2.4 has completely anomerized to α-2.4.
Computational models of α- and β-bromides 2.4 were built by implementing the
same protocol applied for thioglycosides yet using the LACVP basis set due to the presence
of bromine atoms. Only standard 4C1 chair conformations were achieved for compound α2.4, whereas a distorted 1,4B boat (or an unusual 4S2 skew-boat) conformation was located
by DFT calculations as the lowest energy minimum of compound β-2.4 (Appendix, Tables
A-5-2.-6).
Having acquired the evidence of adequate stability of the reactive intermediate β-2.4,
glycosidations of donor α-2.2 with model glycosyl acceptors were conducted. At first,
when Br2 was added to the reaction mixture containing donor α-2.2 and a glycosyl acceptor
at -50°C we observed that the formation of the desired disaccharide was accompanied by
the formation of multiple by-products. These products were formed as a result of
competing side reactions including hydrolysis and partial deprotection of the TBS groups.
Therefore, to suppress the side reactions, we chose to add a sub-stoichiometric amount of
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a base to each glycosylation reaction mixture. Three basic additives were investigated:
triethylamine (TEA), N,N-diisopropylethylamine (DIPEA) and 1,8-diazabicycloundec-7ene (DBU), and all three provided comparable results.

1H

Signal

α-2.1

H/C-1

5.44 (d)

J1,2 = 5.4

82.69

H/C-2

3.64 (dd)

J2,3 = 9.5

78.56

H/C-3

3.85 (t)

J3,4 = 9.4

73.60

H/C-4

3.50 (t)

70.21

H/C-5

4.32 (ddd)

J4,5 = 9.4
J5,6a = 5.1
J5,6b = 1.9
J6a,6b = 12.1

63.98

J1,2 = 4.9

82.54

NMR, ppm

69.86

H/C-1
H/C-2

3.61 (dd)

J2,3 = 7.4

79.25

H/C-3

3.96-3.93 (m)

J3,4 = 6.0

73.92

H/C-4

3.65 (dd)

72.95

H/C-5

4.35-4.31 (m)

J4,5 = 8.7
J5,6a = 7.0
J5,6b = 2.1
J6a,6b = 11.5

64.52

J1,2 = 3.4

79.73

71.65

H/C-1

4.38 (dd)
4.59 (dd)
5.41 (d)

H/C-2

3.68 (t)

J2,3 = 3.7

78.31

H/C-3

4.26-4.22 (m)

J3,4 = 2.7

71.94

H/C-4

3.96 (dd)

71.39

H/C-5

4.42-4.37 (m)

J4,5 = 4.9
J5,6a = 7.9
J5,6b = 3.4

H/C-6

4.45 (dd)
4.74 (dd)

J6a,6b = 11.8

63.48

H/C-6
α-2.3

J, Hz

4.58-4.47 (m)
4.69 (dd)
5.41 (d)

H/C-6
α-2.2

NMR, ppm

13C

Cmpd

Table 2.3. NMR data for thioglycosides α-2.1-2.3

75.12
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Under these reaction conditions, glycosidation of donor α-2.2 with primary 6-OH glycosyl
acceptor 2.5 afforded the desired disaccharide 2.6 in high yields of 82-95% and with
complete α-stereoselectivity (entry 1, Table 2.4). Glycosidation of donor α-2.2 with
secondary 2-OH glycosyl acceptor 2.7 afforded the desired disaccharide 2.8 in good yields
of 74-79% and with good α-stereoselectivity (α/β = 8-13/1, entry 2). Highly reactive
aliphatic alcohols such as iPrOH, cyclohexanol, and benzyl alcohol were investigated,
affording the target glucosides 2.9-2.11 in high yields 78-99%, albeit unremarkable
stereoselectivity (α/β = 2-5/1, entries 3-5). This poor stereoselectivity may be a result of a
direct displacement of the anomeric α-bromide with powerful nucleophiles that does not
take place with sugar acceptors. 3,4-OTIPS protected donor α-2.3 provided a similar
reactivity trend, summarized in Table 2.5, but its glycosidations were compromised by the
competing silyl group cleavage, even in the presence of a base (see the experimental for
additional experimental data).

2.3. Conclusions
We expanded the application of Br2-mediated glycosidation of thioglycosides to
glycosyl donors of the superarmed series. Over the course of this study, we investigated
the formation of the reactive intermediates that were monitored and characterized by NMR
spectroscopic techniques. An extensive conformational analysis of the donor through
coupling constants values and carbon-hydrogen correlation was performed. Furthermore,
the stability of β-bromide in solution over time was studied using NMR. The experimental
data are supported by the molecular mechanic calculations and the DFT studies.
Glycosylation reactions were performed with a group of standard acceptors, achieving high
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yields and high to complete stereoselectivity sugar acceptors. These results complement
our other recent studies dedicated to the activation of glycosyl halides.47-50

Entry

Acceptor

Base

2.5

none
TEA
DBU
DIPEA

1

Product

Yield and α/β ratio
Multiple products
82%, α-only
95%, α-only
95%, α-only

2.6

2
2.7

None
TEA
DBU
DIPEA

Multiple products
79%, 13.0/1
74%, 8.5/1
74%, 8.0/1
2.8

3

i

PrOH

TEA
DBU
DIPEA

99%, 5.0/1
94%, 5.0/1
94%, 4.0/1
2.9

4

CyOH

TEA
DBU
DIPEA

99%, 2.0/1
78%, 4.0/1
78%, 4.0/1
2.10

5

BnOH

TEA
DBU
DIPEA

2.11

Table 2.4. Glycosidation of 3,4-O-TBS donor α-2.2

99%, 3.0/1
81%, 4.0/1
84%, 3.0/1
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Table 2.5. Reactions of 3,4-O-TIPS donor

Entry

Acceptor

1
2.5

2
2.6

3

4

i

PrOH

CyOH

Base

Product

TEA
DBU
DIPEA

Yield and α/β ratio
81%, α-only
70%, 7.5/1
68%, 7.5/1

2.12
TEA
DBU
DIPEA

24%, 3.0/1
50%, 8.5/1
35%, 8.0/1
2.13

TEA
DBU
DIPEA

2.14

TEA
DBU
DIPEA

99%, 1/1
70%, 1/1.4
72%, 1/1.4

99%, 1/1
74%, 1/1.3
86%, 1.6/1
2.15

5

BnOH

TEA
DBU
DIPEA

2.16

99%, 1/1
61%, 1.2/1
44%, 1/1.4
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2.4. Experimental

2.4.1. General experimental
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were
monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination
under UV light and by charring with 10% sulfuric acid in methanol. Solvents were removed
under reduced pressure at <40 °C. CH2Cl2 was distilled from CaH2 directly prior to
application. Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated
in vacuo at 390 °C for 16 h in the first instance and then for 2-3 h at 390 °C directly prior
to application. Optical rotations were measured at ‘Jasco P-2000’ polarimeter. Unless noted
otherwise, 1H NMR spectra were recorded in CDCl3 at 300 or 600 MHz, 13C NMR spectra
were recorded in CDCl3 at 75 or 151 MHz. HRMS determinations were made with the use
of a mass spectrometer with FAB ionization and ion-trap detection.

2.4.2. Synthesis of glycosyl donors and acceptors

Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-α-D-glucopyranoside (α-2.1). Et3N (12 mL) was
added to a stirring solution of ethyl 2-O-benzyl-1-thio-α-D-glucopyranoside37 (2.17, 560
mg, 1.8 mmol) in MeCN (25 mL). The resulting solution was cooled at -30 °C, a solution
of BzCN (237 mg, 1.9 mmol) in MeCN (20 mL) was added, and the resulting mixture was
stirred for 2 h at -30 °C. After that, the reaction was quenched with MeOH (~ 2 mL), and
the volatiles were removed in vacuo. The residue was purified by column chromatography
on silica gel (hexanes-ethyl acetate gradient elution) to give the title compound as a white
amorphous solid in 70% yield (527 mg). Analytical data for α-2.1: Rf = 0.6
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(methanol/DCM, 1/9, v/v); []D22 +151.3 (c 1, CHCl3); 1H NMR (600 MHz, CDCl3): δ,
8.01-8.06 (m, 2H, aromatic), 7.56 (dd, 1H, J = 10.6, 4.3 Hz, aromatic), 7.43 (t, 2H, J = 7.8
Hz, aromatic), 7.39 (d, 2H, J = 7.0 Hz, aromatic), 7.35 (dd, 2H, J = 10.1, 4.7 Hz, aromatic),
7.31 (dd, J = 8.3, 6.0 Hz, 1H, aromatic), 5.44 (d, 1H, J1,2 = 5.4 Hz, H-1), 4.73 (d, 1H, 2J =
11.4 Hz, CH2Ph), 4.69 (dd, 1H, J6a,6b = 12.1 Hz, H-6a), 4.49-4.55 (m, 2H, H-6b, CH2Ph),
4.32 (ddd, 1H, J5,6a = 1.9 Hz, J5,6b = 5.1 Hz, H-5), 3.85 (dd, 1H, H-3), 3.64 (dd, 1H, J2,3 =
9.5 Hz, H-2), 3.50 (dd, 1H, J3,4 = J4,5 = 9.4 Hz, H-4), 3.17 (s, 1H, OH), 2.97 (s, 1H, OH),
2.55 (m, 2H, CH2CH3), 1.26 (t, 3H, J = 7.4 Hz, CH2CH3) ppm;

13

C NMR (151 MHz,

CDCl3): δ, 167.06 (C=O), 137.41 (aromatic), 133.34 (aromatic), 129.89 (x2, aromatic),
129.83 (aromatic), 128.67 (x2, aromatic), 128.51 (x2, aromatic), 128.39 (x2, aromatic),
128.30 (aromatic), 82.69 (C-1), 78.56 (C-2), 73.60 (C-3), 72.10 (CH2Ph), 70.21 (C-4),
69.86 (C-5), 63.98 (C-6), 23.95 (CH2CH3), 14.89 (CH2CH3) ppm; HR-FAB MS [M+Na]+
calcd for C22H26NaO6S+ 441.1348, found 441.1338.

Ethyl

6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-1-thio-α-D-

glucopyranoside (α-2.2). TBSOTf (1.8 mL, 8.1 mmol) was added to a solution of α-2.1
(1.35 g, 3.2 mmol) in 2,6-lutidine (12 mL) and the resulting mixture was stirred for 16 h at
100 °C. After that, the reaction mixture was diluted with DCM (~100 mL) and washed
successively with 1 M HCl (3 x 10 mL), sat. aq. NaHCO3 (3 x 10 mL), and water (3 x10
mL). The organic layer was separated, dried with MgSO4, and concentrated in vacuo. The
residue was purified by column chromatography on silica gel (hexanes-ethyl acetate
gradient elution) to afford the title compound as a colorless syrup in 99% yield (2.05 g).
Analytical data for α-2.2: Rf = 0.8 (ethyl acetate/hexane, 1/4, v/v); []D22 +97.8 (c 1,
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CHCl3); 1H NMR (600 MHz, CDCl3): δ, 8.08-8.03 (m, 2H, aromatic), 7.56 (t, J = 7.4 Hz,
1H, aromatic), 7.43 (dd, J = 14.1, 7.3 Hz, 4H, aromatic), 7.33 (t, J = 7.4 Hz, 2H, aromatic),
7.28 (t, J = 7.3 Hz, 1H, aromatic), 5.41 (d, J1,2 = 4.9 Hz, 1H, H-1), 4.63 (d, 2J = 11.3 Hz,
1H, CH2Ph), 4.59 (dd, J5,6a = 2.1, J6a,6b = 11.5 Hz, 1H, H-6a), 4.55 (d, 1H, CH2Ph), 4.38
(dd, J5,6b = 7.0 Hz, 1H, H-6b), 4.35-4.31 (m, 1H, H-5), 3.95 (m, J3,4 = 8.7 Hz, 1H, H-3),
3.65 (dd, J4,5 = 6.0 Hz, 1H, H-4), 3.61 (dd, J2,3 = 7.4 Hz, 1H, H-2), 2.61-2.49 (m, 2H,
CH2CH3), 1.21 (t, J = 7.4 Hz, 3H, CH2CH3), 0.92 (s, 9H, SitBu), 0.86 (s, 9H, SitBu), 0.15
(s, 3H, SiMe), 0.10 (s, 3H, SiMe), 0.04 (s, 3H, SiMe), 0.00 (s, 3H, SiMe) ppm; 13C NMR
(151 MHz, CDCl3): δ, 166.51 (C=O), 137.79 (aromatic), 133.08 (aromatic), 130.22
(aromatic), 129.76 (x2, aromatic), 128.46 (x2, aromatic), 128.43 (x2, aromatic), 128.30
(x2, aromatic), 127.87 (aromatic), 82.49 (C-1), 79.19 (C-2), 73.86 (C-3), 72.90 (C-4), 72.50
(CH2Ph), 71.60 (C-5), 64.47 (C-6), 26.42 (x3, SiC(CH3)3), 26.20 (x3, SiC(CH3)3), 23.75
(CH2CH3), 18.33 (SiC(CH3)3), 18.23 (SiC(CH3)3), 14.86 (CH2CH3), -2.60 (SiMe), -2.80
(SiMe), -3.38 (SiMe), -4.15 (SiMe) ppm; HR-FAB MS [M+Na]+

calcd for

C34H54NaO6SSi2+ 669.3072, found 669.3082.

Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-O-triisopropylsilyl-α-D-glucopyranoside
(α-2.3). TIPSOTf (1.46 mL, 5.4 mmol) was added dropwise to a solution α-2.1 (450 mg,
1.08 mmol) in 2,6-lutidine (8.0 mL) and the resulting mixture was stirred for 16 h at 100
°C. After that, the reaction mixture was diluted with DCM (~50 mL) and washed
successively with 1 M aq. HCl (3 x 10 mL), NaHCO3 (3 x 10 mL) and water (3 x 10 mL).
The organic layer was separated, dried with MgSO4, and concentrated in vacuo. The
residue purified by column chromatography on silica gel (hexanes-ethyl acetate gradient
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elution) to obtain the title compound as a colorless syrup in 99% yield (782 mg). Analytical
data for α-2.3: Rf = 0.8 (ethyl acetate/hexane, 1/4, v/v); []D23 +58.1 (c 0.7, CHCl3); 1H
NMR (600 MHz, CDCl3): δ, 8.06 (d, J = 8.1 Hz, 2H, aromatic), 7.57-7.53 (m, 1H,
aromatic), 7.42 (dd, J = 15.1, 7.4 Hz, 4H, aromatic), 7.31 (t, J = 7.6 Hz, 2H, aromatic),
7.25 (dd, J = 10.2, 4.0 Hz, 1H, aromatic), 5.41 (d, J1,2 = 3.4 Hz, 1H, H-1), 4.74 (dd, J5,6a =
7.9, J6a,6b = 11.8 Hz, 1H, H-6a), 4.70-4.63 (m, 2H, CH2Ph), 4.45 (dd, J5,6b = 3.4 Hz, 1H, H6b), 4.42-4.37 (m, 1H, H-5), 4.26-4.22 (m, J3,4 = 2.7 Hz, 1H, H-3), 3.96 (dd, J4,5 = 4.9 Hz,
1H, H-4), 3.68 (dd, J2,3 = 3.7 Hz, 1H, H-2), 2.71-2.59 (m, 2H), 1.23 (t, J = 7.4 Hz, 3H),
1.10-1.01 (m, 42H) ppm;

13

C NMR (151 MHz, CDCl3): δ, 166.53 (C=O), 138.08

(aromatic), 133.06 (aromatic), 130.20 (aromatic), 129.81 (x2, aromatic), 128.37 (x2,
aromatic), 128.17 (x2, aromatic), 127.82 (x2, aromatic), 127.56 (aromatic), 79.73 (C-1),
78.31 (C-2), 75.12 (C-5), 72.49 (CH2Ph), 71.94 (C-3), 71.39 (C-4), 63.48 (C-6), 24.81
(CH2CH3), 18.40 (x3, iPr), 18.32 (x3, iPr), 18.30 (x3, iPr), 18.29 (x3, iPr), 17.83 (iPr),
15.13 (CH2CH3), 12.97(x2, iPr), 12.77(x2, iPr), 12.40 (iPr) ppm; HR-FAB MS [M+Na]+
calcd for C34H54NaO6SSi2+ 753.4016, found 753.4031.

Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-β-D-glucopyranoside (β-2.1) was synthesized in
accordance with the reported procedure37 and its analytical data were in accordance with
that previously described.37 Selected analytical data for β-2.1: 1H NMR (600 MHz, CDCl3):
δ, 8.06 (d, J = 8.0 Hz, 2H, aromatic), 7.58 (t, J = 7.4 Hz, 1H, aromatic), 7.45 (t, J = 7.1 Hz,
2H, aromatic), 7.42-7.27 (m, J = 30.7, 16.7, 7.4 Hz, 5H, aromatic), 4.97 (d, 2J = 11.0 Hz,
1H, CH2Ph), 4.69-4.62 (m, 2H, H-6a, CH2Ph), 4.57 (br d, J6a,6b = 12.1 Hz, 1H, H-6b), 4.51
(d, J1,2 = 9.7 Hz, 1H, H-1), 3.63 (dd, J3,4 = 8.7 Hz, 1H, H-3), 3.59-3.55 (m, 1H, H-5), 3.47
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(dd, J4,5 = 9.2 Hz, 1H, H-4), 3.28 (dd, J2,3 = 9.2 Hz, 1H, H-2), 3.09 (br s, 1H, OH), 2.822.69 (m, 2H, CH2CH3), 2.66 (br s, 1H, OH), 1.32 (t, J = 7.4 Hz, 3H, CH2CH3) ppm; 13C
NMR (151 MHz, CDCl3): δ, 167.26 (C=O), 138.03 (aromatic), 133.44 (aromatic), 129.99
(x2, aromatic), 129.76 (aromatic), 128.78 (x2, aromatic), 128.54 (x2, aromatic), 128.49
(x2, aromatic), 128.32 (aromatic), 85.06 (C-1), 80.87 (C-2), 77.95 (C-3), 77.82 (C-5), 75.30
(CH2Ph), 70.13 (C-4), 64.16 (C-6), 25.32 (CH2CH3), 15.26 (CH2CH3).

Ethyl

6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-1-thio-β-D-

glucopyranoside (β-2.2) was synthesized in accordance with the reported procedure and
its analytical data were in accordance with that previously described.36 Analytical data for
β-2.2: Rf = 0.8 (ethyl acetate/hexane 1/4 v/v); 1H NMR (600 MHz, CDCl3): δ, 8.09-8.01
(m, 2H, aromatic), 7.56 (t, J = 7.4 Hz, 1H, aromatic), 7.48-7.27 (m, 7H, aromatic), 4.874.77 (m, 2H, J1,2 = 8.4 Hz, H-1, ½ CH2Ph), 4.68 (d, 2J = 11.2 Hz, 1H, CH2Ph), 4.61 (dd,
J5,6a = 4.9, J6a,6b = 11.3 Hz, 1H, H-6a), 4.41 (dd, J5,6b = 7.4 Hz, 1H, H-6b), 3.97-3.91 (m,
1H, H-5), 3.91-3.86 (m, J3,4 = 5.0 Hz, 1H, H-3), 3.80 (dd, J4,5 = 5.0 Hz, 1H, H-4), 3.42 (dd,
J2,3 = 3.9 Hz, 1H, H-2), 2.83-2.61 (m, 2H, CH2CH3), 1.28 (t, J = 7.4 Hz, 3H, CH2CH3),
0.92 (s, 9H, SitBu), 0.89 (s, 9H, SitBu), 0.11 (s, 3H, SiMe), 0.09 (s, 6H, SiMe2), 0.05 (s,
3H, SiMe) ppm; 13C NMR (151 MHz, CDCl3): δ, 166.34 (C=O), 138.42 (aromatic), 133.09
(aromatic), 130.19 (aromatic), 129.74 (x2, aromatic), 128.43 (x2, aromatic), 128.26 (x2,
aromatic), 127.71 (x2, aromatic), 127.56 (aromatic), 82.81 (C-1), 82.50 (C-2), 79.41 (C5), 76.44 (C-3), 73.51 (CH2Ph), 71.68 (C-4), 65.52 (C-6), 26.31 (x3, SiC(CH3)3), 26.06
(x3, SiC(CH3)3), 25.37 (CH2CH3), 18.20 (SiC(CH3)3), 18.14 (SiC(CH3)3), 15.21
(CH2CH3), -3.30 (SiMe), -3.41 (SiMe), -3.89 (SiMe), -4.26 (SiMe) ppm.
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Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-O-triisopropylsilyl-β-D-glucopyranoside
(β-2.3) was obtained in 99% yield (amount) as described for the synthesis of α-2.3.
Analytical data for β-2.3: Rf = 0.7 (ethyl acetate/hexane 1/4 v/v); []D23 -7.0 (c 1, CHCl3);
1

H NMR (600 MHz, CDCl3): δ, 8.04 (d, J = 8.0 Hz, 2H, aromatic), 7.56 (t, J = 7.4 Hz, 1H,

aromatic), 7.43 (t, J = 7.1 Hz, 2H, aromatic), 7.36-7.23 (m, 5H, aromatic), 5.05 (d, J1,2 =
8.5 Hz, 1H, H-1), 4.91 (d, 2J = 11.3 Hz, 1H, ½ CH2Ph), 4.66-4.59 (m, 2H, J5,6a = 6.6 Hz,
H-6a, ½ CH2Ph), 4.50 (dd, J5,6b = 6.6 Hz, J6a,6b = 11.0, 1H, H-6b), 4.27 (br s, 1H, H-4), 4.24
(dd, 1H, H-5), 4.16 (d, J3,4 = 3.0 Hz, 1H, H-3), 3.60 (d, 1H, H-2), 2.83-2.68 (m, 2H), 1.32
(m, J = 7.4, 1.5 Hz, 3H, CH2CH3), 1.08 (s, 21H), 1.01 (m, 21H) ppm; 13C NMR (151 MHz,
CDCl3): δ, 166.39 (C=O), 138.74 (aromatic), 133.05 (aromatic), 130.28 (aromatic), 129.80
(x2, aromatic), 128.37 (x2, aromatic), 128.10 (x2, aromatic), 127.75 (x2, aromatic), 127.38
(aromatic), 83.09 (C-2), 81.23 (C-1), 80.79 (C-5), 75.71 (C-4), 73.62 (CH2Ph), 70.89 (C3), 66.13 (C-6), 25.27 (CH2CH3), 18.31 (x3, iPr), 18.24 (x3, iPr), 18.15 (x6, iPr), 15.32
(CH2CH3), 12.48 (x3, iPr), 12.33 (x3, iPr) ppm; HR-FAB MS [M+Na]+

calcd for

C34H54NaO6SSi2+ 753.4016, found 753.4025.

Methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.5) was synthesized in accordance
with the reported procedure and its analytical data was in accordance with that previously
described.58-59
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Methyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.7) was synthesized in accordance
with the reported procedure and its analytical data was in accordance with that previously
described.58-59

2.4.3. Synthesis of glycosides
General glycosylation procedure. A mixture of a glycosyl donor (0.046 mmol),
glycosyl acceptor (0.046 mmol), and freshly activated molecular sieves (3 Å, 120 mg) in
CH2Cl2 (2.0 mL) was stirred under argon for 3 h at rt. The mixture was cooled to -50 °C,
Br2 (0.092 mmol, 15.0 µL) and a base (0.014 mmol) were added and the resulting mixture
was stirred for 5 min. After that, the reaction mixture was allowed to warm to rt and stirred
for additional 16 h. Triethylamine (~0.1 mL) was added, the solid was filtered off and
rinsed successively with CH2Cl2. The combined filtrate (~60 mL) was concentrated in
vacuo. The residue was purified by column chromatography on silica gel (toluene-ethyl
acetate gradient elution) to afford the corresponding glycoside.

Methyl

6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α-D-

glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.6) was prepared as a
colorless syrup from donor α-2.2 and acceptor 2.5 in accordance with the general procedure
in the presence of TEA, DBU or DIPEA in 82, 95 or 95% yield, respectively. Analytical
data for 2.6: Rf = 0.65 (ethyl acetate/toluene, 1/9, v/v); []D24 +83.9 (c 1, CHCl3); 1H NMR
(300 MHz, CDCl3): δ, 8.00 (d, J = 7.6 Hz, 2H, aromatic), 7.53 (t, J = 7.3 Hz, 1H, aromatic),
7.43-7.14 (m, 24H, aromatic), 4.96 (d, 2J = 11.0 Hz, 1H, CH2Ph), 4.90-4.74 (m, 3H, CH2Ph,
H-1’), 4.68 (d, 2J = 12.0 Hz, 1H, ½ CH2Ph), 4.64-4.43 (m, 6H, H-1, 6b’, 2 x CH2Ph,), 4.24
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(dd, J5’,6a’ = 6.7 Hz, J6a’,6b’= 11.5, 1H, H-6a’), 4.06-3.89 (m, J3’,4’= 9.2 Hz 3H, H-3, 3’, 5),
3.79-3.68 (m, 2H, H-5, 6b), 3.59-3.49 (m, 2H, H-4, 6a), 3.44 (dd, J4’,5’= 9.2 Hz, 1H, H-4’),
3.40-3.22 (m, 5H, H-2, 2’, OCH3), 0.89 (s, 9H, SitBu), 0.85 (s, 9H, SitBu), 0.13 (s, 3H,
SiMe), 0.10 – -0.06 (m, 9H, 3x SiMe); 13C NMR (151 MHz, CDCl3): δ, 166.4, 139.1, 138.5,
138.4, 133.0, 130.4, 129.8, 128.5 (x3), 128.4 (x2), 128.2, 128.1, 128.0, 127.8 (x2), 127.7,
127.6, 98.0, 96.4, 82.3, 80.4 (x2), 78.4, 77.4, 77.2, 77.0, 75.7, 75.2, 74.1, 73.5, 73.1, 72.5,
71.0, 70.4, 65.8, 64.4, 55.1, 26.8, 26.4, 18.6, 18.3, 0.1, -2.0, -2.1, -2.8, -3.9 ppm; HR-FAB
MS [M+Na]+ calcd for C60H80NaO12Si2+ 1071.5086, found 1071.5088.

Methyl

2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α/β-D-

glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.8) was prepared as a
colorless syrup from donor α-2.2 and acceptor 2.7 in accordance with the general procedure
in the presence of TEA, DBU or DIPEA in 79, 74 or 74% yield, respectively. Selected
analytical data for α-2.8: Rf = 0.6 (ethyl acetate/toluene, 1/9, v/v); 1H NMR (300 MHz,
CDCl3) δ, 8.10-8.04 (m, 2H, aromatic), 7.47-7.10 (m, 29H, aromatic), 5.25 (d, J1’,2’ = 3.4
Hz, 1H, H-1’), 5.11 (d, 2J = 11.0 Hz, 1H, ½ CH2Ph), 4.99 (d, J1,2 = 3.2 Hz, 1H, H-1), 4.844.38 (m, 10H, H-6a’, 4 ½ CH2Ph), 4.22 (dd, J6a’,6b’= 11.4, J5’,6b’= 7.0 Hz, 1H, H-6b’), 4.143.93 (m, 5H, H-2’, 3, 3’, 4, 5’), 3.83-3.76 (m, 1H, H-6a), 3.69 (br s, 1H, H-6b), 3.61-3.47
(m, 2H, H-4’, 5), 3.42 (dd, J2,3 = 9.0 Hz, 1H, H-2), 3.27 (s, 3H, OCH3), 0.89 (s, 10H, SitBu),
0.82 (s, 9H, SitBu), 0.15 (s, 3H, SiMe), 0.09 (d, J = 2.9 Hz, 5H, SiMe), -0.04 (m, 6H, 2 x
SiMe); 13C NMR (151 MHz, CDCl3) δ 166.5, 138.8, 138.5, 138.3, 138.1, 133.0, 130.3,
129.9, 128.6, 128.5, 128.4, 128.2, 128.0, 127.9, 127.8 (x3), 127.7 (x2), 127.6, 96.4, 91.8,
81.2, 79.4, 77.8, 75.8, 75.2, 74.6, 74.5, 73.6, 72.9, 71.4, 71.3, 70.4, 69.1, 64.6, 54.8, 26.7,
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26.4, 18.5, 18.3, 0.1, -2.0, -2.2, -2.9, -3.9 ppm; Selected analytical data for β-2.8: Rf = 0.6
(ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 3.36 (s, 3H, OCH3) ppm;
C NMR (151 MHz, CDCl3): δ, 103.2, 100.2, 83.4, 81.4, 80.9, 78.3, 77.8, 76.0, 75.4, 75.1,

13

73.7, 73.0, 71.5, 70.1, 69.0, 65.6 ppm; HR-FAB MS [M+Na]+ calcd for C60H80NaO12Si2+
1071.5086, found 1071.5081.

Isopropyl

6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α/β-D-

glucopyranoside (2.9) was prepared as a colorless syrup from donor α-2.2 and isopropanol
in accordance with the general procedure in the presence of TEA, DBU or DIPEA in 99,
94 or 94% yield, respectively. Selected analytical data for α-2.9: Rf = 0.7 (ethyl acetate/
toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 4.91 (d, 1H, J1,2 = 3.5 Hz, H-1), 3.55
(dd, 1H, J4,5 = 8.1 Hz, H-4), 3.30 (dd, 1H, J2,3 = 9.2 Hz, H-2) ppm; 13C NMR (151 MHz,
CDCl3): δ, 95.0 (C-1) ppm. Selected analytical data for β-2.9: Rf = 0.7 (ethyl
acetate/toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 4.75 (d, 1H, J1,2 = 7.2 Hz, H-1);
C NMR (151 MHz, CDCl3): δ, 101.0 (C-1) ppm; HR-FAB MS [M+Na]+ calcd for

13

C35H56NaO7Si2+ 667.3457, found 667.3469.

Cyclohexyl

6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α/β-D-

glucopyranoside (2.10) was prepared as a colorless syrup from donor α-2.2 and
cyclohexanol in accordance with the general procedure in the presence of TEA, DBU or
DIPEA in 99, 78 or 78% yield, respectively. Selected analytical data for α-2.10: Rf = 0.8
(ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 4.96 (d, J1,2 = 3.4 Hz, 1H,
H-1), 4.65 (dd, J5,6a = 2.1 Hz, J6a,6b= 11.5, 1H, H-6a), 4.27 (dd, J5,6b = 7.6 Hz, 1H, H-6b),
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4.02 (dd, J3,4 = 9.5 Hz, 2H, H-3, 5), 3.52 (dd, J4,5 = 8.3 Hz, 1H, H-4), 3.30 (dd, J2,3 = 9.2
Hz, 1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 96.4 (C-1) ppm. Selected analytical
data for β-2.10: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ,
4.74 (d, J1,2 = 7.2 Hz, 1H, H-1) ppm; 13C NMR (151 MHz, CDCl3): δ, 100.8 (C-1) ppm;
HR-FAB MS [M+Na]+ calcd for C38H60NaO7Si2+ 707.3775, found 707.3779.

Benzyl

6-O-benzoyl-2-O-benzyl-3,4-di-O-tert-butyldimethylsilyl-α/β-D-

glucopyranoside (2.11) was prepared as a colorless syrup from donor α-2.2 and benzyl
alcohol in the presence of TEA, DBU or DIPEA in 99, 81 or 84% yield, respectively.
Selected analytical data for α-2.11: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300
MHz, CDCl3): δ, 4.83 (d, J1,2 = 3.4 Hz, 1H, H-1), 4.09 (m, J4,5 = 9.2 Hz, 1H, H-4), 4.00
(m, J5,6a = 6.9, J5,6b = 2.1 Hz, 3H, H-5), 3.59 (dd, J3,4 = 8.0 Hz, 1H, H-3), 3.36 (dd, J2,3= 9.1
Hz, 1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 95.4 (C-1), 64.6 (C-6) ppm. Selected
analytical data for β-2.11: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz,
CDCl3): δ, 4.80 (d, J1,2= 6.8 Hz, 1H, H-1), 3.93-3.86 (m, 1H, H-4), 3.84-3.73 (m, 2H, H-3,
5), 3.44 (dd, J2,3 = 4.8 Hz, 1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 100.7 (C-1),
65.4 (C-6) ppm; HR-FAB MS [M+Na]+ calcd for C39H56NaO7Si2+ 715.3462, found
715.3474.

Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-triisopropylsilyl-α-D-glucopyranosyl)2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.12) was prepared as a colorless syrup from
donor α-2.3 and acceptor 2.5 in the presence of TEA, DBU or DIPEA in 81, 70 or 68%
yield, respectively. Analytical data for α-2.12: Rf = 0.7 (ethyl acetate/ toluene, 1/9, v/v);
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[]D24 +58.7 (c 1, CHCl3); 1H NMR (300 MHz, CDCl3): δ, 8.01 (d, J = 7.4 Hz, 2H,
aromatic), 7.53 (t, J = 7.3 Hz, 1H, aromatic), 7.43-7.13 (m, 23H, aromatic), 5.09 (d, J1’,2’ =
2.2 Hz, 1H, H-1’), 4.95 (d, 2J = 11.1 Hz, 1H, ½ CH2Ph), 4.86-4.64 (m, 5H, 2 ½ CH2Ph),
4.61-4.42 (m, 5H, J1,2 = 3.5 Hz, H-1, 6a’, 6b’, CH2Ph), 4.24-4.17 (m, 1H, H-5’), 4.17-4.10
(m, 1H, H-3’), 4.05-3.90 (m, 2H, H-3, 5), 3.86-3.79 (m, 1H, H-4’), 3.71 (dd, J5,6a = 2.7,
J6a,6b = 9.4 Hz, 1H, H-6a), 3.66-3.53 (m, 2H, H-4, 6b), 3.53-3.46 (m, 1H, H-2’), 3.36 (dd,
J2,3 = 9.5 Hz, 1H, H-2), 3.29 (s, 3H, OCH3), 1.02 (m, 42H, 2 x SiiPr3) ppm; 13C NMR (151
MHz, CDCl3): δ, 166.5, 139.2, 138.7, 138.6, 138.4, 133.1, 130.3, 129.8, 128.5, 128.5,
128.2, 128.1, 128.0 (x 2), 127.9 (x 2), 127.7, 127.6, 127.5, 98.2, 95.5, 82.2, 80.3, 78.2,
78.1, 77.4, 77.2, 77.0, 75.7, 75.3, 74.3, 74.1, 73.6, 72.5, 72.0, 70.5, 65.9, 63.9, 55.1, 29.8,
18.5, 18.4, 18.4, 18.3, 13.5, 13.3, 0.1 ppm; HR-FAB MS [M+Na]+

calcd for

C66H92NaO12Si2+ 1155.6025, found 1155.6021.

Methyl

2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-triisopropylsilyl-α/β-D-

glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.13) was prepared as a
colorless syrup from donor α-2.3 and acceptor 2.7 in the presence of TEA, DBU or DIPEA
in 24, 50 or 35% yield, respectively. Selected analytical data for α-2.13: Rf = 0.6 (ethyl
acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 5.33 (d, J1’,2’ = 3.3 Hz, 1H, H1’), 4.99 (d, J1,2 = 2.7 Hz, 1H, H-1), 3.28 (s, 3H, OCH3) ppm. Selected analytical data for
β-2.13: Rf = 0.6 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 5.23 (d,
J1’,2’ = 6.4 Hz, 1H, H-1’), 5.07 (d, J1,2 = 3.5 Hz, 1H, H-1), 3.36 (s, 3H, OCH3) ppm; HRFAB MS [M+Na]+ calcd for C66H92NaO12Si2+ 1155.6025, found 1155.6029.
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Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-triisopropylsilyl-α/β-D-glucopyranoside
(2.14) was prepared as a colorless syrup from donor α-2.3 and isopropyl alcohol in the
presence of TEA, DBU or DIPEA in 99, 70 or 72% yield, respectively. Selected analytical
data for α-2.14: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ,
5.12 (d, J1,2 = 2.9 Hz, 1H, H-1), 3.45 (dd, J2,3 = 6.4 Hz, 1H, H-2) ppm: 13C NMR (151 MHz,
CDCl3): δ, 93.8 (C-1) ppm. Selected analytical data for β-2.14: Rf = 0.8 (ethyl acetate/
toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 5.17 (d, J1,2 = 6.7 Hz, 1H, H-1), 3.54 (d,
1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 99.2 (C-1) ppm; HR-FAB MS [M+Na]+
calcd for C41H68NaO7Si2+ 751.4396, found 751.4402.

Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-triisopropylsilyl-α/β-D-glucopyranoside
(2.15) was prepared as a colorless syrup from donor α-2.3 and cyclohexyl alcohol in the
presence of TEA, DBU or DIPEA in 99, 74 or 86% yield, respectively. Selected analytical
data for α-2.15: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ,
5.17 (d, J1,2 = 3.0 Hz, 1H, H-1), 3.79 (dd, J3,4 = 7.0, J4,5 = 5.2 Hz, 1H, H-4), 3.45 (dd, J2,3 =
6.6 Hz, 1H, H-2) ppm;

13

C NMR (151 MHz, CDCl3): δ, 93.4 (C-1) ppm. Selected

analytical data for β-2.15: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz,
CDCl3): δ, 5.20 (d, J1,2 = 6.5 Hz, 1H, H-1), 3.53 (m, 1H, H-2) ppm; 13C NMR (151 MHz,
CDCl3): δ, 98.7 (C-1) ppm; HR-FAB MS [M+Na]+ calcd for C44H72NaO7Si2+ 791.4709,
found 791.4720.

Benzyl

6-O-benzoyl-2-O-benzyl-3,4-di-O-triisopropylsilyl-α/β-D-glucopyranoside

(2.16) was prepared as a colorless syrup from donor α-2.3 and benzyl alcohol in the
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presence of TEA, DBU and DIPEA in 99, 61 or 44% yield, respectively. Selected analytical
data for α-2.16: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ,
5.03 (d, J1,2 = 2.9 Hz, 1H, H-1), 4.85 (d, 2J = 12.4 Hz, 1H, ½ CH2Ph), 4.67 (d, 2J = 11.8 Hz,
1H, ½ CH2Ph), 4.61-4.45 (m, 4H, H-6a, 6b, CH2Ph), 4.25 (m, 1H, H-5), 4.14 (dd, J3,4 = 4.5
Hz, 1H, H-3), 3.85 (dd, J4,5 = 6.4 Hz, 1H, H-4), 3.51 (dd, J2,3 = 6.0 Hz, 1H, H-2) ppm; 13C
NMR (151 MHz, CDCl3): δ, 94.2 (C-1), 64.2 (C-6) ppm. Selected analytical data for β2.16: Rf = 0.8 (ethyl acetate/ toluene, 1/9, v/v); 1H NMR (300 MHz, CDCl3): δ, 5.14 (d, J1,2
= 6.4 Hz, 1H, H-1), 4.94 (d, 2J = 12.0 Hz, 1H, ½ CH2Ph), 4.79 (d, 2J = 11.7 Hz, 1H, ½
CH2Ph), 4.71-4.61 (m, 2H, H-6b, ½ CH2Ph), 4.61-4.52 (m, 2H, H-6a, ½ CH2Ph), 4.27 (m,
J5,6a = J5,6b = 6.8 Hz, 1H, H-5), 4.16 (d, J3,4 = 3.3 Hz, 1H, H-3), 4.10 (d, 1H, H-4), 3.62 (d,
1H, H-2) ppm; 13C NMR (151 MHz, CDCl3): δ, 99.8 (C-1), 66.0 (C-6) ppm; HR-FAB MS
[M+Na]+ calcd for C45H68NaO7Si2+ 799.4396, found 799.4413.

2.4.4. NMR studies of reaction intermediates
NMR studies were performed at 300 MHz. Molecular bromine (2.0 eq) was injected
into a frozen solution of the donor (15 mg) in CDCl3. The mixture was allowed to melt at
-50 °C and then 1H NMR spectra were recorded at different time points.

2.4.5. Computational studies
All calculations were run using the Schrödinger suite of programs through the
Maestro graphical interface.51 A protocol that relies on the following steps was
implemented to identify representative minimum-energy geometries.
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Molecular Mechanics calculations. Monte Carlo/energy minimization (MC/EM)
conformational searches52 of thioglycosides β-2.2, β-2.3, α-2.2 and α-2.3 and of Br
derivatives β-2.4 and α-2.4 were performed as the first step within the framework of
MacroModel version 11.1,53 using the OPLS2005 force field54 and the implicit water or
chloroform GB/SA solvation model,55 to generate starting geometries for subsequent DFT
calculations. The torsional space of each glycoside was randomly varied with the usagedirected Monte Carlo conformational search. A ring-closure bond was defined in the sixmembered pyranose ring. For each search, at least 1000 starting structures for each variable
torsion angle were generated and minimized until the gradient was <0.05 kJÅ-1mol-1 using
the truncated Newton–Raphson algorithm.56 Duplicate conformations and those with
energy >6 kcalmol-1 above the global minimum were discarded.
DFT optimization and thermochemical analysis. Representative structures
obtained from the above-described conformational search (sampling both the pyranose ring
conformations and the substituent orientations) were fully optimized with DFT calculations
at the B3LYP/6-31G* level (β-2.2, β-2.3, α-2.2 and α-2.3) or at the B3LYP/LACVP level
(β-2.4 and α-2.4) of theory using the Jaguar version 9.1.57 Default convergence criteria
were employed. The obtained stationary points were confirmed as minima by frequency
calculation at the same level of theory and their thermochemical properties, including the
final total Gibbs free energy, were computed. The relative energies (both SCF Energy
DFT/B3LYP and Total Gibbs free energy) of the most stable conformations located by the
DFT calculations for the pyranose ring in each compound are reported in Tables A-1 to A6. The structures are characterized by the values of the four pyranose HCCH dihedral
angles and the corresponding vicinal 3J HCCH calculated by Schrodinger Maestro V16.
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CHAPTER 3

HPLC-assisted automated
oligosaccharide synthesis: the
implementation of the two-way split
valve as a mode of complete
automation
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3.1. Introduction
With improved understanding of functions of glycans, the demand for robust
methods to produce both natural glycans and their mimetics has increased.1-2 Traditional
glycan synthesis in solution involves reiteration of glycosylation-deprotection steps, with
aqueous work-up to remove excess reagents after most steps, and purification of most
intermediates. Many advanced strategies that streamline oligosaccharide synthesis are
based on either chemoselective or selective activation of building blocks.3 Fraser-Reid’s
armed-disarmed,4-5 Danishefsky’s,6 Roy’s7 and Boons’8 active-latent, Ogawa-Ito’s
orthogonal,9-10

Ley’s

tunable,11-12

Wong’s

programmable,13-14

and

Huang-Ye’s

preactivation15 are among the most effective strategies known for glycan synthesis in
solution. Nevertheless, there is still no universal synthetic route to glycans, and this type
of synthesis requires relevant training and qualifications, so it is practically impossible to
implement these reactions outside specialized labs. This significantly hampers the
development

in

glycosciences,

whereas

other

biopolymers,

peptides16-17

and

oligonucleotides,18 can now be produced by machines. Efforts to automate solution
synthesis of glycans using parallel synthesizers have been reported by Takahashi,19-20
Pohl,21-24 and Nokami.25-26 Being still relatively unexplored, these approaches offer viable
alternatives to automated enzymatic syntheses being developed by Wong,27-28 Nishimura,29
Chen,30-32 Wang,33-34 and Boons.35

3.2. Results and discussion
Solid-phase synthesis also involves reiteration of glycosylation-deprotection steps,
but it eliminates the need for conventional reaction work-up and purification of
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intermediates.36-38 Another strength of the solid phase synthesis is its automation
amenability, which was demonstrated in 2001 by Seeberger who adapted a peptide
synthesizer to glycan synthesis.39-42 In 2012, Seeberger reported “the first fully automated
solid-phase oligosaccharide synthesizer”43 that was then commercialized as Glyconeer
2.1.44 Also in 2012, Demchenko and Stine reported HPLC-based automation (HPLC-A) of
solid phase synthesis.45 The underpinning idea for this technology is to use the standard lab
equipment that will allow recording a successful synthetic sequence as a computer
program. To advance our original HPLC-A set-up based on Tentagel,45 we identified
JandaJel resin as a more efficient support for HPLC-A.46 We also implemented the standard
analytical HPLC autosampler for delivering TMSOTf, the promoter for glycosylation.46
This approach was recently applied to the synthesis of the N-glycan core pentasaccharide.47
Even with the addition of the autosampler to deliver the promoter of glycosylation,
the manual component of HPLC-A remained. The building block intake/delivery remained
semi-manual because the reagent bottle swap required the operator. Also switching
between the reaction and discharge/collection modes required the operator intervention. To
enhance our automation capabilities, reported herein is our enhanced HPLC-A platform
that incorporates a preparative autosampler to deliver all building blocks and all reagents
for all steps of the synthesis and a standard two-way split valve. In this application, the
split valve was programmed to switch between the discharge and the product collection
modes, 1 and 2, respectively (Figure 3.1).
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Figure 3.1. Modified HPLC-A set-up to achieve complete automation

This new automated set-up completely eliminates all variabilities that could be
caused by the operator. No operator intervention is necessary after the software start button,
initiating the programmed synthetic sequence, has been pressed and until the final product
has been delivered to the collection flask. This approach was showcased by the synthesis
of regular and alternating 1→6 and 1→4-linked glucans 3.1-3.3 shown in Figure 3.1. The
HPLC was programmed to perform the entire sequence of reactions consisting of a series
of glycosylations with Fmoc deprotections in between, followed by the off-resin cleavage,
and collection of the final product, all in 12 h in the completely automated “press of a
button” mode. To perform the assembly of all oligosaccharide sequences described herein
we chose building blocks 3.4-3.7 shown in Figure 3.1. Glycosyl donor 3.4 and acceptors
3.6 and 3.7 were synthesized as previously reported,45-46 while trichloroacetimidate donor
3.5 was derived from known thioglycoside precursor.43, 48
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Figure 3.2. Glycan sequences 3.1-3.3 obtained in the fully automated mode and
building blocks 3.4-3.7 needed for all syntheses

In accordance with our approach, the first building block, glycosyl acceptor, is
conjugated to the resin on a large scale (5-10 g of the resin) prior the automation steps. The
extent of loading is determined by cleavage/validation sequence on a small portion (50 mg)
of the entire load. This approach helps to avoid overestimation of loading and to ensure
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reproducibility of multiple experiments. Resin functionalized with glycosyl acceptor 3.6 or
3.7 (typical scale 50 mg, typical loading 0.02 mmol) is then packed in an Omnifit column
and the latter is integrated into the HPLC system. Glycosyl donors 3.4 and/or 3.5, promoter
(TMSOTf), and other reagents such as piperidine for Fmoc removal are dissolved in
separate vials that are placed into the autosampler tray. All subsequent steps are automated
by programming the standard operation software without manual intervention.
All glycosylation sequences follow the same basic blueprint. The resin is
washed/swelled with the HPLC grade methylene chloride. Then, the flow rate is lowered,
and the donor and promoter are delivered as follows. The robotic arm of the autosampler
brings the vial containing the donor from the sample tray to the needle that draws the
programmed amount of the donor solution. The robotic arm of the autosampler returns the
donor vial to the sample tray and then brings the vial containing the promoter solution to
the needle. The needle draws the required amount of the promoter, and the donor and
acceptor are premixed in the “needle seat,” a capillary that connects the needle to the valve
of the autosampler. The resulting solution of the pre-activated donor is then injected into
the system. After that, the autosampler needle is washed using a dedicated vial in the
autosampler tray to avoid cross contamination with vials used in subsequent steps. In our
current configuration, recirculation previously performed for each glycosylation, has been
substituted by multiple injections. This ensures that the system is supplemented with small
portions of fresh preactivated donor until the glycosylation completed, as accessed by the
detector monitored at 254 nm. The number of injections, and the amount of the donor
utilized for every injection can be tuned to ensure that only the desired amount of the donor
has been delivered. For instance, 7.5 equiv of donor 3.4 were utilized for each glycosylation
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step for the synthesis of 1→6 linked pentasaccharide 3.1, and 10 equiv of the respective
donors were used to obtain 1→4 linkages in glycans 3.2 and 3.3.
The glycosylations were followed by the Fmoc group removal, and this operation
is performed by delivering a solution of piperidine in DMF/CH2Cl2. This step is monitored
at 254 and 301 nm, with the second wavelength being specific for monitoring
dibenzofulvene-piperidine adduct. Once the desired oligosaccharide sequence is achieved
via the reiteration of the glycosylation and deprotection steps, the reagent for cleavage,
sodium methoxide in methanol-DCM, is delivered to affect the off-resin cleavage. At this
stage, the split valve is programmed to direct the flow towards the collection flask (Figure
3.1, mode 2).
A representative protocol, general for the synthesis of all target glycans, is
exemplified by the synthesis of glycan 3.1 as depicted in Scheme 3.2. Compound 3.8 is
obtained with the iterations of glycosylations and Fmoc removal steps. The complete
sequence of synthetic steps is built as lists of multiple operations including draw, mix, and
inject commands. These operations are then modulated as needed for the synthesis of a
particular target. This approach allows for flexible adaptation to specific targets to
maximize the efficiency and yield. Compound 3.9, resulting from the off-resin cleavage, is
manipulated through a series of post-automation steps, which include acetylation and
purification via column chromatography, to afford the final product 3.1 in 33% yield. The
final yields for glycans 3.2 and 3.3 were 20% and 30%, respectively. Differently from
glycan 3.1, (1→4) linked compound 3.2 and compound 3.3 with alternating (1→6) and
(1→4) linkages were obtained through benzoylation after the off-resin cleavage step.
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Scheme 3.1. Automated synthesis of glycan 3.1

3.3. Conclusions
A new experimental set-up for the HPLC-based automated synthesizer has been
developed. The sequences were written to achieve complete automation of all steps,
starting from delivering sugar building blocks to obtaining glycan targets in the collection
flask. This was made possible by implementing the new two-way switch valve used to
direct the flow and by programming the preparative autosampler to deliver all reagents for
all steps of the synthesis. Machine-assisted synthesis also helps to eliminate variabilities,
and to accurately reproduce experiments multiple times. This in turn will simplify the
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implementation of our protocols in other interested labs, all pre-recorded computer
program sequences for all steps of the synthesis are readily available.

3.4. Experimental

3.4.1. General methods
The reactions were performed using commercial reagents and the ACS grade
solvents were purified and dried according to standard procedures. HPLC grade solvents
used for automation were utilized without purification. Column chromatography was
performed on silica gel 60 (70−230 mesh) or using flash purification system Biotage Isolera
One, reactions were monitored by TLC on Kieselgel 60 F254. The compounds were
detected by examination under UV light and by charring with 10% sulfuric acid in
methanol. Solvents were removed under reduced pressure at <40 °C. CH2Cl2 was distilled
from CaH2 directly prior to application. Amberlite IR20 (H+) was washed three times with
MeOH and stored under MeOH. Optical rotations were measured using a Jasco ‘P-2000’
polarimeter. 1H NMR spectra were recorded at 300 or 600 MHz, 13C NMR spectra were
recorded at 75 or 150 MHz. The 1H chemical shifts are referenced to the signal of the
residual CHCl3 (δH = 7.24 ppm). The

13

C chemical shifts are referenced to the central

signal of CDCl3 (δC = 77.23 ppm). HRMS determinations were made with the use of a
mass spectrometer with FAB ionization and ion-trap detection. Agilent 1260 infinity II
HPLC System and Agilent 1260 Variable Wavelength UV−vis Detector were used to
assemble the automated synthesizer.
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3.4.2. Set up of the HPLC-A synthesizer
The HPLC based synthesizer has been assembled using
•

1260 Agilent Infinity II series Quaternary Pump

•

Variable Wavelength Detector with dual-wavelength mode

•

The Autosampler is the preparative module from 1260 Infinity series. The

autosampler is equipped a 900 µL preparative loop and two trays holding 15 x 6 mL vials
each. The wells of the left tray are numbered from 1 to 15 while the ones of the right tray
are numbered from 101 to 115.
•

The valve is a 2-way 6-port Quick Change Valve.

•

The column utilized is an Omnifit Solvent Plus 50 mm.

The synthesis sequences are programmed using Chemstation software and the
autosampler programming option.

Figure 3.3. The synthesizer set up with the two channels of the valve
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3.4.3. Synthesis of glycosyl donors and glycosyl acceptors
2,3,4-Tri-O-benzoyl-6-O-(9-fluorenylmethoxycarbonyl)-α/β-D-glucopyranosyl
trichloroacetimidate (3.4) was obtained in accordance with the reported procedure and its
analytical data were in accordance with that previously described.[1]
2-O-Benzoyl-3,6-di-O-benzyl-4-O-(9-fluorenylmethoxycarbonyl)-α/β-Dglucopyranosyl trichloroacetimidate (3.5). Water (8.0 mL) and N-bromosuccinimide
(NBS, 1.25 g, 7.03 mmol) were added to a solution of ethyl 2-O-benzoyl-3,6-di-O-benzyl4-O-(9-fluorenylmethoxycarbonyl)-1-thio-β-D-glucopyrano-side[2] (3.10, 4.50 g, 6.39
mmol) in methylene chloride (80 mL) and the resulting mixture was stirred vigorously for
2 h at rt. The reaction was quenched with 10% aq. Na2S2O3 and diluted with methylene
chloride (~120 mL). The organic phase was separated and washed with brine (2 x 30 mL),
dried with MgSO4 and concentrated in vacuo. The residue was filtered through a pad of
silica gel (hexanes - ethyl acetate isocratic elution, 7/3, v/v) to afford 2-O-benzoyl-3,6-diO-benzyl-4-O-(9-fluorenylmethoxycarbonyl)-D-glucopyranose (3.11). Crude residue
containing hemiacetal 3.11 (3.53 g, 5.14 mmol) was dissolved in anhydrous methylene
chloride (80 mL). Trichloroacetonitrile (7.73 mL, 77.10 mmol) and NaH (60% suspension
in mineral oil, 0.025 g, 0.62 mmol) were added and the resulting mixture was stirred under
argon for 3 h at rt. The volatiles were removed under the reduced pressure, and the residue
was purified using a Biotage Isolera One (50 g SNAP ULTRA cartidge, hexane - ethyl
acetate elution) to afford the title compound as an amorphous solid (3.90 g, 73% over two
steps, α/β = 12.5/1). Selected analytical data for 3.5α: Rf = 0.54 (hexane/ethyl acetate, 7/3,
v/v); 1H NMR (300 MHz, CDCl3): δ, 8.54 (s, 1H), 8.02-7.93 (m, 2H, aromatic), 7.77 (dd,
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2H, J = 7.4, 2.7 Hz, aromatic), 7.68-7.51 (m, 4H, aromatic), 7.48-7.05 (m, 20H, aromatic),
6.67 (d, 1H, J1,2 = 3.5 Hz, H-1), 5.41 (dd, 1H, J2,3 = 10.0 Hz, H-2), 5.24 (dd, 1H, J3,4 = J4,5
= 9.9 Hz, H-4), 4.69 (s, 2H, CH2Ph), 4.61-4.52 (m, 2H, CH2Ph), 4.42-4.21 (m, 4H, H-3, 5,
6a, CH/Fmoc), 4.15 (dd, 1H, J5,6a = J6a,6b = 6.9 Hz, H-6b), 3.77-3.60 (m, 2H, CH2/Fmoc)
ppm;

13

C NMR (75 MHz, CDCl3): δ, 165.36, 160.50, 154.25, 143.34, 143.21, 141.41,

137.75, 137.51, 133.58, 129.93, 129.16, 128.56, 128.44, 128.34, 128.04, 128.02, 127.88,
127.79, 127.32, 125.18, 125.10, 120.22, 93.62, 90.96, 76.60, 74.99, 74.54, 73.71, 72.28,
71.54, 70.21, 68.52, 46.80; HR-TOF MS [M+Na+] calcd 852.15044 found 852.15296.
Selected analytical data for 3.5β: Rf = 0.50 (hexane/ethyl acetate, 7/3, v/v); 1H NMR
(300 MHz, CDCl3): δ, 5.97 (d, 1H, H-1), 5.61 (m, 1H, H-2) ppm.
Conjugate 3.6 was obtained from methyl 2,3-di-O-benzyl-6-O-(3-hydroxycarbonylpropanoyl)-α-D-glucopyranoside and JandaJel in accordance with the reported procedure.4 The
acceptor loading of 0.40 mmol/g for conjugate 3.6 was determined by direct cleavage from
the solid support (50 mg of resin) and quantifying on HPLC to mimic conditions for the
subsequent reactions.
Conjugate 3.7 was obtained by reaction of 8-(3-carboxypropanoyloxy)oct-1-yl 2,3,4-triO-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside

with

JandaJel

performed

in

accordance with the reported procedure.4 The acceptor loading of 0.33 mmol/g for
conjugate 3.7 was determined by direct cleavage from the solid support (50 mg of resin)
and quantifying on HPLC to mimic conditions for the subsequent reactions.

3.4.4. Preparation of the reagent vials
All the solutions were freshly prepared using the HPLC grade solvents and kept at
room temperature for the duration of the synthesis.

Matteo Panza | UMSL 2019 | Page 189

Donor: a solution of glycosyl donor (0.08-0.2 mmol) in CH2Cl2 (3.5 mL).
Promoter: a solution of TMSOTf (0.04-0.16 mmol) in CH2Cl2 (2.0 mL
Reagents for Fmoc removal: a solution of piperidine in DMF (5.0 mL, 2/3, v/v).
Reagents for cleaving off the resin: a solution prepared from 1M NaOMe in MeOH
(1.5 mL), CH2Cl2 (1.0 mL) and MeOH (1.0 mL).
Washing solutions and blanks: methylene chloride (6.0 mL).

3.4.5. The automated assembly of oligosaccharides
All reactions were carried out using 50 mg of preloaded resin. The acceptor is
loaded on the resin prior automation, therefore the loading depended on the batch of the
resin. Syntheses with acceptors 3.6 and 3.7 were performed with 0.02 and 0.0165 mmol,
respectively.
Glycosylations. The sequences are comprehensive of washings of the resin pre
and after glycosylation steps. The glycosylations are split in two interations of 5 injections
each. The donor and the promoter are drawn from the vial, mixed in the needle seat and
the injected. Once the activated donor has passed through the column, the same operation
is repeated. The resin is washed with CH2Cl2 and DMF and 5 more injections are
performed. The volume of solvent in the vials is constant, hence the concentration of donor
and promoter varies depending on the equivalents required to successfully glycosylate the
acceptor. Figure 3.3 depicts the programming of the components of the synthesizer. 3.3A
shows the pump timetable, 3.3B shows the autosampler programming and 3.3C the variable
wave-length detector (VWD). The valve was on position 1 during the whole sequence.
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A

B

C
Figure 3.4. Settings of the components of the HPLC synthesizer during glycosylation
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Fmoc removal. The reaction is monitored at λ = 250 and λ = 301 nm. The
dibenzofulvene absorbance at 301 nm is a clear indication of the reaction completion. The
removal is completed within 1 hour, including the washings and the resin is reacidified
with TMSOTf as a last step. Even in this case, the valve was left in position 1 (waste) for
the duration of the sequence. Figure 3.4 A, B and C depicts the settings of the pump,
autosampler and VWD, respectively.
Final cleavage. The cleavage is performed in Zemplen conditions, with the
solution prepared as reported above. The valve after the 30 seconds of the sequence
switches from position 1 to position 2 and divert the flow to the collection flask. The
reaction is monitored at both 250 and 301 nm and the sequence consist of 4 consecutive
injections of the cleaving solution. Figure 3.5 A, B and C depicts the settings of the
modules.
Detection. Representative UV traces for each sequence are depicted in Figure 3.6
A, B and C. The absorbance of the donor at λ = 301 nm is significantly lower compared to
250 nm, therefore the signals are not saturated and in some cases is easier to understand
the proceeding of the reaction. The glycosylation trace A shows a progressive increase in
the concentration of the donor with the number of injections, indication of the lower
availability of free acceptor that can still be glycosylated. The Fmoc removal trace B clearly
indicates the majority of the temporary protecting group being removed in the first injection
of the piperidine solution, with only minor amounts cleaved in the following injections.
The final cleavage trace C shows high absorbance during the injections, corresponding the
the prograssive cleavage of the oligosaccharides from the resin and the Bz and Fmoc
groups from the glycans. The absorbance decreases progressively during the washings.
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A

B

C
Figure 3.5. Settings of the components of the HPLC synthesizer during Fmoc removal
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A

B

C
Figure 3.6. Settings of the components of the HPLC synthesizer during the final
cleavage
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A.

Representative trace for Glycosylation

B.

Representative trace for Fmoc removal

C.

Representative trace for the final cleavage
Figure 3.7. UV traces for the synthetic steps
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3.4.6. Synthesis of oligosaccharides
8-Acetyloxyoct-1-yl

O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-

tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-Dglucopyranoside (3.1). Automation modules: The Omnifit column is filled with resin
(50 mg) preloaded with acceptor 3.7 (0.016 mmol). The vials were prepared according to
the general methods and organized as depicted below. Vial 1 contains donor 3.4 (71 mg,
0.08 mmol, 5.0 equiv), vial 2 contains of TMSOTf (14 µL, 0.08 mmol, 5.0 equiv), and vial
3 contains a piperidine-DMF solution prepared as indicated in the general methods. Vials
B, W and C are blank, washing, and final off-resin cleavage, respectively, were prepared
as described in the general methods.
Vial trays organization:

Automation Sequence:
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
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Fmoc removal 60 min
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Final Cleavage 50 min
Post Automation:

The reaction mixture collected from cleavage step was

evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was
evaporated and dried in vacuo for 1 h. The crude was dissolved in pyridine (2.0 mL) and
acetic anhydride (0.5 mL) was added. The resulting mixture was stirred under argon at
room temperature for 16 h. The reaction was quenched with MeOH, then the solvent was
evaporated and co-evaporated with toluene. The residue was purified by column
chromatography on silica gel (hexanes-acetone gradient elution) to afford compound 3.1
in 33% (10.0 mg, 0.0055 mmol) yield. Analytical data for 3.1: Rf = 0.50 (hexane/acetone,
1/1, v/v); []D21 -2.7 (c 1, CHCl3); 1H NMR (600 MHz, CDCl3): δ, 7.39 – 7.21 (m, 15H),
5.23 – 5.05 (m, 6H), 5.02 – 4.83 (m, 9H), 4.80 – 4.74 (m, 2H), 4.71 (d, J = 3.2 Hz, 1H),
4.62 (d, J = 12.0 Hz, 1H), 4.58 – 4.47 (m, 5H), 4.27 (dd, J = 12.3, 4.9 Hz, 1H), 4.15 – 4.02
(m, 5H), 4.01 – 3.84 (m, 5H), 3.76 – 3.47 (m, 13H), 3.33 (dd, J = 16.0, 6.5 Hz, 1H), 2.14 –
1.87 (m, 42H), 1.67 – 1.53 (m, 8H), 1.31 (s, 8H) ppm; 13C NMR (151 MHz, CDCl3): δ,
171.41, 170.78, 170.43, 170.32, 170.27, 170.24, 169.81, 169.74, 169.66, 169.61, 169.59,
169.53, 169.32, 169.19, 138.97, 138.40, 138.27, 128.75, 128.56, 128.50, 128.15, 128.09,
127.99, 127.97, 127.69, 101.00, 100.77, 100.63, 96.80, 81.98, 80.17, 77.54, 75.76, 75.13,
73.29, 73.27, 73.17, 73.10, 72.92, 72.85, 72.78, 72.10, 71.51, 71.49, 71.24, 71.12, 71.10,
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69.75, 69.24, 69.16, 69.10, 68.49, 68.43, 68.16, 68.15, 68.12, 68.07, 64.77, 62.05, 62.02,
61.95, 29.85, 29.60, 29.51, 29.49, 29.36, 28.74, 26.32, 26.08, 21.20, 20.92, 20.89, 20.87,
20.85, 20.82, 20.80, 20.78, 20.76 ppm; HR-TOF MS [M+Na+] calcd 1837.6728 found
1837.6672
Methyl

O-(2,4-di-O-benzoyl-3,6-di-O-benzyl-β-D-glucopyranosyl)-(1→4)-O-(2-O-

benzoyl-3,6-di-O-benzyl-β-D-glucopyranosyl)-(1→4)-O-(2-O-benzoyl-3,6-di-Obenzyl-β-D-glucopyranosyl)-(1→4)-O-(2-O-benzoyl-3,6-di-O-benzyl-β-Dglucopyranosyl)-(1→4)-6-O-benzoyl-2,3-di-O-benzyl-α-D-glucopyranoside

(3.2).

Automation modules: The Omnifit column is filled with resin (50 mg) preloaded with
acceptor 3.6 (0.02 mmol). The vials were prepared according to the general methods and
organized as depicted below. Vial 1 contains donor 3.5 (160 mg, 0.20 mmol, 10.0 equiv),
vial 2 contains of TMSOTf (5 µL, 0.03 mmol, 1.5 equiv), and vial 3 contains a piperidineDMF solution prepared as indicated in the general methods. Vials B, W and C are blank,
washing, and final off-resin cleavage, respectively, were prepared as described in the
general methods.
Vial trays organization:
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Automation Sequence:
Glycosylation 120 min
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Glycosylation 120 min
Final Cleavage 50 min
Post Automation: The reaction mixture collected from cleavage step was
evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was
evaporated and dried in vacuo for 1 h. The crude was dissolved in pyridine (2.0 mL) and
benzoyl chloride (0.5 mL) was added. The resulting mixture was stirred under argon at
room temperature for 16 h. The reaction was quenched with MeOH, then the solvent was
evaporated and co-evaporated with toluene. The residue was purified by column
chromatography on silica gel (hexanes-ethyl acetate gradient elution) to afford compound
3.2 in 20% (10.3 mg, 0.0044 mmol) yield. Analytical data for 3.2: Rf = 0.20
(hexane/EtOAc, 7/3, v/v); []D21 +25.7 (c 1, CHCl3); 1H NMR (600 MHz, CDCl3): δ, 8.07
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– 7.68 (m, 38H), 7.68 – 6.59 (m, 196H), 5.40 – 5.31 (m, 6H), 5.20 – 5.08 (m, 7H), 5.05 –
4.94 (m, 7H), 4.94 – 4.78 (m, 12H), 4.73 (dd, J = 9.8 Hz, 8H), 4.63 – 4.28 (m, 42H), 4.28
– 4.02 (m, 22H), 4.02 – 3.72 (m, 26H), 3.68 (s, 5H), 3.65 – 3.42 (m, 22H), 3.42 – 3.15 (m,
31H), 2.87 (d, J = 8.8 Hz, 1H), 2.75 (d, J = 10.1 Hz, 3H) ppm;

13

C NMR (151 MHz,

CDCl3): δ, 165.87, 165.34, 165.13, 165.08, 165.02, 164.90, 164.86, 164.79, 138.90,
138.76, 138.38, 138.16, 137.81, 137.54, 133.59, 133.38, 133.09, 132.96, 129.84, 129.60,
129.00, 128.65, 128.57, 128.45, 128.27, 128.12, 127.93, 127.68, 127.39, 127.30, 127.12,
127.02, 101.31, 100.16, 100.03, 99.97, 97.91, 80.41, 80.28, 80.06, 79.88, 79.45, 78.29,
77.37, 77.16, 76.95, 76.44, 76.13, 75.18, 74.90, 74.72, 74.48, 74.00, 73.88, 73.78, 73.56,
73.44, 72.09, 69.95, 68.43, 67.45, 67.16, 62.84, 55.31, 32.08, 29.85, 29.51, 29.28, 22.85,
14.28 ppm; HR-TOF MS [M+Na+] calcd 2390.9097 found 2390.9045.

Methyl O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-(1→4)-O-(2-O-benzoyl-3,6di-O-benzyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tetra-O-benzoyl-β-Dglucopyranosyl)-(1→4)-6-O-benzoyl-2,3-di-O-benzyl-α-D-glucopyranoside

(3.3).

Automation modules: The Omnifit column is filled with resin (50 mg) preloaded with
acceptor 3.6 (0.02 mmol). The vials were prepared according to the general methods and
organized as depicted below. Vial 1 contains donor 3.4 (130 mg, 0.15 mmol, 7.5 equiv),
vial 2 contains of TMSOTf (10 µL, 0.05 mmol, 2.5 equiv), and vial 3 contains a piperidineDMF solution prepared as indicated in the general methods. Vial 4 contains donor 3.5 (83
mg, 0.10 mmol, 5.0 equiv) and vial 2 contains of TMSOTf (7.5 µL, 0.04 mmol, 2.0 equiv).
Vials B, W and C are blank, washing, and final off-resin cleavage, respectively, were
prepared as described in the general methods.

Matteo Panza | UMSL 2019 | Page 200

Vial trays organization:

Automation Sequence:
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Final Cleavage 50 min
Post Automation: The reaction mixture collected from cleavage step was
evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was
evaporated and dried in vacuo for 1 h. The crude was dissolved in pyridine (2.0 mL) and
benzoyl chloride (0.5 mL) was added. The resulting mixture was stirred under argon at
room temperature for 16 h. The reaction was quenched with MeOH, then the solvent was
evaporated and co-evaporated with toluene. The residue was purified by column
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chromatography on silica gel (hexanes-ethyl acetate gradient elution) to afford compound
3.3 in 30% (13 mg, 0.0066 mmol) yield. Analytical data for 3.3: Rf = 0.15 (hexane/EtOAc,
7/3, v/v); []D21 +1.8 (c 1, CHCl3); 1H NMR (600 MHz, CDCl3): δ, 7.98 – 7.71 (m, 26H),
7.61 – 7.12 (m, 66H), 7.05 – 6.87 (m, 9H), 5.66 (m, 2H), 5.53 – 5.46 (m, 2H), 5.43 – 5.39
(m, 1H), 5.33 – 5.26 (m, 2H), 5.17 – 5.12 (m, 1H), 4.91 (dd, J = 11.5, 6.2 Hz, 4H), 4.77
(dd, J = 14.6, 9.6 Hz, 2H), 4.69 (d, J = 12.0 Hz, 1H), 4.63 – 4.58 (m, 2H), 4.55 (d, J = 12.5
Hz, 1H), 4.41 (dd, J = 20.2, 7.6 Hz, 3H), 4.33 (d, J = 12.1 Hz, 1H), 4.07 (ddd, J = 18.1,
10.4, 6.3 Hz, 4H), 3.89 – 3.85 (m, 1H), 3.81 – 3.68 (m, 7H), 3.61 (dd, J = 12.4, 7.2 Hz,
1H), 3.50 – 3.44 (m, 3H), 3.39 – 3.34 (m, 1H), 3.33 – 3.22 (m, 4H), 3.14 – 3.07 (m, 1H),
2.76 (d, J = 9.6 Hz, 1H), 1.26 (s, 17H), 0.94 – 0.77 (m, 5H) ppm; 13C NMR (151 MHz,
CDCl3): δ, 166.16, 166.08, 165.84, 165.79, 165.63, 165.50, 165.32, 165.26, 165.20,
164.82, 139.23, 138.49, 138.41, 138.24, 138.16, 133.76, 133.54, 133.49, 133.44, 133.31,
133.25, 133.15, 133.06, 129.97, 129.91, 129.84, 129.69, 129.61, 129.16, 129.09, 128.95,
128.89, 128.80, 128.66, 128.52, 128.48, 128.42, 128.37, 128.35, 128.22, 128.20, 128.11,
128.05, 127.98, 127.85, 127.50, 127.44, 127.22, 100.66, 100.59, 100.51, 98.16, 80.71,
80.63, 80.60, 77.83, 77.76, 76.21, 74.86, 74.26, 74.21, 73.67, 73.26, 73.05, 72.47, 72.20,
72.11, 69.94, 69.78, 68.55, 67.22, 66.82, 63.12, 63.08, 55.37, 32.08, 31.10, 29.85, 29.52,
22.85 ppm; HR-TOF MS [M+NH4+] calcd 1995.6984 found 1995.7010.
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CHAPTER 4

The development of a dedicated
polymer support for the solid-phase
oligosaccharide synthesis
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4.1. Introduction
With the advances of the field of glycosciences and the increasing number of
structures elucidated and applied in all areas of the field, the need for reliable approaches
to the synthesis of glycans has grown exponentially.1,2 Traditional glycan synthesis in
solution involves iteration of glycosylation and deprotection steps, but some advanced
strategies based on either chemoselective or selective activation of building blocks help
to streamline the oligosaccharide assembly significantly.3 However, no universal route to
glycans can be established, which dramatically hinders progress in glycosciences,
whereas other biopolymers, peptides4,5 and oligonucleotides,6 can be produced by
automated machines. Solid-phase synthesis (SPS) eliminates the need for conventional
reaction work-up and purification of intermediates,7-9 and offers promising automation
amenability. Since early efforts in 2001,10-13 Seeberger et al. developed a dedicated
automated oligosaccharide synthesizer in 201214 that was later commercialized as
Glyconeer 2.1.
Also in 2012, we reported High Performance Liquid Chromatography equipmentbased automation (HPLC-A) of SPS.15 The general idea for developing the HPLC-A is
that a computer interface coupled with standard HPLC components will allow recording a
successful automated sequence as a computer program that can then be reproduced with
the “press of a button.” However, SPS of glycans suffers from certain inherent
weaknesses. “The chemistry and biology of carbohydrates has been a Cinderella field,”16
and the area of SPS wherein everything is “borrowed” from other fields illustrates this
problem very clearly. For example, instead of developing dedicated supports, commercial
resins designed specifically for peptide or nucleotide SPS17-19 are meticulously evaluated
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to determine their possible suitability for glycan synthesis, which often demands different
characteristics.20
Presented herein is the first step of our strategic goal to tackle the key weaknesses
in our previous automation efforts, and those of the SPS in general, both automated and
manual. While HPLC-A and other automated approaches have a potential to
revolutionize the way glycan synthesis is conducted, all current platforms suffer from
inherent weaknesses of SPS as applied to glycans, among which is poor compatibility of
existing commercial resins. Seeberger automation relies on the traditional polystyrenebased Merrifield resin. Our original HPLC-A set-up was based on Tentagel, a polystyrene
grafted with PEG chains.15 Later on, we identified JandaJel polystyrene resin crosslinked
with tetrahydrofuran-derived chains as a better support for HPLC-A.21 Although JandaJel
has better swelling properties compared to the traditional Merrifield resin, it has low
stability in the presence of large amounts of trimethylsilyl trifluoromethanesulfonate
(TMSOTf).22

4.2. Results and Discussion
JandaJel and more traditional Merrifield or Tentagel resins21 are all based on
polystyrene, but differ in functionalization / crosslinking, albeit none were designed
specifically with the SPS of glycans in mind.23 Cross-linked polystyrenes are
mechanically stable and can be obtained on a large scale from broadly available and
inexpensive precursors. However, phenol-based cross-linking used in JandaJel (4.1,
Figure 4.1) may potentially have marginal stability under strongly (Lewis) acidic
conditions that are commonly employed in SPS of glycans. Although this degradation
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was not thought to significantly hinder general progress, we came to the realization that
beads designed for peptides do not have the necessary properties suitable for glycan SPS.
To address this potential weakness, described herein is the investigation of benzyl
alcohol-derived ethylene glycol chain cross-linking (4.2, Figure 4.1) due to the
anticipated greater stability of such structures under (strongly) acidic reaction
conditions.24,25 This type of resin was first synthesized by Itsuno et al,25 but its
application in SPS is unknown. Interestingly, benzylic attachments have been considered
by Janda and co-workers,26,27 but were deemed inferior due to their marginal stability
toward strongly basic reagents, such as BuLi.

Figure 4.1. Selection of the attachment strategies and cross-linkers
To increase the swelling properties in polar protic solvents, we chose to replace
the tetrahydrofuran chain used by Janda with the diethylene glycol (DEG) derived
structure 4.2 depicted in Figure 4.1. Ethylene-glycol,28 its homologs, and other similar
molecules27 have been previously investigated as crosslinkers, but the application of such
resins in SPS is unknown.25 Crosslinker monomer 4.2 was synthesized using paravinylbenzyl chloride 4.3 and diethylene glycol 4.4 in the presence of NaH in DMF,
affording the desired compound in a good yield 85% (Scheme 4.1). The cross-linker
monomer 4.2 was then used in the synthesis of a 2% cross-linked polymer 4.6.
Monomers 4.2, 4.3, and 4.5 in a respective ratio of 2/10/88 (w/w/w) were polymerized in
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the presence of benzoyl peroxide, sodium chloride and Arabic gum in water at 85 °C for
16 h following a procedure previously described by Janda.22 The desired polymer 4.6 was
then purified using a Soxhlet extractor and i-PrOH. The chlorobenzyl group was further
functionalized following Gabriel’s synthesis protocol, wherein the chloride was displaced
with phthalimide in DMF at 55 °C. The resulting phthlaloyl group was then removed
with hydrazine hydrate in a mixture of MeOH and chloroform. This two-step procedure
produced PanzaGel 4.7 equipped with the primary amine functional groups (Scheme 4.1)
with a nominal loading capacity of 1.0 mmol/g.

Scheme 4.1. Synthesis of PanzaGel 4.7
Then, the swelling properties of the polymer were investigated. Swelling was measured
following described procedures,29 using a syringe equipped with a sintered frit. The
volume of dry resin was measured, then solvent was introduced in the syringe and the
mixture was allowed to equilibrate for 1 h. After being vortexed, extra solvent was
removed using another syringe. As listed in Table 1, both polar and non-polar solvents
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were tested, all of them showing good swelling, similar to the volumes reported for
JandaJel.22 The exception is MeOH, which still exhibits better swelling if compared to
data available for JandaJel.

Volume of resin (mL/g)
Solvent
PanzaGel

JandaJel22

Merrifield22

None

1.75

1.5

1.5

CH2Cl2

9.0

11.8

5.8

MeOH

2.5

1.5

1.8

DMF

8.5

14

4.2

THF

10.0

12

5.4

Toluene

8.0

ND

ND

Table 4.1. Comparison of swelled JandaJel and Panzagel
A set of experiments were then conducted to determine physical properties of the
resin and recorded in collaboration with Prof. Stine laboratory by Dharmendra Neupane .
Thermal degradation properties of PanzaGel was assessed by thermogravimetric analysis
(TGA). As shown in Figure 4.2, the thermal decomposition of PanzaGel 4.7 was
investigated at various temperatures. PanzaGel was found thermally stable up to 360 °C,
but about 97% weight loss occurs by 460 °C. To assess the chemical stability of
PanzaGel, the polymer was treated with trimethylsilyl trifluoromethanesulfonate, as this
Lewis acid was found to degrade JandaJel.30 Upon treatment of 100 mg of resin with 100
µL of TMSOTf in 1.0 mL of methylene chloride for 1 h, which exceeds the typical
conditions employed in chemical glycosylations using polymer supports, no
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decomposition was observed. The thermal decomposition temperature and the SEM
images of the polymer showed no significant difference before and after the treatment
with TMSOTf. PanzaGel treated with TMSOTf decomposed by about 85% upon heating
to 600 °C leaving behind a residue, indicating a chemical structure unaltered by the
prolonged contact with the acid.

Figure 4.2. Thermogravimetric analysis (TGA) plots (black line) and Weight
derivatives curves (red line) of PanzaGel
The prepared polymer was also investigated by scanning electron microscopy,
with images recorded by Dharmendra Neupane. As shown in Figure 4.3, polymer 4.7 was
prepared in the form of monospheres with an average size of 157.64 µm (average of 30
polymer beads). Nitrogen adsorption/desorption isotherm plots have been used to
evaluate the pore volume (Vp) and the surface area (S) of the synthesized material. The
total pore volume was calculated as 0.0033 mL/g. The BET surface area was found to be
0.84 m2/g.
To explore the synthetic application of the novel resin, we then moved on to
synthesize disaccharide 4.8 and pentasaccharide 4.9 (Figure 4.4). Our lab has recently

Matteo Panza | UMSL 2019 | Page 216

achieved a full automation of the synthesis of oligosaccharides using a two-way spilt
valve.31 Differently from our previous experimental set up involving reagent delivery
with a preparative autosampler, herein we investigated an HPLC system equipped with
an analytical autosampler instead. This module is common on HPLC systems, which
would allow to broaden the scope of HPLC-A. To accommodate this adjustment, a higher
concentration of donor 4.11 was used. 7.5 equiv of donor were dissolved in 2.7 mL of
methylene chloride and the donor solution was split in two vials.

Figure 4.3. SEM images of PanzaGel polymer at 100x (a) and 150x magnification (b)
The autosampler was programmed to draw 500 µL of donor 4.11 solution (0.12
mmol) and 100 µL of TMSOTf solution in methylene chloride, mix them in the needle
seat and inject them onto the column. After 1.0 minute, the appropriate amount of time
needed to allow all of the activated donor to flow into the column containing the
acceptor-bound resin 4.10, the flowrate was lowered to 0.02 ml/min to maximize the time
of exposure of the acceptor to the reactive donor. The flow rate was kept at the minimum
level for 10 min, then increased to 1.0 mL/min of CH2Cl2 to wash the column and prepare
for a new injection of the activated donor. The same operation was repeated for five
iterations and the glycosylation sequence was completed by alternating washings of
methylene chloride and DMF. Following the glycosylation step, the temporary Fmoc
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group was removed using a 20% solution of piperidine in DMF. Three injections of the
piperidine solution were performed, and the reaction was followed using the variable
wavelength detector set at 301 nm. The sequence was completed by washings using
CH2Cl2 and DMF. Last, the polystyrene resin was reacidified through an injection of
TMSOTf. The two reactions were repeated to afford the target glycans. As previously
described, the two-way split valve diverts the flow to a collection flask. The compounds
are then cleaved using a solution of sodium methoxide in MeOH/CH2Cl2 (1/1, v/v). The
partially deprotected oligosaccharides, through a series a post automation steps afforded
the target glycans 4.8 and 4.9 in 80% and 30% yield, respectively. Noticeably, both
syntheses were conducted at room temperature and without utilizing an inert atmosphere.

Figure 4.4. Target compounds and building blocks to investigate how well the new resin
works in application to SPS
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4.3. Conclusions
A new polystyrene-based resin for polymer supported glycan synthesis has been
developed. The resin showed similar swelling properties to other existing solid supports
but superior TMSOTf stability compared to JandaJel that was routinely used in our lab.
The synthesis of these resins is fairly straightforward, and the length of the linker and its
composition can easily be varied to achieve best results in terms of swelling, mechanical
and chemical stability, flow-through applicability, and loading capacity. The glycan
synthesis performed at the end of this study showcased how the improved polymeric
support works in application to the HPLC-A. The target oligosaccharides were obtained
using the same spilt valve introduced recently in the HPLC-A, albeit with the use of an
analytical autosampler. New sequences were specifically developed for this modified setup. A new solid support available specifically for oligosaccharide synthesis will increase
the attractiveness of automated technologies, setting the ground for further
improvements.

4.4. Experimental
4.4.1. General Methods
The reactions were performed using commercial reagents and the ACS grade
solvents were purified and dried according to standard procedures. HPLC grade solvents
used for automation were utilized without any further purification. Column
chromatography was performed on silica gel 60 (70−230 mesh) or on Biotage Isolera
One, reactions were monitored by TLC on Kieselgel 60 F254. The compounds were
detected by examination under UV light and by charring with 10% sulfuric acid in
methanol. Solvents were removed under reduced pressure at <40 °C. CH2Cl2 was
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distilled from CaH2 directly prior to application. Pyridine was dried by refluxing with
CaH2 and then distilled and stored over molecular sieves (3 Å). Amberlite IR20 (H+) was
washed three times with MeOH and stored under MeOH. Optical rotations were
measured using a Jasco ‘P-2000’ polarimeter. IR spectra were recorded using an Agilent
Cary 630 FTIR or a Thermo Nicolet Avatar 360 FTIR. 1H NMR spectra were recorded at
300 or 600 MHz,

13

C NMR spectra were recorded at 75 or 150 MHz. The 1H chemical

shifts are referenced to the signal of the residual CHCl3 (δH = 7.26 ppm). The

13

C

chemical shifts are referenced to the central signal of CDCl3 (δC = 77.23 ppm). HRMS
determinations were made with the use of a mass spectrometer with FAB ionization and
ion-trap detection. Agilent 1260 infinity II HPLC System and Agilent 1260 Variable
Wavelength UV−vis Detector were used to assemble the automated synthesizer.

4.4.2. Set up of the HPLC-A synthesizer
The HPLC based synthesizer has been assembled using
•

1260 Agilent Infinity I series Quaternary Pump

•

Variable Wavelength Detector with single-wavelenght mode

•

The Autosampler is the analytical module from 1260 Infinity series. The
autosampler is equipped a 900 µL loop and one tray holding 100 x 2 mL
vials.

•

The valve is a 2-way 6-port Quick Change Valve.

•

The column utilized is an Omnifit Solvent Plus 50 mm.

The synthesis sequences are programmed using Chemstation software and the
autosampler programming option.
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Figure 4.5. The synthesizer set up

4.4.3. Synthesis of Panzagel crosslinker and Panzagel resin
Di (ethylene glycol) bis (4-vinylbenzyl) ether (4.2) was obtained in accordance with the
reported procedure and its analytical data were in accordance with that previously
described.30 Selected analytical data for 2: Rf = 0.49 (hexane/acetone, 7/3, v/v); 1H NMR
(300 MHz, CDCl3) δ 7.38 (d, J = 8.2 Hz, 4H, aromatic), 7.30 (d, J = 8.2 Hz, 4H,
aromatic), 6.71 (dd, J = 17.6, 10.9 Hz, 2H, CHCH2), 5.74 (dd, J = 17.6, 0.8 Hz, 2H,
CHCH2-trans), 5.23 (dd, J = 10.9, 0.7 Hz, 2H, CHCH2-cis), 4.56 (s, 4H, PhCH2), 3.66 (m
16H, OCH2CH2);

13

C NMR (75 MHz, CDCl3) δ 137.94 (CCH2), 136.98 (CCH), 136.59

(CCHCH2), 128.02 (CH aromatic), 126.28 (CH aromatic), 113.83 (CH2CH), 73.02
(PhCH2), 70.77 (CH2O), 69.46 (CH2O).

Panzagel-Cl Resin (4.6) was obtained in accordance with the reported procedure.27 In a
round bottom flask equipped with a paddle mechanical stirrer, acacia gum (9 g) and NaCl
(5.62 g) were added to water (225 mL) under vigorous stirring. Flush Ar through the
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resulting solution to deoxygenate. Styrene (11.7 mL, 102 mmol), vinylbenzyl chloride
(2.1 mL, 15 mmol), cross-linker 4.2 (0.79g, 2.34 mmol) and benzoyl peroxide (0.22g)
were dissolved in chlorobenzene (15 mL). The resulting solution was added dropwise to
the aqueous mixture under vigorous stirring and the emulsion was heated at 85 °C for
16h. The obtained beads were washed in a sintered funnel with water (2x50 mL), acetone
(2x50 mL), methylene chloride (2x70 mL) and methanol (2x50 mL). The polymer was
then further purified in a Soxhlet extractor with iPrOH for 16 h and dried in vacuo. The
beads were analyzed using solid state FT-IR.

Panzagel-NH2 Resin (4.7)
Panzagel-Cl beads (6, 1.0 g) and dimethylformamide (15 mL) were added to a
round-bottom flask equipped with a mechanical stirrer, and the resin was allowed to swell
for 1 h at rt. Potassium phthalimide (1.0 g) was added, and the resulting mixture was
stirred for 16 h at 55 °C. The resin was filtered off and washed successively with CH2Cl2
(3 x 30 mL), MeOH (3 x 30 mL), acetone (3 x 30 mL) and water (3 x 30 mL) and dried at
60 °C in vacuo. The resulting resin and MeOH/CHCl3 (20 mL, 3/7, v/v) were added to a
found-bottom flask equipped with a mechanical stirrer, and the resin was allowed to swell
for 1 h at rt. H2NNH2-H2O (3.0 mL) was added and the resulting mixture was stirred at rt
for 48 h. The resin was filtered off and washed successively with CH2Cl2 (3 x 30 mL),
MeOH (3 x 30 mL), acetone (3 x 30 mL) and water (3 x 30 mL) and dried at 60 °C in
vacuo. The polymer was characterized using FT-IR, SEM, BET and the presence of NH2
groups was confirmed using the Kaiser test. Analytical data for 4.7: FT-IR: 3025, 2920,
1493, 1452, 1082, 1028, 820, 756 cm-1.
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4.4.4. Synthesis of glycosyl donors and glycosyl acceptors
2,3,4-Tri-O-benzoyl-6-O-(9-fluorenylmethoxycarbonyl)-

α/β-D-glucopyranosyl

trichloroacetimidate (4.11) was obtained in accordance with the reported procedure and
its analytical data were in accordance with that previously described.15

Conjugate 4.10 was obtained by reaction of 8-(3-carboxypropanoyloxy)oct-1-yl 2,3,4tri-O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside with JandaJel in accordance with
the reported procedure.21 The loading of 0.33 mmol/g for 4.10 was determined by direct
cleavage from the solid support (50 mg) on HPLC to mimic conditions for the subsequent
reactions.

4.4.5. Preparation of the reagent vials
All the solutions were freshly prepared using the ACS-grade solvents and kept at
room temperature for the duration of the synthesis.
Donor: a solution of glycosyl donor (0.120 mmol) in CH2Cl2 (2.7 mL), split in
two vials containing 1.6 mL and 1.1 mL of solution.
Promoter: a solution of TMSOTf (0.124 mmol) in CH2Cl2 (500 µL). Both the
amounts were doubled to prepare an excess of acidic solution to acidify the resin after
Fmoc removal.
Reagents for Fmoc removal: a solution of piperidine in DMF (2.5 mL, 2/3, v/v).
Reagents for cleaving the products from the resin: a solution prepared from 1M
NaOMe in MeOH (1.5 mL), CH2Cl2 (1.0 mL) and MeOH (1.0 mL), split equally in 2
vials.
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Washing solutions and blanks: methylene chloride in W1, MeOH in W2 and
methylene chloride in B (2.0 mL).

4.4.6. The automated assembly of oligosaccharides
All reactions were carried using 50 mg of the preloaded resin. The acceptor was
loaded on the resin prior automation, therefore the loading depended on the batch of the
resin. Syntheses with acceptor 4.10 were performed with 0.0165 mmol.

Glycosylation. The sequences included washing of the resin before and after
glycosylation steps. The glycosylations were performed in five iterations of donor
injections. The donor and the promoter are drawn from the vial, mixed in the autosampler
needle seat and the injected. The flowrate was then lowered to maximize the presence of
the donor in the column. Once the activated donor has passed through the column, the
same operation was repeated. At the end of the glycosylation the resin was washed with
CH2Cl2 and DMF.
Figure 4.6 depicts programming of the components of the synthesizer. Figure
4.6A shows the pump timetable, Figure 4.6B shows the autosampler programming. The
valve was in position 1 during the whole sequence.

Fmoc removal. The reaction was monitored using the UV detector set at λmax =
301 nm. The dibenzofulvene absorbance at 301 nm is a clear indication of the reaction
completion. The removal is completed within 1 h, including the washings and the resin is
reacidified with TMSOTf as a last step. Even in this case, the valve was left in postion 1
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(waste) for the duration of the sequence. In figure 4.7 A, B and C the settings of the
pump, autosampler and VWD respectively, are reported. Default volume is 500 µL.

Final cleavage from the resin.

The cleavage is performed in Zemplen

conditions, with the solution prepared as reported above. The valve after the 30 seconds
of the sequence switches from position 1 to position 2 and divert the flow to the
collection flask. The reaction is monitored at both 250 nm and the sequence consists of 4
consecutive injections of the cleaving solution. In figure 4.8 A, B and C are depicted the
settings of the modules.

A
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B
Figure 4.6. Settings of the components of the HPLC synthesizer during glycosylation.

A
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B

C
Figure 4.7. Settings of the components of the HPLC synthesizer during Fmoc removal.

Matteo Panza | UMSL 2019 | Page 227

A

B

C
Figure 4.8. Settings of the components of the HPLC synthesizer during the final
cleavage.
Detection. Representative UV traces for each sequence are depicted in Figure
4.9A and B. The absorbance of the donor at λ = 301 nm is significantly lower compared
to 250 nm, therefore the signals are not saturated and in some cases is easier to
understand the proceeding of the reaction.
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The Fmoc removal trace A clearly indicates the majority of the temporary
protecting group being removed in the first injection of the piperidine solution, with only
minor amounts cleaved in the following injections.
The final cleavage trace B shows high absorbance during the injections,
corresponding the the prograssive cleavage of the oligosaccharides from the resin and the
Bz and Fmoc groups from the glycans. The absorbance decreases progressively during
the

A. Representative trace for Fmoc removal

washings.
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B. Representative trace for the final cleavage
Figure 4.9. UV traces for the synthetic steps

4.4.7. Synthesis of oligosaccharides
8-Acetyloxyoct-1-yl

O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-

O-benzyl-α-D-glucopyranoside (4.8).
Automation modules: The Omnifit column is filled with resin (50 mg) preloaded
with acceptor 4.10 (0.016 mmol). The vials were prepared according to the general
methods and organized as depicted below. Vials 1 and 3 contain donor 4.11 solution (106
mg, 0.12 mmol, 7.5 equiv) split as described in the general methods, vial 2 contains of
TMSOTf (22 µL, 0.12 mmol, 7.5 equiv), and vial 3 contains a piperine-DMF solution
prepared as indicated in the general methods. Vials B, W and C are blank, washing, and
final off-resin cleavage, respectively, were prepared as described in the general methods.
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Vial tray organization:

Automation Sequence:
Glycosylation 120 min
Fmoc removal 60 min
Post Automation:

The reaction mixture collected from cleavage step was

evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was
evaporated and dried in vacuo for 1h. The crude was dissolved in pyridine (2.0 mL) and
acetic anhydride (0.5 mL) was added. The resulting mixture was stirred under argon at
room temperature for 16h. The reaction was quenched with MeOH, then the solvent was
evaporated and co-evaporated with toluene. The residue was purified by column
chromatography on silica gel (hexanes-acetone gradient elution) to afford compound 4.8
in 80% yield. Analytical data matched what has been previously reported.32
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8-Acetyloxyoct-1-yl

O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-

tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-Dglucopyranoside (4.9).
Automation modules: The Omnifit column is filled with resin (50 mg) preloaded
with acceptor 4.10 (0.016 mmol). The vials were prepared according to the general
methods and organized as depicted below. Vials 1 and 3 contain a solution of donor 4.11
(106 mg, 0.12 mmol, 7.5 equiv) split as described in the general methods, vial 2 contains
of TMSOTf (22 µL, 0.12 mmol, 7.5 equiv), and vial 3 contains a piperine-DMF solution
prepared as indicated in the general methods. Vials B, W and C are blank, washing, and
final off-resin cleavage, respectively, were prepared as described in the general methods.

Vial tray organization
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Automation Sequence:
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Fmoc removal 60 min
Glycosylation 120 min
Final Cleavage 50 min
Post Automation:

The reaction mixture collected from cleavage step was

evaporated under reduced pressure, then diluted with MeOH (2.0 mL) and quenched with
Amberlite IR20 H+ form. The resin was filtrated and washed with MeOH, the solvent was
evaporated and dried in vacuo for 1h. The crude was dissolved in pyridine (2.0 mL) and
acetic anhydride (0.5 mL) was added. The resulting mixture was stirred under argon at
room temperature for 16h. The reaction was quenched with MeOH, then the solvent was
evaporated and co-evaporated with toluene. The residue was purified by column
chromatography on silica gel (hexanes-acetone gradient elution) to afford compound 4.9
in 30% yield. Analytical data matched what has been previously reported.
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Scheme A-1. Conversion of 3,4-di-O-TBS α-SEt glucoside α-2.2 into α,β-bromides
2.4
Table A-1. DFT-optimized structures (hydrogens and protecting groups have been
omitted for clarity in 3D ball and stick representations) and calculated coupling
constants of compound β-2.2

Conformation
4

C1 chair

E (kcal/mol)

G (kcal/mol)

Dihedral angle (degrees)

Calculated J (Hz)

0.00

0.00

H-C1-C2-H (172.6°)

J1,2 = 8.7

H-C2-C3-H (-167.0°)

J2,3 = 7.7

H-C3-C4-H (172.5°)

J3,4 = 8.3
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1

C4 chair

3,O

2

B boat

SO skew-boat

2.83

0.75

2.74

1.32

3.39

4C
1

2.53

H-C4-C5-H (-176.5°)

J4,5 = 9.0

H-C1-C2-H (85.5°)

J1,2 = 0.8

H-C2-C3-H (-79.1°)

J2,3 = 1.7

H-C3-C4-H (75.2°)

J3,4 = 2.2

H-C4-C5-H (-80.2°)

J4,5 = 0.8

H-C1-C2-H (120.9°)

J1,2 = 3.1

H-C2-C3-H (-78.7°)

J2,3 = 1.7

H-C3-C4-H (91.4°)

J3,4 = 0.4

H-C4-C5-H (-147.0°)

J4,5 = 6.5

H-C1-C2-H (151.4°)

J1,2 = 7.0

H-C2-C3-H (175.2°)

J2,3 = 9.6

H-C3-C4-H (163.2°)

J3,4 = 6.9

H-C4-C5-H (-112.6°)

J4,5 = 2.0

chair

3,OB

boat

1C
4

chair

2S

skew-boat

O
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Table A-2. DFT-optimized structures (hydrogens and protecting groups have been
omitted for clarity in 3D ball and stick representations) and calculated coupling
constants of compound β-2.3

Conformation
3

S1 skew-boat

1

C4 chair

2

SO skew-boat

E (kcal/mol)

G (kcal/mol)

Dihedral angle (degrees)

Calculated J (Hz)

0.00

0.00

H-C1-C2-H (156.4°)

J1,2 = 7.5

H-C2-C3-H (-96.1°)

J2,3 = 0.3

H-C3-C4-H (66.9°)

J3,4 = 3.3

H-C4-C5-H (-100.0°)

J4,5 = 1.0

H-C1-C2-H (90.9°)

J1,2 = 0.8

H-C2-C3-H (-82.4°)

J2,3 = 1.3

H-C3-C4-H (73.8°)

J3,4 = 2.3

H-C4-C5-H (-77.2°)

J4,5 = 0.9

H-C1-C2-H (153.8°)

J1,2 = 7.3

H-C2-C3-H (178.0°)

J2,3 = 9.4

H-C3-C4-H (156.8°)

J3,4 = 5.9

H-C4-C5-H (-106.2°)

J4,5 = 1.4

1.66

4.33

2.24

4.72
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3S

1

1C
4

skew-boat

2S

O

chair

skew-boat

Table A-3. DFT-optimized structures (hydrogens and protecting groups have been
omitted for clarity in 3D ball and stick representations) and calculated coupling
constants of compound α-2.2

Conformation
1

C4 chair

E (kcal/mol)

G (kcal/mol)

Dihedral angle (degrees)

Calculated J (Hz)

2.10

0.00

H-C1-C2-H (-49.1°)

J1,2 = 1.1

H-C2-C3-H (-75.0°)

J2,3 = 2.2

H-C3-C4-H (74.7°)

J3,4 = 2.2
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4

C1 chair

0.00

0.39

1C
4

H-C4-C5-H (-80.6°)

J4,5 = 0.8

H-C1-C2-H (47.5°)

J1,2 = 5.7

H-C2-C3-H (-173.3°)

J2,3 = 8.5

H-C3-C4-H (174.9°)

J3,4 = 8.6

H-C4-C5-H (-176.7°)

J4,5 = 9.0

chair

4C
1

chair

Table A-4. DFT-optimized structures (hydrogens and protecting groups have been
omitted for clarity in 3D ball and stick representations) and calculated coupling
constants of compound α-2.3

Conformation
1

C4 chair

E (kcal/mol

G (kcal/mol)

Dihedral angle (degrees)

Calculated J (Hz)

0.58

0.00

H-C1-C2-H (-47.3°)

J1,2 = 1.3

H-C2-C3-H (-75.2°)

J2,3 = 2.1

H-C3-C4-H (74.8°)

J3,4 = 2.2
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4

C1 chair

0.00

1.07

1C
4

H-C4-C5-H (-79.5°)

J4,5 = 0.8

H-C1-C2-H (46.4°)

J1,2 = 5.8

H-C2-C3-H (-172.7°)

J2,3 = 8.5

H-C3-C4-H (174.6°)

J3,4 = 8.5

H-C4-C5-H (179.3°)

J4,5 = 9.1

chair

4C
1

chair

Table A-5. DFT-optimized structures (hydrogens and protecting groups have been
omitted for clarity in 3D ball and stick representations) and calculated coupling
constants of compound β-2.4

Conformation
1,4

B boat or unusual 4S2
skew-boat

E
(kcal/mol)

G
(kcal/mol)

Dihedral angle
(degrees)

Calculated J
(Hz)

0.00

0.00

H-C1-C2-H (54.7°)

J1,2 = 2.9
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4

C1 chair

2

SO skew-boat

3.09

1.84

2.89

4.88

H-C2-C3-H (-95.0°)

J2,3 = 0.3

H-C3-C4-H (149.3°)

J3,4 = 4.6

H-C4-C5-H (-178.4°)

J4,5 = 9.0

H-C1-C2-H (169.0°)

J1,2 = 7.8

H-C2-C3-H (-168.3°)

J2,3 = 8.0

H-C3-C4-H (173.5°)

J3,4 = 8.4

H-C4-C5-H (-177.3°)

J4,5 = 9.0

H-C1-C2-H (141.3°)

J1,2 = 5.1

H-C2-C3-H (178.8°)

J2,3 = 9.4

H-C3-C4-H (159.3°)

J3,4 = 6.3

H-C4-C5-H (-113.3°)

J4,5 = 2.0

4C
1

4S

2

skew-boat

2S

O

skew-boat

chair
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Table A-6. DFT-optimized structures (hydrogens and protecting groups have been
omitted for clarity in 3D ball and stick representations) and calculated coupling
constants of compound α-2.4

Conformation
4

C1 chair

E (kcal/mol)

G (kcal/mol)

Dihedral angle (degrees)

Calculated J (Hz)

0.00

0.00

H-C1-C2-H (59.7°)

J1,2 = 3.8

H-C2-C3-H (177.4°)

J2,3 = 9.6

H-C3-C4-H (176.6°)

J3,4 = 8.8

H-C4-C5-H (-175.3°)

J4,5 = 9.0

4C
1

chair
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α-2.1

CDCl3 600 MHz
Figure A-1: H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-α-Dglucopyranoside (α-2.1)
1

CDCl3 151 MHz
Figure A-2: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-α-Dglucopyranoside (α-2.1)

Matteo Panza | UMSL 2019 | Page 247

α-2.1

CDCl3 600 MHz
Figure A-3: 2-D NMR COSY spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-α-Dglucopyranoside (α-2.1)
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α-2.2

CDCl3 600 MHz
Figure A-4: 1H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-1-thio-α-D-glucopyranoside (α-2.2)

CDCl3 151 MHz
Figure A-5: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-1-thio-α-D-glucopyranoside (α-2.2)
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α-2.2

CDCl3 600 MHz
Figure A-6: 2-D NMR COSY spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-1-thio-α-D-glucopyranoside (α-2.2)
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α-2.3

CDCl3 600 MHz
Figure A-7: 1H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-Otriisopropylsilyl-α-D-glucopyranoside (α-2.3)

CDCl3 151 MHz
Figure A-8: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-Otriisopropylsilyl-α-D-glucopyranoside (α-2.3)
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α-2.3

CDCl3 600 MHz
Figure A-9: 2-D NMR COSY spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-diO-triisopropylsilyl-α-D-glucopyranoside (α-2.3)
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α-2.3

CDCl3 600 MHz
Figure A-10: 2-D NMR HMQC spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4di-O-triisopropylsilyl-α-D-glucopyranoside (α-2.3)
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β-2.2

CDCl3 600 MHz
Figure A-11: 1H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-1-thio-β-D-glucopyranoside (β-2.2)

CDCl3 151 MHz
Figure A-12: 13C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-1-thio-β-D-glucopyranoside (β-2.2)
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β-2.2

CDCl3 600 MHz
Figure A-13: 2-D NMR COSY spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otert-butyldimethylsilyl-1-thio-β-D-glucopyranoside (β-2.2)
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β-2.2

CDCl3 600 MHz
Figure A-14: 2-D NMR HMQC spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otert-butyldimethylsilyl-1-thio-β-D-glucopyranoside (β-2.2)
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β-2.3

CDCl3 600 MHz
Figure A-15: 1H NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-Otriisopropylsilyl-β-D-glucopyranoside (β-2.3)

CDCl3 151 MHz
Figure A-16: C NMR spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4-di-Otriisopropylsilyl-β-D-glucopyranoside (β-2.3)
13
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β-2.3

CDCl3 600 MHz
Figure A-17: 2-D NMR COSY spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4di-O-triisopropylsilyl-β-D-glucopyranoside (β-2.3)
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β-2.3

CDCl3 600 MHz
Figure A-18: 2-D NMR HMQC spectrum of Ethyl 6-O-benzoyl-2-O-benzyl-1-thio-3,4di-O-triisopropylsilyl-β-D-glucopyranoside (β-2.3)
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2.6

CDCl3 300 MHz
Figure A-19: 1H NMR spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.6)

CDCl3 151 MHz
Figure A-20: C NMR spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.6)
13
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2.6

CDCl3 300 MHz
Figure A-21: 2-D NMR COSY spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4di-O-tert-butyldimethylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-Dglucopyranoside (2.6)
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2.8

CDCl3 300 MHz
Figure A-22: H NMR spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.8)
1

CDCl3 151 MHz
Figure A-23: 13C NMR spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.8)
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2.8

CDCl3 300 MHz
Figure A-24: 2-D NMR COSY spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4di-O-tert-butyldimethylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-Dglucopyranoside (2.8)

Matteo Panza | UMSL 2019 | Page 263

2.9

CDCl3 300 MHz
Figure A-25: 1H NMR spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α/β-D-glucopyranoside (2.9)

CDCl3 151 MHz
Figure A-26: 13C NMR spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α/β-D-glucopyranoside (2.9)
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2.9

CDCl3 300 MHz
Figure A-27: 2-D NMR COSY spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-diO-tert-butyldimethylsilyl-α/β-D-glucopyranoside (2.9)
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2.10

CDCl3 300 MHz
Figure A-28: H NMR spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α/β-D-glucopyranoside (2.10)
1

CDCl3 151 MHz
Figure A-29: C NMR spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α/β-D-glucopyranoside (2.10)
13
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2.10

CDCl3 300 MHz
Figure A-30: 2-D NMR COSY spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-diO-tert-butyldimethylsilyl-α/β-D-glucopyranoside (2.10)
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2.11

CDCl3 300 MHz
Figure A-31: 1H NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α/β-D-glucopyranoside (2.11)

CDCl3 151 MHz
Figure A-32: 13C NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-O-tertbutyldimethylsilyl-α/β-D-glucopyranoside (2.11)
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2.11

CDCl3 600 MHz
Figure A-33: 2-D NMR COSY spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otert-butyldimethylsilyl-α/β-D-glucopyranoside (2.11)

Matteo Panza | UMSL 2019 | Page 269

2.12

CDCl3 300 MHz
Figure A-34: 1H NMR spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.12)

CDCl3 151 MHz
Figure A-35: C NMR spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.12)
13
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2.12

CDCl3 300 MHz
Figure A-36: 2-D NMR COSY spectrum of Methyl 6-O-(6-O-benzoyl-2-O-benzyl-3,4di-O-triisopropylsilyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside
(2.12)
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2.13

CDCl3 300 MHz
Figure A-37: H NMR spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.13)
1

CDCl3 151 MHz
Figure A-38: 13C NMR spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.13)
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2.13

CDCl3 300 MHz
Figure A-39: 2-D NMR COSY spectrum of Methyl 2-O-(6-O-benzoyl-2-O-benzyl-3,4di-O-triisopropylsilyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside
(2.13)

Matteo Panza | UMSL 2019 | Page 273

2.14

CDCl3 300 MHz
Figure A-40: 1H NMR spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α/β-D-glucopyranoside (2.14)

CDCl3 151 MHz
Figure A-41: 13C NMR spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α/β-D-glucopyranoside (2.14)
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2.14

CDCl3 300 MHz
Figure A-42: 2-D NMR COSY spectrum of Isopropyl 6-O-benzoyl-2-O-benzyl-3,4-diO-triisopropylsilyl-α/β-D-glucopyranoside (2.14)
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2.15

CDCl3 300 MHz
Figure A-43: H NMR spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α/β-D-glucopyranoside (2.15)
1

CDCl3 151 MHz
Figure A-44: 13C NMR spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α/β-D-glucopyranoside (2.15)
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2.15

CDCl3 300 MHz
Figure A-45: 2-D NMR COSY spectrum of Cyclohexyl 6-O-benzoyl-2-O-benzyl-3,4di-O-triisopropylsilyl-α/β-D-glucopyranoside (2.15)
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α-2.16

CDCl3 300 MHz
Figure A-46: H NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α-D-glucopyranoside (α-2.16)
1

CDCl3 151 MHz
Figure A-47: C NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α-D-glucopyranoside (α-2.16)
13
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α-2.16

CDCl3 300 MHz
Figure A-48: 2-D NMR COSY spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-α-D-glucopyranoside (α-2.16)
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β-2.16

CDCl3 300 MHz
Figure A-49: 1H NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-β-D-glucopyranoside (β-2.16)

CDCl3 151 MHz
Figure A-50: 13C NMR spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-β-D-glucopyranoside (β-2.16)
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β-2.16

CDCl3 300 MHz
Figure A-51: 2-D NMR COSY spectrum of Benzyl 6-O-benzoyl-2-O-benzyl-3,4-di-Otriisopropylsilyl-β-D-glucopyranoside (β-2.16)
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3.1

CDCl3 600 MHz
Figure A-52: 1H NMR spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-Dglucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-triO-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.1)

Matteo Panza | UMSL 2019 | Page 282

3.1

CDCl3 151 MHz
Figure A-53: 13C NMR spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-Dglucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-triO-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.1)
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3.1

CDCl3 600 MHz
Figure A-54: 2-D NMR COSY spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-Oacetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-Dglucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.1)
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4.6

Figure A-55: IR spectrum of Panzagel-Chloride
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4.7

Figure A-56: IR spectrum of Panzagel-NH2
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4.10

Figure A-57: IR spectrum of glycoconjugate 4.10
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4.2

CDCl3 300 MHz
Figure A-58: H NMR spectrum of Di (ethylene glycol) bis (4-vinylbenzyl) ether (4.2)
1

CDCl3 75 MHz
Figure A-59: 13C NMR spectrum of Di (ethylene glycol) bis (4-vinylbenzyl) ether (4.2)
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4.2

Figure A-60: 2-D NMR COSY spectrum of Di (ethylene glycol) bis (4-vinylbenzyl)
ether (4.2)
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4.8

CDCl3 300 MHz
Figure A-61: H NMR spectrum of Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-Dglucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.8)
1
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4.8

CDCl3 300 MHz
Figure A-62: 2-D NMR COSY spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-Oacetyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.8)
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4.9

CDCl3 600 MHz
Figure A-63: H NMR spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-O-acetyl-β-Dglucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-triO-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.9)
1
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4.9

CDCl3 600 MHz
Figure A-64: 2-D NMR COSY spectrum of 8-Acetyloxyoct-1-yl O-(2,3,4,6-tetra-Oacetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O(2,3,4-tri-O-acetyl-β-D-glucopyranosyl)-(1→6)-O-(2,3,4-tri-O-acetyl-β-Dglucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (4.9)
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Figure A-65: Thermogravimetric analysis (TGA) plots (black line) and Weight
derivatives curves (red line) of Panzagel-TMSOTf

Figure A-66: SEM images of Panzagel-TMSOTf
magnifications

polymer at a)100x and b) 150x
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Figure A-67: BET adsorption-desorption curves of the Panzagel

